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Abstract  
Introduction 
Osteoarthritis (OA) is a multifactorial musculoskeletal disorder and its aetiology is under 
investigation. Current research and therapeutic interventions for hip OA are limited. In early 
or advanced stages of hip OA, imaging techniques can be used to scrutinize overall structural 
and muscular changes in the joint such as bone marrow lesions (BMLs), hip cartilage defects, 
hip effusion-synovitis, bone shape and muscle health. Investigating these factors can provide 
information on interactive pathways vital for understanding the aetiology of OA. This thesis 
reports the results of six such investigations.  
Materials and Methods 
The Tasmanian Older Adult Cohort (TASOAC) is a large population based cohort study 
initiated in 2002. Older adults aged 50-80 years (51% female, mean age 62yrs) were enrolled 
into the study at baseline (Phase 1) with a first follow-up approximately 3 years later (Phase 
2), a second follow up (Phase 3) approximately 5 years from baseline and a third follow up 
(Phase 4) approximately 10 years from baseline. Hip and knee pain was assessed using the 
WOMAC (Western Ontario and McMaster Universities Osteoarthritis). Pedometers and a 
dynamometer were used to measure physical activity and muscle strength respectively. Hip 
structural abnormalities and hip muscle cross-sectional area (CSA) were assessed from MRI 
scans. Bone mineral density (BMD) was estimated by dual-energy x-ray absorptiometry 
(DXA). Morphological shape of the hip was assessed by Active Shape Modelling (ASM) 
imaging software and radiographic hip OA (ROA) was determined from X-rays.  
Results 
The first two studies focus on hip BMLs and their cross-sectional and longitudinal 
associations with hip and knee pain, high cartilage signal and BMD.  Overall, the proportion 
of hip BMLs at the femoral and/or acetabular site was 28%. About 8% of the population had 
a large hip BML. In the first study, those with large hip BMLs had greater hip pain. Incidence 
of larger hip BMLs (femoral and acetabular) was associated with an increase in hip pain. On 
the other hand, resolution of femoral BMLs was associated with a decrease in knee pain. 
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Additionally, 1 S.D increase in hip BML size was associated with worsening hip pain. High 
cartilage signal intensity was strongly associated with hip BMLs but not with hip pain. This 
study identified that hip BMLs associate not only with hip and knee pain but also with early 
changes in the hip cartilage. In the second study, irrespective of size, hip BMLs were found 
to be associated with local (total hip and femoral neck) BMD but not with distant (spine) 
BMD. Femoral BMLs were associated with higher femoral neck BMD while acetabular 
BMLs were associated with lower hip and femoral neck BMD. This novel study suggests that 
hip BMLs located in two different compartments might represent bone areas undergoing 
different pathological changes. 
  
In the third study, correlates of hip cartilage defects were examined. About 76% of the 
subjects had a hip cartilage defect. Any and grade 2 hip cartilage defects were associated with 
higher prevalence of hip pain. Any hip cartilage defects associated with lower muscle 
strength, particularly among men. The associations of grade 1 defect with high cartilage 
signal were stronger for men than for women. However, associations between grade 1 defects 
and BMLs were equivalent in both sexes. Grade 2 defects were linked with several outcomes 
such as hip BML, larger hip effusion-synovitis and hip ROA (in men), and lower steps per 
day. This study indicates that cartilage defects/damage, especially grade 2 hip cartilage 
defects are associated with major clinical and structural risk factors relevant to hip OA even 
in the general population.  
 
The fourth study describes the cross-sectional and longitudinal correlates of hip effusion-
synovitis.  Cross-sectionally, presence of hip effusion-synovitis at multiple sites was 
associated with presence of hip pain, and hip cartilage defects were associated with greater 
hip effusion-synovitis CSA. No other associations were found. Longitudinally, independently 
of each other, persistent hip BMLs and incident hip cartilage defects predicted larger hip 
effusion-synovitis size. However, change in hip pain from baseline to follow up and baseline 
hip ROA were not associated with hip effusion-synovitis. Additionally, baseline hip cartilage 
defects were associated with worsening hip BMLs at follow up. Similarly, baseline hip BMLs 
were associated with hip cartilage defects at follow-up. Overall, these results suggest that hip 
cartilage defects, hip BMLs and hip effusion-synovitis share possible causal pathways and 
the extent of hip effusion-synovitis might influence hip pain. 
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The fifth study explored the link between hip musculature (hip muscle CSA), muscle strength 
and bone mass (BMD). Among older adults, hip flexor CSA had the strongest association 
with BMD of the hip. The associations for pectineus and sartorius hip muscles CSA with 
BMD were stronger for women in comparison to men. Most of hip muscles CSA were 
associated with muscle strength and muscle strength was weakly associated with BMD. 
These findings suggest that for older adults, muscle bulk contributes to hip bone mass more 
so than muscle strength and maintaining muscle mass would aid in preservation of bone 
health. 
 
The sixth and the final study focused on hip morphology (shape) and its associations with 
various outcomes. Using Active shape modelling (ASM) imaging software and SHAPE 
software, hip shape was assessed and the first six principal components (modes) describing 
the variations in measurements of hip shape were extracted. These modes explained 68% of 
total hip shape variations in the sample population.  At baseline, modes 1, 2, 4 and 6 were 
associated with hip ROA, modes 1, 3, 4 and 6 correlated with hip cartilage volume and all 
except mode 2 with muscle strength. Higher mode 1, and lower mode 3 and 6 scores at 
baseline predicted greater hip pain at follow-up and higher mode 1 and mode 2 scores were 
associated with hip effusion-synovitis. Greater scores for modes 2 (decreasing acetabular 
coverage) and 4 (non-spherical femoral head) at baseline predicted 10-year total hip 
replacement (THR); while mode 4 alone correlated with bone marrow lesions (BMLs), 
effusion-synovitis, and increased cartilage signal.  
Conclusions 
Overall, structural changes are slow and relatively uncommon in the preclinical stages of hip 
OA. Nevertheless, hip BMLs, hip cartilage defects, high cartilage signal and hip effusion-
synovitis are inter-related and contribute to changes in the subchondral bone; with a probable 
role in the pathogenesis of hip OA. Additionally, muscle bulk and strength could aid in 
preservation of bone density and assessing bone shape using ASM could benefit in improving 
assessment and monitoring of disease progression and identifying those at higher risk of OA.  
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Definitions 
Osteoarthritis (OA) is one of the most prevalent forms of chronic and painful arthritis. 
Traditionally, OA was labeled as a degenerative non-inflammatory disease with cartilage loss 
as the central pathologic feature.1 This concept has been ‘remodeled’ mainly due to the 
introduction of MRI–based studies which demonstrated that pathogenesis of OA involves all 
the joint tissues with active anabolic and catabolic processes.1-3 Thus, OA is now defined as a 
disease of the whole organ/joint involving cartilage, subchondral bone, ligaments, menisci, 
peri-articular muscles, peripheral nerves and synovium. Furthermore, as OA progresses, 
abnormality in one component of the joint leads to changes in other components resulting in 
irreversible damage to the joint as a whole.4  
Epidemiology of OA 
OA is a slow and progressive musculoskeletal disease with a diverse aetiology, targeting 
single or multiple sites. OA commonly affects the knee, hip, spine4 and hand.5 Worldwide, 
about 10% of the population suffers from OA.6 It’s the 6th most common cause of disability7 
and one of the predominant causes of functional decline not only in aging but also in working 
population.8, 9 In Australia, 1.9 million people were reported to suffer from OA in 2012. 
Furthermore, it is projected that by 2034, OA would be one of the four most common and 
fastest growing musculoskeletal disorders.9  
Overall impact of OA  
The prevalence and incidence of OA is higher in women than in men.10, 11 Worldwide 
estimates of OA in men and women aged more than 65 years is 9.6% and 18% respectively.  
The incidence of OA, (irrespective of age) for men was 1.75 per 1000 population and for 
women 2.95 per 1000 population.11 When it comes to joints affected by OA, prevalence rates 
of knee OA are the highest in comparison to OA at the hip, hand, and spine.11 
Along with an increase in prevalence, the socio-economic impact of OA is steadily rising. In 
Australia, arthritis is the fourth most expensive group of diseases costing around 2.6 billion 
dollars annually.12 There is no adequate monitoring for the indirect costs and most of this 
expenditure is on hospitalisation and surgical procedures.12 For instance, in 2007 about 
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40,000 knee and hip replacement procedures were performed.13 However, in 2012 this 
number doubled to 85,000 joint replacements for both knee and hip, with each procedure 
costing an average of $15,000–$31,900.14  
OA is not life threatening, but the burden of the disease is substantial. An OA patient 
experiences not only pain and disability but may also experience an overall loss of health, 
psychological distress, reduced quality of life and loss of leisure time. These factors add 
towards loss of productivity mainly due to absenteeism and reduced work capacity.9 Thus, 
not surprisingly, years lived with disability (YLDs) in those with either knee or hip OA were 
greater in comparison to healthy people, and YLDs jumped from 10 million in 1990 to 17.1 
million in 2010.10 
Clinical Symptoms 
Joint pain is the major clinical symptom in OA. It’s usually episodic during early stages but 
with disease progression, pain becomes chronic.15 Other symptoms may include joint 
stiffness, joint instability, tenderness, crepitus, muscle weakness and variable degrees of 
inflammation.2, 16 Together, these symptoms cause major difficulties in daily activities such 
as working, walking, climbing stairs and housekeeping.  
Risk factors  
The pathophysiology of OA is driven by both systemic and extrinsic risk factors.17 Age is a 
primary, non-modifiable risk factor for OA. In general, over 30-50% of adults over the age of 
65 years develop OA.18-20 Ageing and OA are inter-related but not interdependent21 because 
rather than directly causing OA, age related changes in the joint make it susceptible towards 
other risk factors such as injury. Sex is another key risk factor for this musculoskeletal 
condition. In comparison to men, women tend to have a higher risk of incidence and severity 
of OA.7, 9-11, 22 Biological factors rather than hormonal factors may have a greater influence, 
as studies show that hormone replacement therapies have no impact on OA.7, 22  
Twin studies have demonstrated heritability estimates of OA ranging from 40-60% and 
ascertain that genetics have a significant role in OA.23-26  Surprisingly, these estimates are 
greater for hip and hand OA than for knee OA25 and it is hypothesized there may be certain 
genes protective against the development of knee OA.27 Thus, knee OA may be more 
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dependent on extrinsic risk factors rather than genetics in certain races. However, this notion 
needs to be confirmed as a recent study has demonstrated that the offspring of subjects who 
underwent total knee replacement (TKR) had a greater risk of developing knee OA.24 
Overall, a strong link between genetics and OA has been identified. However, OA is 
influenced by multiple loci (specific location of a gene) and each loci has a small effect 
(OR<1.2). Hence, for genetic mapping of OA, a very large sample size would be needed to 
discover any rare large-effect mutations.23 
With genetics playing a major role, it’s not surprising studies have demonstrated a variation 
in prevalence of OA across races and ethnicity. For example, older adults from China, in 
comparison with those from the US, had a lower prevalence of hip28 and hand OA.29 
Nevertheless, the prevalence of lateral knee OA was higher in both Chinese men and women 
compared to Caucasians.30 In the US, African Americans were more likely to develop knee 
OA than non-Hispanic whites31 and Caucasians.32  
Meta-analyses based on clinical and population-based studies show obesity is a significant 
risk factor for the incidence of OA.7, 33, 34 However, when it comes to disease progression it 
might be more of a mediator rather than a driving factor.33, 34 Obesity is strongly linked with 
knee and hand OA, but not with hip OA. In comparison to knee OA, the association between 
hand OA and obesity is weaker.35 This link between OA and obesity may be due to the 
involvement of biomechanical factors.36, 37 Additionally, studies show that excess leptin 
generated due to adiposity causes a decrease in the synthesis of extracellular matrix (ECM) 
and directly affects the cartilage and indirectly causes cartilage degeneration.35-38 Not 
surprisingly, bone marrow of the cancellous bone of the femoral head in those with end-stage 
hip OA had higher fat mass. 39 Thus, metabolic factors such as obesity and adiposity have a 
deleterious impact on the bone and cartilage.  
Micronutrients such as vitamin D have multiple roles in the musculoskeletal system. Studies 
demonstrated that those with lower levels of vitamin D and exposure to sun could be more 
likely to develop OA40, 41 and moderate vitamin D deficiency is associated with pain at both 
the hip and knee.42, 43 In addition, previous studies based on other micronutrients, such as 
vitamin C, demonstrated that it was protective against cartilage degeneration44 and incidence 
of OA45 and is also associated with lower knee pain.46 However, these findings are 
questionable because recent clinical trials show that intake of micronutrients (such as 
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Vitamin A, Vitamin C, Vitamin D or Vitamin E) separately or in a combination have no 
effect on arthritis or OA.42, 43, 47, 48   
Injury is a very common risk factor that places young, middle and elderly populations at a 
higher risk of developing OA. In older adults, a high impact injury involving many tissues is 
a significant risk factor for the development of accelerated knee OA.49 Although, less 
prevalent than knee injury, hip injury estimates a five-fold risk of incidence and progression 
of hip OA.50, 51 While injury might trigger OA, changes in joint alignment (a key determinant 
of load distribution) is also a well-known mechanical risk factor for OA progression.52 In 
OA, cartilage loss along with a decrease in joint space causes disproportionate transmission 
of loads leading to joint misalignment and deformities.53, 54  
Generally speaking, it is well demonstrated that OA is of a heterogeneous nature which 
makes it difficult to manage or control. Additionally, with several existing risk factors, two or 
more of these factors could be interdependent creating a pool of individuals who are more 
exposed to this disabling disease.  
Interrelationship between OA and osteoporosis (OP) 
OA and osteoporosis (OP) are common musculoskeletal disorders that may coexist within 
one population55. Nevertheless, their inter-relationship still remains unresolved, as a few 
reports suggest that there is an inverse relationship between the two while others demonstrate 
that all the subjects with OA may not necessarily develop OP.55-59 For instance, a study 
revealed that women who had sustained a recent fracture were less likely to develop 
radiographic OA57. These findings were supported by another study which found that those 
with OP had lower odds of knee OA.58 Nevertheless, other studies demonstrated that 
although there is an association between OA and increase in BMD, OA may not be protective 
against fractures.56, 59, 60  
The link between OP and OA may depend on various pathophysiological mechanisms, 
including genetic mechanisms. Recent studies have suggested that OA and OP might share 
genetic components and a few OA susceptibility genes have been shown to be associated 
with the disparity in BMD.61 In addition, subjects with high bone mass (HBM) may be more 
susceptible towards higher prevalence of hip OA and osteophytosis (multiple osteophytes).62 
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Further observations may provide clues into the pathogenesis of OA and how it relates to OP 
and vice versa.   
Changes in BMD are possible in those with OA but specific OP may or may not be found, 
and as discussed above these may be linked to several factors. A few recent studies have 
found sclerotic bone in women with end-stage knee OA who had a bone marrow lesion 
(BMLs).63 This small study put forth a new hypothesis, but it is unknown if BMLs are the 
link between OA and OP.  Similarly, studies have found that in subjects with and without hip 
OA there is a variation is muscle strength and reduction in muscle size64. Both, muscle 
strength and muscle size influence bone mass65, 66 and these three factors are inter-related 
with each other. Perhaps, this might be another cause of loss of bone mass in those with OA. 
Further details about BMLs, muscle size or strength and BMD have been discussed in other 
sections of this thesis. 
 
Treatment and management 
Overall, non-pharmacological and pharmacological treatments have been suggested for OA 
but pharmacological interventions such as non-steroidal anti-inflammatory drugs (NSAIDs) 
and analgesics may be more effective in managing symptoms of OA.67-70 However, there is a 
steady rise in evidence suggesting that a balance of both non-pharmacological and 
pharmacological interventions could be more beneficial for patients with OA. Intra-articular 
(IA) corticosteroids or hyaluronic acid (HA) injections can be used to manage moderate to 
severe OA71 but their long-term efficiency is questionable.68 There is an increased emphasis 
that bone-active treatments such as bisphosphonates could be effective in OA, but these are 
still in developmental stages.72-74  With limited effective treatments for OA, in advanced 
stages, due to pain and complete loss of joint function, joint replacement surgery is the only 
option. 
Although, the major risk factors of OA have been identified, current treatments fail because 
these are targeted on symptoms rather than disease process. Also, there is limited knowledge 
regarding the mechanisms behind pathophysiology of OA.  
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Hip OA  
Hip is the second most affected site by OA, reported in approximately one out of four older 
adults. Hip OA, may be divided into a continuum of four stages: an asymptomatic molecular 
phase, pre-radiographic phase, radiographic phase and final end-stage.1, 20, 75 Nevertheless, 
the progression of hip OA is very unpredictable and its natural history remains unclear. This 
is because osteoarthritic changes may or may not be precursors of hip OA. Thus, not all cases 
in the pre-radiographic phase progress into end-stage disease. Additionally, a recent 
systematic review reported that traditional prognostic factors such as age, body mass index 
and joint space narrowing (JSN) may be associated with incidence of hip OA but do not 
estimate its progression.8 Altogether, due to its non-linear development, lack of 
comprehensive data and inadequate knowledge of pathophysiological mechanisms, it is 
difficult to estimate or identify those at higher risk of hip OA.  
Detection and Diagnosis 
Techniques for assessing hip OA are slowly changing but for now radiographs remain the 
‘gold standard’ method for detection of OA. Several atlases have been published which 
provide comprehensive guidance for assessments of different stages of knee and hip OA.76-78 
Radiographic hip OA was first defined by Kellgren and Lawrence (K-L). Table 1-1 describes 
this simple and basic semi-quantitative method which is still widely used in both clinical and 
epidemiological studies. Radiographic assessment of hip OA includes assessing femoral or 
acetabular JSN and osteophytes. JSN (superior and axial) and osteophytes (femoral and 
acetabular) are traditional hallmark surrogate measures used to assess cartilage loss and 
disease severity.79, 80 While, greater JSN indicates loss of articular cartilage ;81, 82 osteophytes 
are bony outgrowths or spurs along the joint margins formed due to abnormal endochondral 
ossification. 17  
Other X-ray based techniques used to measure radiographic hip OA are minimal joint space 
(MJS) and croft grading system.83, 84 The K-L grading system is preferred due to its higher 
inter-rater reliability and proven proficiency to predict end-stage hip OA85 but it is non-linear 
and insensitive towards changes over time. For radiographic assessment of hip in this thesis; 
the Osteoarthritis Research Society International (OARSI) grading system based on Altman’s 
atlas was applied.76, 77 This grading system (Table 1-2) includes individual assessment of JSN 
8 
 
and osteophytes on a 4-point scale (grade 0-3). This method allows assessment of 
radiographic features either separately or altogether (as a total radiographic OA score). This 
scale was chosen because it is a standardized semi-quantitative technique for assessing 
radiographic features, has widespread accessibility, validity, and relevance in cross-sectional 
and longitudinal studies.85, 86  
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Table 1-1: The Kellgren and Lawrence (K-L) grading system for hip OA 
Definition grades Description 
Grade 0 No osteoarthritis  
 Grade 1 Doubtful  
Possible narrowing of the joint space medially and 
possible osteophytes around the femoral head; or 
osteophytes alone.  
Grade 2 Mild 
Definite narrow of joint space inferiorly, definite 
osteophyte and slight sclerosis. 
Grade 3 Moderate  
Marked narrowing with joint space, definite 
osteophytes, some sclerosis and cyst formation and 
deformity  
Grade 4 Severe 
Gross loss of joint space with sclerosis and cysts; 
marked deformity of the femoral head and 
acetabulum and large osteophytes.  
Hips classified as grade 2 or more were defined as having osteoarthritis.79 
 
 
Table 1-2: Individual radiographic features measured by the OARSI atlas for hip OA 
Feature Score 
Hip joint space narrowing (JSN)    
Axial  0-3 
Superior  0-3 
Hip osteophytes   
Superior femoral  0-3 
Superior acetabular  0-3 
OARSI: Osteoarthritis Research Society International 77 
Score ranging from 0 to 3 where 0= no disease and 3= most severe disease 
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The clinical diagnosis of hip OA is based on both radiographic and clinical factors. In 
comparison to radiographic assessments, the American College of Rheumatology (ACR) 
classification combines clinical, radiographic and laboratory findings for diagnosis of hip 
OA. 87 This diagnosis is chiefly based on hip pain, along with other symptoms such as 
changes in joint movement, morning stiffness, age and confirmation by negative laboratory 
testing. Such methods not only allow diagnosis of hip OA but also provide an opportunity for 
a differential.    
Assessment of pain is highly subjective and its intensity is variable. Thus, pain assessment in 
OA is a challenging task.  Hence, rather than using self-reported questionnaires which, only 
assess pain as yes or no; comprehensive pain scales that record intensity of pain, severity of 
disease and impairment of function are preferred. For instance, symptomatic hip OA can be 
evaluated using a VAS (Visual Analog Score).88 However, the hip specific WOMAC 
(Western Ontario and McMasters Universities Osteoarthritis Index)89 or HOOS (Hip 
disability and Osteoarthritis Outcome Score)90 are far more comprehensive scales and mostly 
preferred in epidemiological studies.  
Disadvantages of X-rays 
As X-rays are non-invasive and inexpensive they have been extensively used in large 
population-based studies. Nevertheless, meta-analyses reveal that hip radiographic features 
relate poorly with significant clinical features such as hip pain and also suggest that 
radiographic features have low prognostic value. In addition, X-rays provide limited 
visualization of the joint and are less sensitive to early degenerative changes and/or change in 
disease status over time.8, 75, 91  Due to these flaws, radiological assessments of hip OA could 
lead to higher measurement error in longitudinal and large multicentre-based clinical trials. 
Hence, to study temporal progression of hip OA at two or more time points, development of 
better techniques are required.  
Increasing importance of MRI 
Recent guidelines for clinical trials strongly recommend using both X-rays and MRI for 
assessment of OA.92 MRI is comparatively superior to conventional radiographs, as it 
provides high-spatial-resolution, multiplaner imaging, and excellent tissue contrast. MRI 
11 
 
allows a three-dimensional assessment of all the components of the joint along with the 
cartilage. Despite its exclusive features, only a few studies have used MRI’s to examine hip 
OA. Features including cartilage defects, bone marrow lesions (BMLs) subchondral cysts, 
paralabral cysts, osteophytes, labrum tears, synovitis, effusion and loose bodies have been 
used to develop semi-quantitative MRI-based scoring systems for overall evaluation of 
structural changes in hip OA.93, 94 Both, HOAMS (Hip osteoarthritis MRI scoring system) 
and SHOMRI (Scoring Hip Osteoarthritis with MRI) suggest assessing similar MRI features 
to evaluate hip OA on MRI. While hip OA features assessed in HOAMS associated with K-L 
grading system, hip OA features assessed in SHOMRI are associated with clinical 
parameters, K-L and OARSI radiographic grading systems.93, 94 Although the inter-rater 
reliability of these techniques is high, sensitivity and usefulness of such methods in 
predicting disease progression still need to be validated in larger studies.  
 
In the next sections of this review, important MRI-based and morphological determinants of 
early hip OA shall be described.  
Bone marrow lesions (BMLs)  
Bone marrow is a soft tissue found in the interior of long bones.95 It’s a compartment that is 
separated from the joint cavity by a very thin layer of bone and harbors fat cells (adipocytes) 
and a dense network of trabecular bone.96 A collection of immune cells and microvessels in 
the bone marrow replace the fat cells, leading to an increase of water content. Such 
inflammatory infiltrates adjacent to the subchondral bone are called bone marrow lesions 
(BMLs) (Figure 1-1).96 BMLs appear as non-specific, irregular areas of low signal intensity 
on T1 MRI’s or as  high signal intensity areas on T2 or STIR (Short T1 Inversion Recovery) 
MRI images.97 BMLs are not visible on X-ray, ultrasound (US), computed tomography (CT) 
or Doppler scans.98 
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                          Figure 1-1: An example of hip BML located in the femoral head. 
                                            
Studies have identified BMLs in subjects with hip osteonecrosis99, hip transient 
osteoporosis65 and femoral head stress fracture.100 In general, the pathophysiology of BMLs 
is heterogeneous and may very likely differ in different types of musculoskeletal conditions 
such as injury, tendinitis, osteoporosis, rheumatoid arthritis (RA) and OA.101 
Pathology of BMLs 
As only a limited number of histological studies have examined BMLs, its pathology remains 
fragmentary. From what is known, BMLs consists of fibrosis, lymphocytic infiltrates and 
increased vascularization with mostly a small amount of actual edema. Furthermore, BMLs 
in OA also contain bone marrow fat necrosis, trabecular fractures and areas of active bone 
formation/resorption.97, 101, 102  
 
The biochemical profile of BMLs present with some interesting insights. For instance, in a 
study, biochemical markers such as bone-specific alkaline phosphatase (bone ALP), 
osteocalcin (OC), procollagen Type 1 N-terminal propeptide (PINP) and C-terminal cross-
linking telopeptide (ICTP) were extracted from decompressed femoral heads. In comparison 
to those without a BML, samples of calcaneus bones with a BML had significantly elevated 
levels of these biochemical markers.103 These results suggest an increase in bone turnover in 
bone areas with BMLs. In addition, another study demonstrated that angiogenesis factors 
(formation of new capillary blood vessels) like VEGF and CYR61 were also elevated in bone 
cores with BMLs.97 In summary, BML patterns seen on MRI are most likely driven by 
elevation of biochemical markers and increased expression of cytokines and angiogenic 
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factors in the subchondral bone. Thus, presence of a BML adjacent to the subchondral bone 
may represent a local area of high bone turnover and the presence of such lesions might be a 
response of the bone towards a disease process.   
Significance of hip BMLs in OA 
BMLs were first described and identified in 1988 and their association with pain was 
demonstrated.104 In OA, the association between BMLs and end stage knee OA was 
confirmed in 2000.105 Over the years, several studies have demonstrated that participants with 
BMLs are at greater risk of worsening knee pain and larger BMLs correlate with higher 
intensity of knee pain.106-108 Reports based on longitudinal data present with similar evidence. 
For instance, increase in BML size was associated with an increase in knee pain while 
resolving BMLs were associated with a decrease in pain.106, 107, 109, 110 Additionally, larger 
BMLs not only predicted worsening pain but also greater cartilage damage.108 The current 
emphasis on BML has increased as BMLs play a crucial role not only as a ‘pain generator’ 
and associate with structural changes in cartilage and subchondral bone from early stages of 
the disease pathophysiology.97 Much is known about knee BMLs, but very less emphasis has 
been placed on BMLs at other sites, such as the hip.  
 
Hip BMLs were primarily described in MRI’s of twelve subjects with rapidly destructive hip 
osteoarthritis (RDOA). Hip BMLs along with extensive hip effusion and synovitis were 
found in MRIs of all the subjects. However, BMLs were not specifically studied.102 
Nevertheless, a subsequent study confirmed that hip BMLs patterns seen on MRI correlate 
with BMLs found on histopathological examination of the femoral head.111 In a study 
analyzing the role of hip BMLs in sixteen subjects with end-stage hip OA, some interesting 
primary results were presented. It demonstrated an association between weight bearing focal 
hip BMLs, hip pain, radiographic features and most of all micro-fractures in the subchondral 
bone.101 Subsequently, some preliminary research on hip BMLs has been carried out in a 
small set of MRI studies. Two of such studies focused on developing standardized scoring 
systems for hip OA which included hip BMLs. While these studies found no or modest 
correlations of hip BMLs with pain and other symptoms;93, 94 a small case-control study 
demonstrated that hip BMLs were not only associated with hip pain but also hip cartilage 
defects, particularly acetabular cartilage defects.112 These histopathological and semi-
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quantitative assessments of hip BMLs present with little evidence and there are no 
longitudinal or prospective population-based studies on hip BMLs.  
 
We know that knee BMLs play a far more extensive role; as these are transient and an 
increase or decrease in knee BML size may influence knee pain,106 knee structure113, 114 and 
also elevate the risk of subsequent knee joint replacement.107, 113 To make matters worse, 
BMLs due to their location and composition may cause bone demineralization, in turn 
affecting bone architecture rendering it vulnerable towards attrition.63, 106,  114, 115 And yet, the 
natural history of hip BMLs remains unexplored. Furthermore, existing data on hip BMLs is 
not generalizable and hardly puts any emphasis on the actual role of hip BMLs in the 
progression of hip OA.  
 
The interactive role of hip BMLs makes it a potential target for treatment of hip OA. Given 
the deficiencies in the data, studies describing the actual role of hip BMLs and exploring its 
pathophysiology may lay a foundation for future clinical trials. Thus, chapters 4 and 5 of this 
thesis focus on the associations of hip BMLs in a population-based cohort.   
Cartilage and OA 
Cartilage is a non-vascular structure found in various parts of the body, but articular cartilage 
is a type of hyaline cartilage specifically found on the joint surface. The hyaline articular 
cartilage is an alymphatic, aneural and avascular tissue predominately made up of ECM with 
chondrocytes. As it’s avascular it depends on synovial fluid and subchondral bone for 
nourishment.116 The cartilage is made up of four layers (zones) and each has its own distinct 
matrix as seen in Figure 1-2.117 The overall tensile meshwork of cartilage and its strength is 
due to its primary composition of ECM, type II collagen and PG (proteoglycan) Aggrecan.118  
 
Due to such properties, the cartilage can provide a frictionless surface for bones and plays a 
vital role in joint loading.119 The function of chondrocytes is to maintain the ECM, but these 
can be influenced by growth factors (GF), cytokines, adipokines, inflammatory mediators and 
matrix fragments leading to breakdown of the ECM.120 Also, deep and superficial lacerations 
(defects) in the cartilage, due to disease pathology or injury, can affect the ECM. Moreover, 
in OA the inflow of water increases into the cartilage (probably through defects) 
compromises its integrity and thus increases its susceptibility towards injury.  Unfortunately, 
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due to its avascular nature and lack of stem cells, the cartilage is difficult to regenerate or 
repair.121  
 
 
 
 
                             
Figure 1-2: Structure of the articular cartilage. Reproduced from Carry-Beth et.al 105 
 
Hip cartilage and high cartilage signal 
Due to the significance of joint cartilage, research involving cartilage morphology is in high 
demand.81 MRI has been widely used to calculate cartilage volume and assess structural 
damage in knees with and without OA. Some cross-sectional studies have utilized T2 MRI 
images to evaluate hip cartilage volume81 but measuring cartilage volume at the hip is a 
challenging task due to its three-dimensional shape and thin cartilage. Additionally, 
assessment of cartilage volume in longitudinal studies is susceptible towards measurement 
error due to a high CV (coefficient of variation). In OA, the idea behind measuring cartilage 
volume is to track and analyze changes in cartilage health, but for this purpose, other imaging 
predictors or techniques can also be applied.  
 
High signal intensity change is described as a variation in the signal intensity of the articular 
cartilage. It represents a break in any part of the hyaline cartilage through which water leaks 
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inside the cartilage and appears as a bright band visible on MRI (Figure 1-3).122, 123 This 
feature is visible in early stages of OA, however, in the later stages when articular cartilage 
may be replaced by fibrocartilage this signal might decrease or may not be visible on MRI.122 
Due to its characteristics it has been proposed that high cartilage signal can be a good 
predictor for estimating cartilage health.124 
 
                     
Figure 1-3: Presence of high cartilage signal and acetabular BML on a STIR MRI of the hip. 
 
Significance of high cartilage signal in hip OA 
In OA, high cartilage signal forms a part of the classification system for measuring changes 
in cartilage morphology of the knee.125, 126 For the hip, it was first mentioned in a small 
prospective study of eighteen subjects with the objective of developing a grading system to 
assess the severity of hip OA,122 but the authors did not describe correlations of cartilage 
signal. Nevertheless, in a second study, a decrease or increase in hip cartilage signal intensity 
was recorded and it was correlated with cartilage integrity. However, change in signal was 
not associated with pain.123 Cartilage is aneural and the presence of cartilage signal intensity 
is an indicator of cartilage breakdown.127 Therefore, it’s less likely to be associated with pain. 
However, this concept needs further consideration, as one study reported associations 
between cartilage signal change and knee pain.128 Newer studies describing MRI-based 
scoring systems for grading hip OA have not included this feature in the classification 
system93, 94 and instead describe changes in cartilage from grade 0-3 beginning with <25% 
cartilage damage. In general, change in cartilage signal intensity may be a useful predictor of 
cartilage integrity and features of this predictor can be confirmed by examining its 
associations with other characteristics of OA. 
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Significance of cartilage defects in hip OA 
Cartilage is a three-dimensional tissue with unique morphological features and biomechanical 
properties, and it is best visualised on MRI.129 Cartilage defects are superficial or deep 
breaches in articular cartilage that ultimately lead to ulceration of the subchondral bone. 
These generally start off as ‘micro defects’ or small cracks in the joint cartilage that widen 
over time.130  
The significance of cartilage in OA is now being debated; as many researchers suggest that 
other features of the joint need equal attention. The reason cartilage remains in the ‘limelight’ 
is because the joint depends on articular cartilage for smooth functioning and any change in 
joint structure due to extrinsic or systemic factors have a direct impact on the cartilage.17 For 
example, MRI-based studies have shown that structural changes in the knee joint due to 
injury (joint/ligaments),49, 131 meniscal tears,132, 133 knee BMLs107, 114 and knee effusion-
synovitis134 have a direct impact on the knee cartilage and encourages formation of knee 
cartilage defects and/or cartilage degradation. 
  
Even though cartilage is the susceptible target in incidence and progression of OA, apart from 
knee cartilage, in-depth examination of cartilage at other sites, including the hip has not been 
conducted. Hip cartilage defects were reported in asymptomatic young and elderly 
subjects,123 in those with RDOA102 and histopathological examinations of the femoral head of 
subjects with end-stage hip OA.101 However, these small cross-sectional studies did not 
report correlations of hip cartilage defects. In the last few years, there has been some 
development in research involving hip cartilage defects. For example, in a few small recently 
published MRI-based studies, hip cartilage defects was associated with radiographic hip OA, 
hip pain and hip BMLs.93, 112, 135 Also, hip cartilage defects are associated  with lower hip 
cartilage volume136 and obesity.137 However, no in-depth or longitudinal investigations based 
on hip cartilage defects have been carried out.  
 
Cartilage is non-restorable and as yet, no man-made material can replace it. Developing 
preventive or therapeutic techniques for hip OA could rely on decoding the pathophysiology 
of hip cartilage defects. However, the present data on hip cartilage defects is sketchy and 
comprehensive research or data describing the impact of hip structural abnormalities on hip 
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cartilage does not exist. Additionally, there are very few clinical trials or population-based 
studies examining changes in at hip cartilage. New techniques such as cartilage regeneration 
remain experimental, and there is no certainty that replacing the cartilage would halt the 
development of the disease. Thus, methods for repairing/restoring cartilage in OA may not be 
successful due to lack of information. Accordingly, chapter 5 of this thesis aims to identify 
the interactions of hip cartilage defects with clinical, demographical, structural and 
radiographic changes in older adults.  
Synovitis-effusion  
Synovial fluid (SF) is a viscous, straw-colored fluid present in cavities of synovial joints such 
as the hip and knee (Figure 1-4). The major source of SF is the synovial membrane (SM) 
which also nourishes the cartilage.116 SF has several biomechanical, metabolic and regulatory 
functions.138 One of its primary functions is to lubricate joint cartilage along with reducing 
friction. SF consists of two important components lubricin and hyaluronic acid (HA).116, 138 
These components are responsible for joint lubrication and also maintain the integrity of 
articular cartilage. Along with this, SM is responsible for removal of metabolites and 
products of matrix degeneration.116, 139  
                                              
Figure 1-4: Typical synovial joint (available and reproduced from the public domain).            
URL: http://study.com/academy/lesson/what-is-synovial-fluid-definition-function.html 
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SM inflammation occurs in OA, but it may not be the dominant driving force. However, 
synovitis-effusion is one of the factors in OA pathophysiology which contributes to higher 
joint pain and reduction of joint function.17 Additionally, at any stage of OA or other 
diseases, inflammation of the SM alters the composition and function of the SF, which in turn 
has an adverse effect on cartilage and surrounding joint tissue.139 Joint effusion can be 
visually distinguished from synovitis using contrast-enhanced gadolinium injection, but this 
technique is not commonly used due to potential side effects and high cost. Recently, the 
term effusion-synovitis has been proposed for effusion and synovitis because these two 
features cannot be differentiated by non-contrast MRI. 
 
Significance of hip effusion-synovitis in hip OA  
In regards to OA, the significance of synovial membrane is high due to its link with cartilage, 
joint structure, and clinical symptoms. Although, OA is not traditionally considered an 
inflammatory type of arthritis, ‘pain flares’ in OA subjects are common.115, 140 In addition, 
studies have revealed that inflammatory markers such as CRP (C-reactive protein) and TNF-
α (tumor necrosis factor-α) associate with knee pain, knee ROA and cartilage loss.141, 142 
 
Joint effusion can be visually distinguished from synovitis using contrast-enhanced 
gadolinium injection, but this technique is not commonly used due to potential side effects 
and high cost. Recently, the term effusion-synovitis has to be proposed for effusion and 
synovitis because these two features cannot be differentiated by non-contrast MRI.143 Clinical 
examination of effusion-synovitis is challenging, especially in deep joints like the hip,139 and 
MRI and US are the best non-invasive techniques to examine hip effusion-synovitis. Several 
types of studies, including MRI-based, have reported associations of knee joint effusion-
synovitis proving that it is one of the causes of knee pain, has an adverse effect on cartilage 
and is linked with radiographic knee OA.115, 134, 144-146 However, at the hip, limited literature 
exists and the current data is inconsistent.  
 
Hip effusion and synovitis were assessed individually and reported in those with RDOA and 
end stage hip OA. However, these studies did not describe the associations of hip effusion or 
synovitis.101, 102 A clinical based studied hip effusion-synovitis using US, and revealed that 
hip effusion-synovitis greater than 9 mm was associated with higher hip pain and severe hip 
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Radiological OA (ROA).147 On the other hand, a small subsequent retrospective study found 
no association between hip effusion and hip pain148. The results from subsequent two MRI-
based studies were also controversial. The first study reported that grade 1 but not grade 2 
synovitis was associated with hip pain, but hip effusion did not show any such associations.93 
In  the second study, no relationship between hip effusion-synovitis and hip pain was found.94 
It should be noted that the primary goal of these investigations was to validate a scoring 
system. However, in both studies, effusion and synovitis (assessed together or individually) 
were associated with severe hip ROA, but other correlates were not investigated. These 
differences in data could heavily rely on the sample population, disease severity and methods 
used to assess hip effusion-synovitis, and there is a need for further studies.  
 
Effusion-synovitis may be associated with hip ROA and only one study reports its association 
with hip pain. Given the impact of effusion-synovitis on the joint and lack of data, MRI-
based studies on hip effusion-synovitis are necessary. Data generated by such studies could 
be very beneficial in designing interventions targeting effusion-synovitis, which could in turn 
aid in controlling OA and preserving cartilage. Thus, chapter 6 in this thesis is the first 
population-based longitudinal study describing the correlates of hip effusion. 
Bone and muscles 
Muscles are responsible for smooth joint movements through muscle contractions and 
relaxations. Along with the joint capsule and ligaments, muscles are also accountable for 
joint stability and also contribute to physiological strength.149 Muscles insert into the bone 
and are further interlinked to the skeletal system by a dense network of nerves and vessels. 
Hence, a constant strain caused by muscles encourages bone remodeling because the bone is 
a dynamic tissue that is designed to meet mechanical demands.66 Along with the mechanical 
aspect, muscle-bone interlink is influenced by factors such as genetics, environment, lifestyle, 
hormones and pathology.150 Joint stability, especially of the lower limb, is important for high 
quality of life in those with chronic musculoskeletal disorders. OA is now considered a 
disease of the whole joint, and there is considerable loss of muscle mass and function in those 
with OA.17, 151 Thus, it has been suggested that along with structural assessment, a focus on 
muscle health is essential for subjects with OA.66, 152 
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Significance of muscles in hip OA 
Although the role of muscle is well known, its importance in OA has escalated recently as 
researchers and clinicians have started weighing the impact of physical activity on bone and 
cartilage.153, 154 Muscle health can be assessed in several ways and the simplest method is to 
use dual-energy x-ray absorptiometry (DXA). DXA calculates skeletal muscle mass, along 
with lean and fat mass. DXA has been used in several studies to describe the correlations 
between sarcopenia (loss of muscle mass) and changes in bone in those with OA.155-157 
Nonetheless, to study the physiological or anatomical effect of OA pathology on muscles, 
MRI and CT scans are superior to DXA because these imaging techniques can be used to 
visualize, quantify and assess muscles individually. Also, instead of measuring the entire 
muscle volume, a validated and surrogate measure termed muscle cross-sectional area (CSA) 
(Figure 1-5) is preferred.158  
  
                    
Figure 1-5: An example of assessment of hip muscle CSA (Sartorius and quadratus femoris) 
using T1 MRI images. Images obtained from TASOAC study. 
 
Although muscles are identified as important determinants of OA progression, only a handful 
of muscles have been studied. In a pain-free community-based study, vastus medialis and 
lateralis muscle CSA was positively associated with patellar cartilage and bone volume,159 
but in those with patellofemoral pain, there was a reduction in quadriceps muscle CSA.160 
Hence, OA pathology influences changes in muscle CSA. Joint pathology at one site, 
especially at the hip may affect muscles of the lower limb. For instance, in twenty-two 
subjects with and without hip OA, reduction in muscle CSAwas not only seen in muscles of 
hip such as gluteus but also in muscles of the knee such as vast and hamstrings.161 In 
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addition, in a study including eighteen women and four men with end-stage hip OA; atrophy 
of the hip, knee, calf and ankle muscle CSA was reported. Nevertheless, after total hip 
replacement (THR) or removal of joint pathology, all these muscles regenerated to a certain 
extent.162 This outcome could be due to the reduction of pain and/or improvement in joint 
biomechanics. However, it’s unknown if these subjects underwent rehabilitation and there 
have been no subsequent studies following up these results.  
 
Muscle atrophy could be  an indicator of changes in bone density because studies show that 
larger muscle CSA correlates with better bone structure and size.151 Changes in BMD are 
plausible in those with OA and maintaining muscle might be helpful but this concept has 
been sparsely studied. A small clinical trial based on post-menopausal women proposed that 
muscles involved in major skeletal movements, which insert into the bone and were local to 
the ‘affected joint’ might be worth targeting during rehabilitation for the preservation of local 
bone density.163 This might be very true because another study demonstrated that 
deconditioning of the hip joint (joint unloading) resulted in a decrease in bone density and 
muscle CSA .164  
 
Alterations in BMD may not be   an apparent symptom, but a loss in muscle strength due to 
muscle atrophy is a clear indication of loss in joint function in subjects with OA. Muscles are 
one of the main force generators and muscle strength and CSA vary with age and lifestyle.165 
For instance, in young athletes gluteal muscles were found to be strongly correlated with 
muscle strength, but in the elderly, quadriceps muscle CSA was correlated with knee 
extension strength during sit-to-stand testing.166, 167 The inter-relationship of muscle CSA and 
strength also relies on joint loading and muscle recruitment168 but not all muscles have 
identical intrinsic strength. For example, amongst young soccer players, the correlation of 
CSA of gluteus maximus with muscle strength was stronger in comparison to iliopsoas 
muscle CSA.166 This could rely on both joint loading and recruitment of muscle during 
activity. With aging and  muscle infiltration due to excess adiposity, muscles such as  
proximal gluteal muscle may become weak leading to lower  muscle strength and joint 
stability.169  
 
Muscle atrophy in OA could be a result of joint disuse, pathology or pain. Furthermore, 
muscle atrophy is one of the causes of further bone loss and it also causes a reduction in 
muscle strength, which affects the gait and in turn, daily activities. Yet, regardless of the 
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importance of muscles, the studies discussed above are small and have examined either one 
or two muscles. Additionally, most of them have not been conducted at the hip and the 
overall data is not generalizable. A study of hip muscle morphology and its associations with 
bone density and muscle strength could be a great addition to the literature and could provide 
a better insight into these aspects, especially in an older population (chapter 8).  
Bone shape and progression of OA  
End stage OA leads to deformation of the bone with severe cartilage damage and destruction 
of the surrounding joint tissue.101 Such changes are accompanied by thickening of the 
subchondral bone plate, higher bone mineral density (BMD), bone stiffness and change in the 
bone trabecular structure.170 It’s unknown when or how these changes are triggered, but these 
have a starting point which could determine the severity of the disease. As discussed earlier, 
hip OA is heterogeneous and not every case requires a THR. The severity of hip OA depends 
on the intensity of its progression and number of risk factors that an individual is exposed to. 
In addition, there is no known way to monitor or track the progress of hip OA because 
radiographs are insensitive to minor changes and frequent MRI’s may not be feasible.  
 
Gross geometrical measures have been applied to predict incidence and prevalence of hip OA 
and anatomical malformations of the hip.171, 172 Hip geometry has been vastly studied by 
using validated geometrical measures such as centre-edge angle or Wiberg angle, triangular 
index, hip-axis-length, femoral-neck-width etc. These geometrical measures have been used 
to predict hip-related anatomical malformations such as pistol grip deformity and 
femoroacetabular impingement in large population-based cohorts.172, 173 However, these are 
less sensitive to change, are liable towards higher measurement errors and do not provide a 
global assessment of bone. Thus, perhaps it’s time to shift our attention from the use of non-
linear semi-quantitative measurements to semi-automatic measurements, especially for three-
dimensional joints like the hip.174, 175 
Quantification of small and large variants in the bone morphology can be achieved by using 
software such as active shape modeling (ASM).174 ASM is an imaging tool which is widely 
used from face recognition to medical imaging.174 Overall, ASM is a method of analyzing 
differences in patterns of bone shape that have inherent variability. In ASM, radiographs, 
DXA and MRI images can be used to build semi-automatic computerized statistical models. 
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The ASM is used to build a Statistical Shape Model (SSM) using points that are placed 
around selected anatomical features (Figure 1-6). The ASM software then generates distinct 
hip shapes or modes of variations across the entire cohort. Each mode is a descriptor of 
change in hip shape a number of standard deviations (SD) away from the average shape of 
the entire cohort.176 All shape modes are independent of each other. Such quantitative 
assessments techniques have been used in studies to assess the shape of the knee177, spine178, 
179 and foot180. SSM can be applied to measure proximal femur shape and this method has 
several advantages over traditional geometric measurements as it captures a global bone 
shape rather than a limited subset of components of that shape.181  
 
                                                
Figure 1-6: Application of SSM to study hip shape.  
Image from the TASOAC study 
 
 
ASM is semi-automated computerized technique and easily reproducible. For instance, in a 
study using ASM models to investigate different shapes of the hip, the point to point 
variability between two observers (distance between a points coordinates when placed by 
each observer) has been reported as good as 1.3mm.175  In a subsequent study, ASM was used 
to assess spine on MRI images, and inter and intra-observer reliability was between 0.98-
1.00. In the same study, the relative error in the shape models was reported between 4-9%, 
much lower than conventional measurements.179    
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Significance of bone shape in hip OA 
In hip OA, SSM was first used to assess hips of one hundred and ten subjects with no 
radiographic hip OA at baseline. Three peculiar shapes of the hip (modes) at baseline 
projected incidence and severity of hip OA at the end of six years of follow-up. For instance, 
the sharp transition of the femoral head into the upper femoral neck (mode 3) or lower 
femoral neck (mode 6) at baseline was linked with a greater probability of development hip 
OA at follow-up. 170 In a subsequent study, shape variations in the femoral head and neck, 
along with anatomical disproportions in the proximal femoral head were significant in 
predicting the two-fold risk of hip OA. Such disproportions included a larger femoral head in 
comparison to rest of the hip joint.182  
 
These studies used plain radiographs to conduct hip measurements, but DXA images which 
are two-dimensional images generated by a three-dimensional scanner can also be used in 
ASM. In an SSM model of the femoral head which also included the acetabulum; it was 
demonstrated that changes in bone density and position of the femoral head in the acetabulum 
predicted a higher risk of hip pain. In this study, the shape modes that associated with clinical 
features did not associate with radiological features and vice versa.183 It could be assumed 
that the link of hip shape variations may be stronger with structural changes than clinical 
symptoms.184 Thus, different hip shapes may predict either clinical or radiological elements 
of hip OA.  
 
SSM, due to its accuracy and sensitivity, can be applied in monitoring and predicting hips at 
greater risk. SSM is being updated and tested to be used in the clinical field such as planning 
orthopedic surgeries.185 The application of SSM needs to be assessed further, especially in a 
large community-based population. SSM has the ability to identify hip shapes that predict hip 
OA or hip shapes that are protective against the development of hip OA. Studies based on 
this concept could have a dual outcome. Firstly, SSM can be used to monitor or track patterns 
of progression of hip OA and secondly it could help us understand the mechanisms behind 
these subtle bone changes.  
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Summary 
Prevalence of OA is high and with increasing age and obesity rates, its pace is estimated to 
grow in the near future. Today, a vast knowledge of OA exists but it’s mostly focused at the 
knee. OA of the hip is one of the major causes of disability and joint surgery in older adults, 
and yet only a few studies have focused on investigating its natural history. Evidence 
suggests that well known traditional prognostic factors of hip OA such as age and JSN may 
not be helpful in estimating the severity of the disease. Thus, there is a need for newer larger 
population-based studies to investigate the roles of BMLs, change in cartilage signal 
intensity, cartilage defects, effusion-synovitis, bone shape and muscles at the hip. These 
imaging biomarkers may not only be linked with clinical and radiographic OA but also with 
changes in the subchondral bone. Such studies could lay foundations for future research and 
help in identifying therapeutic targets for developing disease-modifying drugs for those 
suffering from OA.  
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Chapter 2  Research questions  
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Research questions 
The aim of this thesis is to study the hip as a whole joint and to describe the associations of 
major risk factors which might be involved in the pathogenesis of hip OA and if possible 
explain the conceivable mechanisms.  
Each chapter of this thesis attempts to describe one research question which then contributes 
towards the overall aim of the thesis 
Research questions:  
1) What are the cross-sectional and longitudinal associations between hip BMLs, hip and 
knee pain? Also, does change in hip cartilage signal associate with hip pain and hip 
BMLs? 
2) Are hip BMLs associated with hip, femoral neck and spine BMD?  
3) What are the associations of hip cartilage defects with hip pain, muscle strength, 
physical activity, hip BMLs, high cartilage signal, hip effusion-synovitis and hip 
ROA?  
4) Does hip effusion-synovitis associate cross-sectionally and longitudinal with hip pain, 
hip BMLs, hip cartilage defects and radiological hip OA? 
5) What are the cross-sectional associations between hip muscle CSA, muscle strength, 
and BMD of the total hip, femoral neck and spine?  
6) Hip shape, how does it relate to clinical features, structural and radiological changes 
in older adults with early hip OA? 
 
Key hypothesis 
 
1) Standardized and reproducible methods can be developed to assess hip structural 
changes (BMLs, defects, and effusion-synovitis), hip muscles and hip shape using hip 
MRI and DXA images.  
2) Changes in hip structure, muscles and hip shape are associated with clinical, 
demographical, subchondral bone changes and radiographic factors relevant for the 
pathophysiology of early hip OA. 
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3) Structural changes at the hip might be co-dependent on each other, and have a causal 
link relevant to the pathogenesis of early hip OA.  
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Chapter 3 Materials and methods 
 
 
 
 
 
Preface 
The research reported in this thesis is based on the data collected on participants in the 
Tasmanian Older Adult Cohort (TASOAC). This chapter describes the TASOAC study and 
its design, and provides an outline of the protocols of measurement that were used. Further 
specific details are provided in each chapter.  
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Subjects 
The TASOAC study is a prospective, population-based study that was initiated in 2002. The 
goal of this study was to identify the environmental, genetic and biochemical factors 
associated with the development and progression of OA at multiple sites including the hand, 
knee, hip and spine. Using a sex-stratified random sampling technique, older adults between 
the ages 50-80 years were selected from the state electoral roll for Southern Tasmania 
(population 229,000). Electoral rolls represent a complete listing of Australian residents that 
is available because voting in state and federal elections is compulsory and, the coverage of 
the population is comprehensive. The sample was stratified by sex to provide an equal 
number of men and women in Southern Tasmania. The TASOAC study was designed to 
cover community-dwelling older adults and institutionalized older adults were excluded. 
Additionally, as MRI was a requirement to assess OA progression, participants were 
excluded if they reported any contraindication for magnetic resonance imaging (MRI).  
 
Figure 3-1 provides an overview of the recruitment of study participants. Of the 2135 eligible 
participants, 1100 were enrolled in the study, and 1,099 attended a baseline (Phase 1) clinic 
between March 2002 and September 2004. The overall response proportion was 51.5%.  
Follow-up data (Phase 2) was collected for 875 participants at a clinic 2.6 years later, and 
then again for 769 participants (Phase 3) at a clinic approximately 2.3 years after Phase 2. A 
third follow-up (Phase 4) was conducted for 568 participants at a clinic approximately 5 
years after Phase 3.   
 
The sub-sample analysed in this thesis included those who had a hip MRI scan at Phase 2 
(n=228) and/or Phase 3 (n=215). The MRI images from Phase 2 and Phase 3 were used in all 
the studies reported in this thesis other than the final study (Chapter 9), for which DXA 
images were used. 
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Figure 3-1: Flow chart of TASOAC study 
describing recruitment and participation from phase 1 to phase 3 
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Measurements 
Anthropometrics 
Demographic characteristics, medical history and lifestyle factors were assessed by self-
administered questionnaires. Weight was measured to the nearest 0.1kg with shoes, socks and 
bulky clothing removed) using a single pair of electronic scales (Seca Delta Model 707, 
Hamburg, Germany). Height was measured to the nearest 0.1cm using a stadiometer (with 
shoes, socks and bulky clothes removed). Body mass index (BMI) was calculated.  
Clinical measures 
Hip and knee-specific Western Ontario and McMaster Universities Osteoarthritis (WOMAC) 
index pain score was assessed for each subject. Physical activity and muscle strength was 
calculated using pedometers and dynamometer. BMD was calculated using DXA scans and 
radiographic hip OA (ROA) was assessed using X-rays. These measures and their relevant 
methods of assessments have been described in details in the relevant chapters of this thesis. 
Examples of hip and knee WOMAC and pedometer diaries have been included in the 
appendices I-IV.  
Magnetic Resonance Imaging (MRI) 
For those with a hip MRI, the right hip was imaged in the sagittal plane using a 1.5 Telsa G.E 
signal whole-body magnetic resonance unit with a phased-array flex coil. Two types of MRI 
sequences were used.  
T1-weighted sequence 
Details of the sequence are as follows: T1-weighted fat-suppressed 3-dimensional gradient-
recalled acquisition in the steady state; flip angle 55 degrees; repetition time 58 ms; echo time 
12 ms; field of view 16 cm; 60 partitions; 512 x 512–pixel matrix; acquisition time 11 mins 
56 s, and one acquisition. Sagittal images were obtained at a partition thickness of 1.5 mm 
with an in-plane resolution of 0.39 x 0.39 mm (512 x 512 pixels).  
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STIR (Short T1 inversion recovery)-weighted sequence  
Details of the sequence are as follows: STIR-weighted, fat saturation two-dimensional fast 
spin echo sequence; repetition time 4340 ms, echo time 28.4 ms; field of view 20 cm; 15 
partitions (16 slides) and 512 x 512-pixel matrix. Sagittal images were obtained at a slice 
thickness of 3.5 mm with an inter slice gap of 1.5mm.  
OsiriX imaging software  
All MRI-related semi-quantitative and quantitative measurements were conducted using 
OsiriX software (University of Geneva, Geneva, Switzerland). OsiriX is imaging software 
(32-bit Mac version) that allows DICOM images generated by MRI to be uploaded and 
visualized in multiple planes. This software allows visualization of both bony and muscular 
aspects of the joint.  
Measurement of hip BMLs 
Subchondral hip BMLs were quantitatively assessed on STIR-weighted MRI images using 
OsiriX. BMLs were identified as irregular areas of increased signal intensity adjacent to the 
subchondral bone on the femoral head and/or the acetabulum. Once the BML was identified, 
the observer (HA) selected the MRI slice with the largest BML. To quantitatively assess the 
BML size, contours were drawn around the outer edges of the lesion (Figure 3-2a). The 
maximum cross-sectional area (CSA) of the hip BML was recorded in cm2. The BML was 
classified as a femoral BML if present in the femoral head, or as an acetabular BML if 
present in the acetabulum. If more than one BML was present at either site, the size of the 
larger BML was recorded. In a reliability study (n=25) with re-measurement of BMLs after 
two weeks, the intra-class correlation coefficient (ICC 1,3) for hip BML CSA was 0.98. 
High Cartilage Signal 
The presence of high cartilage signal at the hip joint was defined as high signal intensity band 
within the cartilage either adjacent to the hip BML or at any location on the MRI slice if there 
was no BML. High cartilage signal was measured semi-quantitatively on STIR MRI images 
and was graded as 0 for absent and 1 for present (Figure 3-2a). These were measured together 
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with hip BMLs by the same observer (HA). In a reliability study (n=25), the intra-rater 
agreement (kappa) for presence of high cartilage signal was 0.88. 
Hip cartilage defects 
Hip cartilage defects were identified as any change in the hip cartilage at either the femoral or 
acetabular site. Hip cartilage defects were assessed on STIR MRI images. The scoring 
algorithm was an adaptation of previously-used semi-quantitative methods for knee 
cartilage107, 126. Hip cartilage defects were categorized as follows: grade 0 = normal hip 
cartilage, grade 1= focal blistering or irregularities on the hip cartilage surface or a partial 
thickness defect, and grade 2= full-thickness hip cartilage defect with bone ulceration and/or 
exposure of bone.  If a hip cartilage defect was located at the femoral head, it was labelled as 
femoral cartilage defect and if a hip cartilage defect was located at the acetabulum it was 
labelled as acetabular cartilage defect. If more than one hip cartilage defect was present at 
one site, the highest score was used. Assessment of hip cartilage has been demonstrated in 
Figure 3-2b. All the measurements were carried out by one observer (HA). In a reliability 
study of 40 subjects with re-measurements after four weeks, the intra-rater agreement (kappa) 
was 0.89.186 
Quantitative assessment of hip effusion-synovitis  
Hip effusion-synovitis was assessed as presence of intra-articular fluid-equivalent signal on 
sagittal STIR MRI. The MRI sequence used to examine hip effusion-synovitis did not allow 
separation of physiological and pathological effusion. The observer (HA) selected the MRI 
slice with the largest effusion-synovitis and the maximum CSA of hip effusion-synovitis was 
assessed and recorded (Figure 3-2c). If the effusion-synovitis was present in more than one 
site around the femoral head (anterior, posterior or both), then the largest CSA of effusion-
synovitis on each site was measured. In the reliability study of 40 subjects with re-
measurements after four weeks, the intra-rater agreement (kappa) for presence of hip 
effusion-synovitis was 0.84, and the ICC (3, 1) for hip effusion-synovitis CSA was 0.97. 
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Measurement of muscle cross-sectional area (CSA) 
Hip muscles were identified within the MRI field of view as shown in Figure 3-2. 
Measurements of muscle CSA, of clearly defined muscles for which the entire area of the 
muscle was visible and distinguishable from any adjacent muscles, were made at the 
anatomical landmarks described in Chapter 8. Muscle CSA (cm2) of eight hip muscles 
gluteus maximus, obturator externus, Gemelli (superior and inferior), quadratus femoris, 
piriformis, pectineus, sartorius and iliopsoas was assessed. Figure 2d demonstrates 
assessment of iliopsoas hip muscle CSA. The CSA of each muscle was measured on two 
consecutive slices by the observer (HA) and the average was used as the final measurement.  
If any of the hip muscles were not distinguishable from adjacent muscles, they were not 
measured; hence, not all eight muscles were measured for all subjects. All hip muscles, 
except iliopsoas, were measured on sagittal MRI images. For better visualization, iliopsoas 
was measured by reformatting the whole sagittal plane into an axial plane. In a reliability 
study of 40 subjects with re-measurements after two weeks, the ICC (3, 1) for hip muscle 
CSA ranged from 0.98 to 0.99. 
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Figure 3-2: Methods for assessment of MRI-related hip features. 
a) acetabular BML CSA and high cartilage signal. b) Categories of hip cartilage defects. c) Hip 
effusion-synovitis CSA. d) Hip muscle (iliopsoas)  CSA. 
 
 
 
Figure 3-3: Approximate MRI field of view used for identifying hip muscles to be measured. 
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Radiological assessment 
Anteroposterior radiographs of the hip were assessed by two trained readers using the OARSI 
(Osteoarthritis Research Society international) grading system. The radiographic features of JSN and 
osteophytes of the right hip were graded on a 4-point scale, ranging from 0 to 3 where 0=no disease 
and 3=most severe disease by using an Altman’s atlas.  The intra-observer reliability for x-rays was 
carried out in 40 subjects and the ICC scores ranged from 0.60-0.87.  A non-zero score of either JSN 
or osteophytes was regarded as evidence of hip ROA. Thus, after combining JSN and osteophytes 
score, the presence of hip ROA was defined as a total score of 1 or greater. 
 
Measurement of hip shape using dual-energy X-ray absorptiometry (DXA) 
images  
At Phase 1, DXA images were taken of the left hip using a Hologic Delphi scanner. These 
images were extracted from the hologic data files (p files) using custom-made Matlab 
software (Math Works Inc, Natick, United States) and saved as 8bit BMP files as described in 
Figure 3-4. Once the images were converted they were uploaded in imaging software’s 
customized for assessing bone shape.  
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Figure 3-4: Flow chart describing processing of DEXA images for measuring hip shape. 
 
 
Statistical shape modelling (SSM) 
To quantify the morphology of the proximal femoral head, two types of imaging software 
were used. These were the ASM (Active Shape Modeling) toolkit (Manchester University, 
Manchester UK)174, 176 and SHAPE (University of Aberdeen, UK) software. The processed 
DXA images were transferred to a workstation and ASM was used to develop an 85-point 
model (Figure 3-5a).  This model was designed not only to evaluate proximal femoral head 
shape but also the shape of the acetabulum and any osteophytes. The SSM template is a set of 
landmark points that define the shape to be identified. For comparison between several 
images, each point is placed at the same feature of the outline of the bone. Two types of 
points are used. The key points are placed at well-identified anatomical landmarks such as 
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beginning of greater trochanter, the highest point of the greater trochanter, higher and lower 
points of lesser trochanter; while the remaining points are evenly placed between the key 
points.  
 
 
Figure 3-5: Examples of SSM of hip  
a) Illustration of 85-point shape model in ASM tool kit software b) Demonstrates the hip 
shape model in SHAPE software. c) Rechecking of data image generated by Matlab. 
 
Once the measurements were compiled in (X, Y) coordinates using the ASM tool kit, the 
information was transferred onto SHAPE software in the form of a ‘point file’. The point file 
included the coordinates of each of the 85 points of the SSM model for each subject. The data 
were aligned into a common coordinate frame using Procrustes Analysis which translates, 
rotates and scales each shape so that it minimizes the sum of squared distances from the mean 
of the set.176 The 85-point model was then compared with the DXA images to check the 
alignment of the points against the anatomical features, with adjustments made if necessary 
(Figure 3-5 b & c). The distribution of the data for all subjects was examined as a two-
dimensional point cloud, allowing further checking for discrepant values (Figure 3-6). The 
SHAPE software was then used to extract the principal components of the data (each is 
referred to as a mode of shape). The first six principal components explained 68% of the 
variation of the data as shown in the scree plot in Figure 3-7. These shape modes have been 
extensively explained in chapter 9.  
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Figure 3-6: Two-dimensional point cloud of the hip shape data. 
 
 
 
 
         
 
       Figure 3-7: Scree plot representing variance and cumulative variance for 40 shape modes 
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Outcome factors, study factors, and covariates This research aims to gain further 
understanding of the pathophysiology of hip OA and to attain this goal it was critical to 
investigate the associations between clinical, radiological and MRI-related features pertaining 
to early hip osteoarthritic changes. Hence, each chapter of this thesis focuses on one 
structural change, describes its correlates and attempts to describe its relevance in early hip 
OA. Table 3-1 presents a summary of the outcomes, study factors and covariates involved in 
the analyses of each chapter that is included in this thesis.  
 
Table 3-1: Summary of the outcome factors, study factors and covariates 
Chapter  Outcome factors   Study factors   Covariates 
4 Hip and knee pain*  Hip BMLs and high 
cartilage signal  
 Age, sex BMI  
5 Total hip, femoral neck 
and spine BMD 
 Hip BMLs   Age, sex, BMI and 
spine BMD 
6 Hip pain*, hip BMLs, high 
cartilage signal, hip ROA* 
and hip effusion-synovitis 
 Hip cartilage 
defects 
 Age, sex, BMI and 
hip BMLs. 
7 Hip pain*, hip BMLs, high 
cartilage signal, hip ROA* 
and hip cartilage defects  
 Hip effusion-
synovitis 
 Age, sex, BMI, hip 
BMLs and hip 
cartilage defects  
8 Total hip, femoral neck 
and spine BMD   
 Muscle CSA  
Muscle strength 
 Age, sex, BMI and 
spine BMD. 
9 Hip pain*, muscle strength, 
hip cartilage volume*, hip 
BMLs, hip cartilage 
defects, hip effusion-
synovitis, hip ROA* and 
THR*  
 Hip shape   Age, sex, BMI, hip 
BMD.  
* The measurement protocol used is described in the “Material and Methods” section of the 
relevant chapter. 
BMLs: Bone marrow lesions, BMI: Body mass index, BMD: Bone mineral density, ROA: 
radiographic osteoarthritis, CSA: Cross-sectional area.   
 
44 
 
Sample size and the role of candidate in the TASOAC study  
Data for the TASOAC study at Phase 1 (baseline), Phase 2 (first follow-up) and Phase 3 
(second follow up) was already collected before the commencement of the candidate’s PhD. 
Thus the number of participants included in each study reported in this thesis was limited to 
the numbers recruited at each phase of the TASOAC study, and for those whom 
measurements of the relevant outcome and study factors were available. All those with 
complete data on relevant outcomes and study factors were included in analyses of each 
study. The reasons for exclusion of other subjects have been exclusively described in each 
chapter. In consequence, formal sample size calculations were not undertaken as a part of the 
design of the studies reported in this thesis.  
 
The candidate was involved in TASOAC data acquisition and collection, data management, 
data analyses and interpretation of results. The candidate was responsible for drafting and 
revising each manuscript. The candidate assisted in data collection at phase 4.  Data 
acquisition for this study was conducted by a number of TASOAC staff and volunteers, 
including Prof Graeme Jones, Prof Chang-hai Ding, Dr. Dawn Aitken, Catrina Boon, Dale 
Pitt, Bronwyn Archer, Pam McDonald, Dr. Stella Foley, Tim Albion, Alistair Chilcott and 
Dr. David Scott. Many colleagues had begun using TASOAC data before the candidate 
commenced her Ph.D. The candidate gratefully acknowledges Dr. Guangju Zhai for 
measuring hip cartilage volume, and Dr. Dawn Aitken for cleaning and managing the datasets 
of measurements by DXA, pedometer counts, THR and muscle strength. 
Ethical considerations  
All procedures in the TASOAC study were approved by the Southern Tasmanian Health and 
Medical Human Research Ethics committee (Ethics Approval number: H6488). Written 
informed consent was obtained from all the participants prior to enrolment in the study.  
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Statistical analyses  
T-test and chi-squared tests were used to compare differences in means and proportions as 
required. A p-value of <0.05 (two-tailed) was considered statistically significant. In several 
chapters, data on subjects at Phase 2 and Phase 3 were combined in analyses, and the 
correlation between repeated measurements on individuals was taken into account by 
adjusting standard errors using the sandwich (robust) estimator of variance. This sandwich 
estimator was developed by Huber187 and White.188 This estimator produces consistent 
standard errors from clustered data provided that the clusters are drawn as a simple random 
sample from its population.189 The clusters in our analysis are repeated observations on the 
same person and that person was selected randomly from the population of southern 
Tasmania. Under this sampling design, the repeated observations within the clusters may not 
be treated as independent but the clusters are independent. The Huber-White method is 
generalized to this setting by substituting for the meat of the sandwich, a matrix formed from 
the outer product of the cluster-level score, where within each cluster the cluster-level score 
is obtained by summing the observations. William et.al190 provides a general proof that this 
modified sandwich estimator is unbiased for cluster-correlated data regardless of the setting. 
This method has been described briefly in each study. Besides clustering, several other 
methods were applied to investigate the associations between outcomes and exposures and 
these have been described in detail in each chapter. All statistical analyses were performed on 
Intercooled Stata version 12 (Stata Corp, college station, TX, USA) 
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Preface 
 
The aim of this thesis is to study the hip as a whole joint and to attempt to provide probable 
mechanisms relevant to the progression of hip OA. From here on, each chapter of this thesis 
addresses one research question which then contributes towards the overall aim of the thesis.  
All the chapters of this thesis are based on TASOAC cohort. This is a prospective population-
based study which includes older adults between the ages of 65-80 years with mostly mild 
clinical or radiographic evidence of hip OA. Thus, in this thesis, we have referred to this 
cohort as ‘preclinical hip OA’ or ‘early hip OA’.  
Chapters 4-7, examine the associations of structural changes at the hip. These structural 
changes include hip BMLs, change in high cartilage signal, hip cartilage defects, and hip 
effusion-synovitis. Thus, each chapter focuses on only one structural change (except for 
BMLs) and reports its associations with various outcomes relevant for hip osteoarthritis. 
Chapter 8 describe the association of hip muscles with muscle strength and bone mineral 
density and Chapter 9 aims to describe the associations of hip shape (morphology) over the 
period of 10-years 
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Chapter 4 : A population-based study of the association between hip bone 
marrow lesions (BMLs), high cartilage signal and hip and knee pain.  
 
 
 
 
 
 
Published in the Journal of Clinical Rheumatology  
2013, 33:369-376 
Harbeer Ahedi, Dawn Aitken, Leigh Blizzard, Flavia Cicuttini and Graeme Jones  
 (Original article included as Appendix V) 
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Introduction 
Osteoarthritis (OA) is a disease of the whole-organ characterized by gradual loss of articular 
cartilage. The prevalence of hip OA is lower than knee OA but is still a major cause of 
disability in the elderly.2 Pain is one of the most common and important clinical symptoms in 
OA and has multiple causative factors.2 Bone marrow lesions (BMLs) are now recognized as 
one of the key features in knee OA where they are associated with pain, cartilage loss107, 191 
bone density63, 192 and joint replacement.107, 113 Studies demonstrate that participants with 
BMLs are at greater risk of worsening knee pain and size or grade of BMLs is correlated with 
intensity of knee pain.106, 107, 193 Longitudinal studies show that an increase in BML size is 
associated with an increase in knee pain106, 107, 110 while resolving BMLs were associated with 
a decrease in pain. 107, 109 Recent data also suggests hand BMLs are independently associated 
with joint tenderness. 194 Evidence to date suggests that the association between BMLs and 
pain is local but it’s unknown if the presence of BMLs at one joint is independently linked 
with painful adjoining joints.  
 
To the best of our knowledge, there are very few studies on hip BMLs in relation to hip OA. 
In a retrospective MRI-based study involving 12 participants with advanced hip OA, Boutry 
et.al reported presence of hip BMLs in all the participants. Of these, all had femoral BMLs 
and 10/12 had acetabular BMLs. Histopathologically, the femoral head revealed severe 
degenerative changes, subchondral defects and articular trabecular fractures with fatty bone 
marrow.102 In a recent study, Taljanovic et.al evaluated the cross-sectional relationship 
between bone marrow edema size, clinical and radiological findings in hip OA in 16 
participants. Despite the small sample size, focal bone marrow edema was found to correlate 
with hip pain (r=0.51, p<0.05). Further, in the same study subjects with hip BMLs had 
greater radiographic scores.101 Additionally, Roemer et.al used a semi-quantitative method to 
assessed hip BMLs and found no association between hip pain and hip BMLs although 
subjects with large hip BMLs tended to have higher odds of hip pain.93 Nevertheless, no 
longitudinal studies have described the association between hip BMLs and hip pain. 
 
Referred pain is common in OA and its occurrence may be due to neurological or 
biomechanical factors.195 Studies have reported about 50% of subjects with hip pain also 
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report knee pain.196 Khan et.al demonstrated that 27% of subjects awaiting total hip 
replacement (TKR) reported knee pain and it escalated (57%) in subjects requiring revised 
TKR.195 Lastly, we have demonstrated an association between hip joint space narrowing 
(JSN) and knee pain.197 Thus, it is possible that BMLs in the hip may also associate with knee 
pain but this concept has not been explored as yet.  
 
Besides pain, BMLs of the knee are also associated with cartilage defects and volume.114, 198, 
199 However, the assessment of cartilage volume and defects at the hip is challenging due to 
the complex structure of the hip joint. Although, these have been utilized in some studies93, 
197, additional techniques are required for assessing hip cartilage in a larger cohort. High 
cartilage signal is described as change in signal intensity of the articular cartilage due to 
increased water content in cartilage, which appears as a bright band in the cartilage on T2 
MRI images.122, 124, 128 Studies suggest that before formation of cartilage defects or cartilage 
loss, vascularization and calcification of cartilage leads to changes in cartilage signal 
intensity.122, 128, 200 Totterman S.M et.al developed a quantitative method to analyze bone and 
cartilage of the knee, to test the longitudinal association between change in cartilage signal, 
progression of knee OA and pain. The authors found that signal intensity of central femur 
regions was correlated with progression of knee OA and change in signal intensity in medial 
and lateral femoral compartments was associated with change in knee pain.128, 200 To date, 
there are no studies at the hip. 
Hence, the aim of this population-based study was to describe the cross-sectional and 
longitudinal relationship between hip BMLs, high cartilage signal and hip and knee pain.  
Materials and methods 
Subjects  
This study was conducted as a part of the Tasmanian Older Adult Cohort (TASOAC) study, a 
prospective, population-based study initiated in 2002 aimed at identifying the environmental, 
genetic and biochemical factors associated with the development and progression of OA at 
multiple sites (hand, knee, hip and spine). Subjects between the ages of 50 to 80 years were 
selected from the electoral roll of Southern Tasmania (population 229,000) using a sex-
stratified simple random sampling technique. The overall response rate was 57%. As 
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TASOAC was designed to examine community-dwelling older adults, institutionalized older 
adults were excluded. Participants were also excluded if they reported contraindication for 
MRI. Of all initially eligible participants, 1,100 enrolled in the study, and 1,099 attended a 
baseline (Phase 1) clinic between March 2002 and September 2004. Follow-up data (Phase 2) 
was collected for 875 participants at a clinic approximately three years later, and then again 
for 769 participants (Phase 3) at a clinic approximately five years later.  
 
During the TASOAC study, a hip protocol was added during the latter part of phase 2. In the 
current study a sample of 245 consecutive participants which had a STIR (Short T1 Inversion 
Recovery) MRI sequence at phase 2 and/or phase 3 were included. Of these 245 participants, 
30 participants were lost to follow-up at phase 3 and 17 participants did not have a STIR 
sequence at phase 2 hence the total number of participants who had a hip STIR MRI scan at 
both phases was 198 (figure 4-1). This study was approved by the Southern Tasmanian 
Health and Medical Human Research Ethics Committee and written informed consent was 
obtained from all participants. 
 
 
  
 
                  
Figure 4-1: Sample population inclusion flow chart
  
Clinical measurements  
Demographic characteristics, medical history and lifestyle factors were assessed by self-
administered questionnaires. Height was measured to the nearest 0.1 cm using a stadiometer 
(with shoes, socks and bulky clothes removed). Weight was measured to the nearest 0.1 kg 
(with shoes, socks and bulky clothes removed) using a single pair of electronic scales (Seca 
Delta model 707; Hamburg, Germany). Body mass index (BMI) was calculated. 
Magnetic Resonance Imaging  
An MRI scan of the right hip was performed. The hip was imaged in the sagittal plane using a 
1.5 Telsa G.E signal whole-body magnetic resonance unit with a phased-array flex coil. The 
following image sequence was used: STIR-weighted fat saturation two dimensional fast spin 
echo sequence; repetition time 4340 msec, echo time 28.4 msec; field of view 20 cm; 15 
partitions and 512 x 512-pixel matrix. Sagittal images were obtained at slice thickness of 3.5 
mm with an interslice gap of 1.5mm.  
Measurement of hip BMLs  
For quantitative assessment of subchondral hip BMLs on STIR-weighted MR images, Osiris 
X software (University of Geneva, Geneva, Switzerland) was used. BMLs were identified as 
areas of increased signal intensity adjacent to the subchondral bone on the femoral head 
and/or the acetabulum. The slices were divided into femoral and acetabular regions. One 
trained observer assessed hip BML size by measuring the maximum area of the lesion at both 
baseline and follow-up. The observer manually selected the MR slice with the largest BML 
and then determined the BML size by manually drawing contours around the outer edges of 
the lesion (Figure 4-2). Intra-observer repeatability was assessed in 25 subjects (at both time 
points) with a two-week gap between the measures. The intra-class correlation coefficient 
(ICC) for hip BMLs was 0.98, similar to the reproducibility of our knee quantitative BML 
measure107. 
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High Cartilage Signal 
The presence of high cartilage signal at the hip joint was defined as high signal intensity band 
within the cartilage either adjacent to the hip BML or at any location on the STIR MR slice if 
there was no BML. High cartilage signal was graded as 0 for absent and 1 for present (Figure 
4-2) by the same observer along with hip BMLs. The reproducibility was assessed in 25 
subjects (at both time points) with a two-week interval between the readings. The intra-rater 
agreement (kappa) for high cartilage signal was excellent at 0.88. 
 
 
Figure 4-2: Measurement of femoral BML size with an adjacent high cartilage signal 
 
 
WOMAC scores  
Hip and knee pain for all the subjects who had a hip MRI was determined using a hip specific 
and knee specific Western Ontario and McMaster Universities Osteoarthritis (WOMAC) 
index pain score. WOMAC uses a 10-point scale from 0 (indicating no pain) to 9 (indicating 
severe pain). For the purpose of this study pain in the hips (5 items) and knees (5 items) was 
assessed separately using the following questions: Referring to your hips only how much pain 
did you experience when walking on flat surface, going up and down the stairs, at night while 
in bed, sitting or lying and standing upright.89 These 5 items were summed to create a total 
hip and total knee pain score each with a possible range from 0 – 45.  
54 
 
Statistical analyses  
Descriptive data were summarized as means and standard deviations with right skewed data 
transformed by taking logarithms. Differences in demographical characteristics were 
calculated using unpaired t-tests and chi-square tests. Due the lack of overall associations 
between BMLs and pain, we performed an exploratory data driven analysis (post-hoc 
analysis). This resulted in a femoral BML area less than 0.45cm2 being categorized as small 
and one greater or equal to 0.45cm2 being categorized as large. Similarly, acetabular BMLs 
of size less than 1.5cm2 were categorized as small while those greater than or equal to 1.5cm2 
were categorized as large. Small femoral and acetabular BMLs were combined together and 
labeled as any small BMLs. Large acetabular and femoral BMLs were combined together and 
labeled as any large BMLs. No subject had a large femoral and small acetabular or a small 
femoral and a large acetabular BML. For determining the relationship between presence of 
pain and presence of hip BMLs, WOMAC score was modified into a binary variable, where 
subjects with no pain were graded as 0 and subjects with pain >0 were graded as 1.  
 
In the cross-sectional analysis, logistic regression was used to compare the odds of no pain 
(pain score=0) and the odds of pain (pain score>0), and linear regression was used to model 
the pain scores of those with pain in analysis restricted to those with a non-zero pain score. 
Further, odds of presence or absence of high cartilage signal were estimated using logistic 
regression. Data on subjects at phase 2 and phase 3 were combined in analyses, and the 
correlation between repeated measurements on individuals was taken into account by 
adjusting standard errors using the sandwich (robust) estimator of variance.  
 
For longitudinal analysis, linear regression models were used to estimate the association 
between change in hip and knee pain scores and presence or absence of BMLs. For the 
purpose of this analyses, hip BMLs present at baseline and not at follow-up were categorized 
as resolved BMLs, and hip BMLs present at follow-up but not at baseline were categorized as 
incident BMLs. Additionally, these methods were also used to estimate the association of 
change in pain and change in hip BML size from baseline to follow-up for subjects with a 
BML at either time point. All models were adjusted for age, sex and body mass index. 
Further, models for hip pain were adjusted for knee pain and models for knee pain were 
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adjusted for hip pain. All statistical tests were two sided and p values < 0.05 were considered 
significant. All statistical analysis was conducted using Intercooled Stata 12 for Mac (Stata 
Corp, College station, TX, USA). 
Results 
Characteristics of the population 
Table 4-1 outlines the demographic characteristics of the sample population. The data is 
presented for those with and without any BML. A total of 28% (n=55/198) had one or more 
BMLs and 8% (n=15/198) had large BMLs present at the femoral and/or acetabular site. Age, 
height, weight and BMI of participants with or without hip BMLs were similar, but males 
were over represented in subjects with BMLs. On average, femoral BML size (0.15 cm2) was 
smaller than acetabular BML size (0.74 cm2). The percentage with high cartilage signal was 
higher in subjects with hip BMLs when compared with those without hip BMLs. Proportions 
with knee and hip pain tended to be lower in the hip BML group but there was no statistically 
significant difference. Additionally, knee pain was more common but generally less severe 
than hip pain. 
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Table 4-1: Characteristics of the population 
 
 
 
 
 
 
 
 
 
Characteristics  
Hip BML absent 
(n=143) 
Any hip BML 
present 
(n=55) 
P 
values 
Mean age (yrs.) 64.3 (7.07) 64.5 (6.40) 0.90 
Male sex 54%  62%  0.33 
Mean height (cms) 167 (9.15) 168 (9.00) 0.31 
Mean weight (kgs) 77.8 (14.3) 77.1 (14.8) 0.65 
Mean BMI (kg/cm2) 27.8 (4.40) 27.2 (4.61) 0.35 
Mean femoral CSA (cm2) - 0.15 (0.41) - 
Mean acetabular CSA (cm2) - 0.74 (0.55) - 
High cartilage signal 51% 87% <0.001 
Presence of knee pain 71% 67% 0.45 
Severity knee pain score* 2.47 (0.39) 2.38 (0.35) 0.87 
Presence of hip pain 33% 25% 0.27 
Severity hip pain score* 3.89 (0.67) 3.10 (0.94) 0.33 
Data presented in means (SD) 
Bold face indicates statistically significant results ( p <0.05) 
Pain score calculated by using Western Ontario and McMaster Universities Osteoarthritis 
Index (WOMAC)          
* Pain score presented after log transformation.  
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Hip BMLs and hip pain 
Figure 4-3 shows the cross-sectional association between presence of no/small and large hip 
BMLs with presence of hip pain. Only presence of large hip BMLs, irrespective of BML site, 
were associated with higher odds of hip pain.  
 
 
 
 
Figure 4-3: Cross-sectional relationship between presence of BMLs and presence of hip pain. 
 
 
 
 
 
Dependent variable: hip pain. Independent variable: hip BMLs. Y-axis: Percentage of 
subjects with hip pain. X-axis: Subjects with no/small and large hip BMLs. Odds ratios and 
confidence intervals, adjusted for age, sex and body mass index and clustering of 
observations of subjects at phase 2 and phase 3 was taken into account. Further, models were 
adjusted for presence of knee pain. Boldface indicates statistically significant results.  
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Hip pain severity and large hip BMLs  
Cross-sectionally severity of hip pain (WOMAC>0) was not associated with presence of 
large hip BML (Table 4-2). However, severity of hip pain was associated with per cm2 
increase in size of acetabular BML (βeta: 4.18; 95% CI: 1.54, 6.88) but not with increase in 
size of femoral or any BML. Longitudinally, resolving acetabular BMLs had no association 
with hip pain while incident femoral and acetabular BMLs were strongly associated with an 
increase in hip pain (Table 4-3). Lastly, change in any BML size was significantly associated 
with change in hip pain (Table 4-4). 
Hip BMLs and knee pain  
Cross-sectionally, presence of knee pain or severity of knee pain (table 4-2) was not 
associated with hip BMLs. Longitudinally, despite the small number with change in BMLs, 
an association between resolving femoral BMLs and knee pain was noted (table 4-3). Lastly, 
change in knee pain from baseline to follow up showed no association with change in hip 
BML size at any site (table 4-4).  
Hip BMLs and high cartilage signal  
The odds of presence of high cartilage signal intensity were much higher in subjects with any 
hip BML [OR: 6.45, 95% CI: 3.37, 12.6], especially in those with acetabular BMLs [OR: 
8.41, 95% CI: 3.68, 19.4].
  
 
Table 4-2: Cross-sectional relationship between severity of pain (WOMAC scores) and presence of large BMLs 
 
 
                   Hip pain Knee pain 
    Difference     Difference  
Study factor N* Mean (SD) Mean (95% CI)† N* Mean (SD) Mean (95% CI)† 
Femoral BML         
No/small BMLs 142 6.03 (6.93) 
 -1.54 (-3.98, +0.93) 
304 3.58 (3.60) 
-0.34 (-1.24, +0.50) 
Large BMLs (≥0.45 cm2) 6 4.33 (3.20) 7 3.61 (1.13) 
           
Acetabular BML            
No/small BMLs 144   5.83 (6.81) 
 +3.35 (-2.46, +9.05) 
307 3.55 (3.65) 
 -0.89 (-3.92, +2.39) 
Large BMLs (≥1.5 cm2) 4  10.50 (4.04)     4 5.50 (1.73) 
           
Any BML‡           
No/small BMLs 139  5.90 (6.99) 
+0.43 (-3.16, +4.03) 
301 3.55 (3.61)  
 -0.43 (-1.97, +1.04) 
Large BMLs 9     6.77  (4.93) 10 4.30 (1.70) 
Dependent variable: Hip and knee pain score (WOMAC). Independent variable: presence of hip BMLs. 
*Numbers shown are from measurements of 198 subjects at phase 2 & phase 3 and include repeated observation on the same subjects. Further, these 
analysis only includes subjects with a WOMAC score>0. 
† Data adjusted for age, sex and body mass index and with clustering of observations on individuals taken into account. Further hip pain models were 
adjusted for presence of knee pain and knee pain models for presence of hip pain.   
‡
 
Any large BMLs: category including the combination of femoral BMLs ≥0.45 & acetabular BML≥1.5. 
   Boldface indicates statistically significant results (P<0.05) 
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Table 4-3: Longitudinal association between change in prevalence of large BMLs and change in pain 
 
 
 
   Hip pain   Knee pain  
Study factor n  Means (SD)  
Adjusted Mean 
difference (95% CI) †   
Means 
(SD)  
Adjusted Mean 
difference (95% CI) †  
          
Femoral BML (>0.45 cm2)          
Absent 188  0.09 (4.94)    1.04 (3.32)   
Resolving BML  2  −3.00 (2.82)  −2.24 (-4.76, +0.41)  −2.00 (2.83)  −3.18 (-5.99, -0.50) 
Incident BML 4  0.75 (0.50)  +1.18 (+0.23, +1.94)  0.25 (2.43)  −0.71 (-2.53, +1.12) 
Acetabular BML (>1.5 cm2)          
Absent 192  0.06 (4.90)    1.00 (3.34)   
Resolving BML 2  0.00 (N.A)  +0.42 (-0.64, +1.45)  1.00 (N.A)  −0.37 (-1.17, +0.43) 
Incident BML 1  4.00 (N.A)  +5.90 (+3.78, +8.15)  0.00 (N.A)  −0.81 (-2.34, +0.72) 
Any BML‡          
Absent 185  0.07 (4.97)    1.05 (3.32)   
Resolving BML 4  −1.50 (2.40)  −0.95 (-2.85, +1.04)  -0.50 (2.40)  −1.81 (-3.82, +0.21) 
Incident BML 5  1.40 (1.52)  +2.08 (+0.22, +3.94)  0.20 (2.05)  −0.75 (-2.34, +0.82) 
Dependent variable: change in hip and knee pain. Independent variable: change in prevalence hip BMLs.  
*n indicates number of subjects with pain (n)/total number of subjects in each category. 
†Data adjusted for age, sex and body mass index. Further hip pain models were adjusted for change in knee pain and knee pain models for change in 
hip pain.   
‡ Any BMLs: category including the combination of femoral BMLs ≥0.45 & acetabular BML≥1.5. 
Analysis excludes one subject with BML at both time points. 
Boldface indicates significant results 
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Table 4-4: Relationship between change in hip BML size and change in pain 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Change in hip pain   Change in knee pain  
Study factor   βeta (95% CI) †   βeta  (95% CI) †  
Femoral BML size (cm2) +0.96 (-0.55, +1.96) +1.02 (-0.76, +2.80) 
Acetabular BML size (cm2) +0.80 (-0.42, +2.90) −1.90 (-2.00, +0.30) 
Any BML size‡ (cm2) +0.85 (-0.00, +1.71) −0.42 (-1.41, +0.61) 
Dependent variable: change in hip and knee pain. Independent variable: change in hip BML size.  
βeta coefficient indicates the values of change in pain score per 1unit change in BML size (cm2) 
†Data adjusted for age, sex and body mass index. Further, hip pain models were adjusted for change 
in knee pain and knee pain models for change in hip pain.  
‡ Any BMLs: category including the combination of femoral BMLs & acetabular BMLs. 
Boldface indicates significant results. 
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Discussion 
This is the first large population-based study describing the cross-sectional and longitudinal 
relationships of hip BMLs with pain at either the hip or knee joint. A total of 28% had a BML 
of which 8 % were large. Of these, only large BMLs were associated with pain, most notably 
at the hip. Incident but not resolving BMLs were associated with changes in hip pain and 
only resolving femoral BMLs were associated with decrease in knee pain.  Lastly, there was 
also a strong association of hip BMLs with high cartilage signal. 
The nature of pain in OA is controversial. Studies show, with some exceptions, that knee 
BMLs, especially large ones, are associated with knee pain.193, 197 In our study, presence of 
large hip BMLs was associated with overall fourfold higher odds of hip pain. Further, 
acetabular BML size was associated with more severe hip pain. These findings are supported 
by Taljanovic’s study in which focal hip BMLs were significantly correlated with hip pain.101  
Further, Roemer et.al also reported that subjects with grade 3 hip BMLs had higher odds of 
having hip pain [OR: 6.10, 95% CI 0.75, 49.6] but this association didn’t reach statistical 
significance.93  
In the second part of our study, we analyzed the longitudinal association between change in 
pain and change in hip BML presence and BML size over approximately 2.3 years. Despite 
the small numbers of changing BMLs there were a number of significant results. Incident 
large hip BMLs (femoral or acetabular) were independently associated with worsening hip 
pain while any large resolving femoral BML was also independently associated with reduced 
knee pain. Furthermore, increase in BML size was associated with an increase in hip pain. 
These findings are similar to longitudinal data on knee BMLs,106, 107, 193 however the 
association between resolving femoral BMLs and knee pain is novel. We have reported an 
association between hip JSN and knee pain 197 and previous studies have described a strong 
link between hip and knee pain in hip OA.195, 196 Based on our findings, it can be speculated 
that besides JSN, hip BMLs might also be one of the causes of referred knee pain. However, 
this finding requires confirmation in studies conducted in subjects with severe hip OA and a 
higher prevalence of BMLs.  
Previous studies based on assessing cartilage signal intensity suggest that high cartilage 
intensity on MRI can be used as a predictor to detect early degeneration of articular 
cartilage.122, 124, 127 In the present study, high cartilage signal was strongly associated with the 
presence of large BMLs (most notably acetabular) but not with pain, which contrasts with the 
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study conducted by Totterman et.al that reported change in cartilage signal was positively 
correlated with change in knee pain. These differences may be due to site variations (hip and 
knee) and/or the methodology as change in cartilage signal appears to be a marker for 
changes in cartilage composition124. Hence, change in the cartilage signal is likely to reflect 
deleterious changes in articular cartilage at either site. The cross-sectional nature of this 
analysis does not allow causal inferences to be made. Additionally, these may well be 
interdependent as has been seen at the knee where, using longitudinal data, Dore et.al 
reported higher cartilage defect worsening in subjects with knee BMLs and vice versa114.  
Limitations 
This study has a few potential limitations. The analyses were carried out with a relatively 
small number of large hip BMLs, nevertheless most of our hip pain results were consistent 
and statistically significant.  Further, these analyses are based on data driven cut points which 
should be considered hypothesis generating and require confirmation in other studies. 
WOMAC scores used in this study assessed hip and knee pain separately; however, did not 
differentiate between right/left sides. Hence, we were unable to conduct analysis that only 
included subjects with pain in the right hip or knee. Additionally, this study included some 
subjects who reported both hip and knee pain, thus we adjusted all models for pain (hip 
models for knee pain and vice versa) in order to examine the independent associations. The 
scoring of BMLs at the hip and the use of cross-sectional BML area is novel and reflects our 
experience with knee BMLs and has good performance characteristics suggesting 
measurement error is not substantially affecting our results.  
Conclusions  
In conclusion, the evidence is consistent for hip but not knee pain, and strongly suggests that 
large hip BMLs are associated with hip pain. Further, high cartilage signal is asymptomatic 
but strongly associated with hip BMLs. These findings suggest hip BMLs play an important 
role in hip OA.  
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Postscript  
Hip BMLs are rare in older adults. This study determines that hip BMLs are one of the causes 
of hip pain and perhaps referred knee pain. Regardless of size, hip BMLs were strongly 
associated with early changes in the hip cartilage (high cartilage signal) revealing that 
subchondral BMLs have an impact on cartilage health. Along with pain, BMLs are also 
known to associate with changes in the bone density. Thus, the next chapter focuses on 
describing the relationship between BMLs and BMD.  
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Introduction 
Bone marrow lesions (BMLs) are a key features of osteoarthritis (OA) and are associated 
with pain107, cartilage defects, cartilage volume loss114  and joint replacement.107 Similarly, 
BMLs of the hip are associated with hip pain and hip joint space narrowing.101 
 
Bone density is usually higher in subjects with OA201 and its relationship with knee BMLs 
has been explored. Lo et.al documented an increased ratio of compartment specific local 
tibial BMD in association with knee BMLs.202 We found a positive correlation between knee 
BMLs and subchondral bone density in a community based sample.203 Furthermore, Hunter 
et.al, demonstrated an increased bone volume fraction but a decrease in tissue mineral density 
in cores of bone area affected by knee BMLs in women awaiting knee replacement.63 The 
increase in bone density may be due to ongoing remodeling of damaged trabeculae in areas 
where BMLs were located.202  
 
Studies looking into the association between BMLs and bone density in joints other than the 
knee are limited.204 Similar changes in bone density are seen in subjects with hip OA,201 
however the association between hip BMLs and BMD is yet to be examined. Hence, the aims 
of this study were to describe the cross-sectional and longitudinal relationship between hip 
BMLs and total hip, femoral neck and spine BMD. 
Materials and Methods  
Subjects 
The Tasmanian Older Adult Cohort (TASOAC) study is a population-based cohort and the 
study design has been extensively described in previous manuscripts.107, 114, 203 The hip 
protocol was added during the latter part of phase 2. In the current study a sample of 245 
consecutive participants with a STIR (Short T1 Inversion Recovery) MRI sequence at phase 
2 and/or phase 3 were included (figure 5-1). Of these 245 participants, 30 participants were 
lost to follow-up at phase 3 and 17 participants had missing STIR sequences at phase 2 hence 
the total number of participants who had a hip STIR MRI scan at both phases was 198. This 
study was approved by the Southern Tasmanian Health and Medical Human Research Ethics 
Committee and written informed consent was obtained 
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Figure 5-1: Sample population inclusion chart 
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Clinical and DXA measurements 
Height, weight and BMI were measured using standard protocols. BMD of the hip, femoral 
neck and spine at both phase 2 and phase 3 was assessed by DXA using a Hologic Delphi 
scanner as previously described.203 
Magnetic Resonance imaging  
The right hip was imaged in the sagittal plane using a 1.5 Tesla G.E signal whole-body 
magnetic resonance unit with a phased-array flex coil. The following image sequence was 
used: STIR-weighted fat saturation two dimensional fast spin echo sequence; repetition time 
4340 msec, echo time 28.4 msec; field of view 20 cm; 15 partitions and 512 x 512-pixel 
matrix. Sagittal images were obtained at slice thickness of 3.5 mm with an interslice gap of 
1.5mm.  
Measurement of hip BMLs 
For quantitative assessment of subchondral hip BMLs OsiriX software (University of 
Geneva, Geneva, Switzerland) was used. Hip BMLs were identified as areas of increased 
signal intensity adjacent to the subchondral bone on the femoral head and/or the acetabulum. 
One trained observer manually selected the MR slice with the largest BML and then scored 
the maximum area (cm2) of all the identified lesions by manually drawing contours around 
their outer edges (figure 5-2). The BML with the highest score was used if more than one 
lesion was present at the same site.  Intra-observer repeatability was assessed and the intra-
class correlation coefficient (ICC) of the hip, femoral and acetabular BMLs was 0.98, 0.96 
and 0.99 respectively (n=25), similar to the reproducibility of our knee quantitative BML 
measure107. 
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Figure 5-2: Measurement of femoral BML 
 
Statistical analysis 
Student’s t-tests and chi-squared tests were applied to determine the differences in means and 
proportions. The fit of all models were tested and all assumptions were fulfilled. Cross-
sectional and longitudinal analyses were based on linear regression. Cross-sectionally, the 
relationship between hip BML presence or absence and BMD of the hip, femoral neck and 
spine was estimated by determining the mean difference in BMD of subjects with and 
without hip BMLs. These analyses were adjusted for age, sex, BMI and presence or absence 
of radiological hip OA, as adding covariates for these factors to the models changed the 
estimated coefficient of the study factor (BMLs) by more than 10%.  For all cross-sectional 
analyses, data on subjects at phase 2 and phase 3 was combined and the correlation between 
repeated measurements on individuals was taken into account by adjusting standard errors 
using the sandwich (robust) estimator of variance.187, 188, 190 Lastly, the relationship between 
change in BML size and change in BMD of the hip, femoral neck and spine from baseline to 
follow-up for subjects with a BML at either time point was analyzed. All models were 
adjusted for age, sex and body mass index. All statistical tests were two sided and p values < 
0.05 were considered significant. 
 
70 
 
  
Results 
Characteristics of the sample population  
Of the 198 subjects, 28% (N=55) had a hip BML. Subjects with and without BMLs were 
similar in gender distribution (62% v 54% male), mean age 64yrs for both and mean (SD) 
BMI [27.2 (4.40) v 27.8 (4.61)]. BMD at the hip, spine and femoral neck was lower in 
subjects with any hip BML and the difference at the femoral neck [p=0.03] was statistically 
significant. Lastly, acetabular BMLs [mean (SD): 0.74 (0.55)] were larger in comparison to 
femoral BMLs [mean (SD): 0.15 (0.41)]. 
 
Cross-sectional relationship between hip BMLs and BMD  
Table 5-1 shows the cross-sectional relationship between hip BML presence and BMD at the 
hip, femoral neck and spine. The presence of acetabular BMLs was associated with lower 
BMD at the hip and femoral neck. Further, these associations persisted after adjustment for 
radiographic hip OA.  BML size was not significantly associated with BMD but subjects with 
femoral BMLs had 12% lower femoral neck BMD as the difference in BMD per unit increase 
in femoral BML was −0.12 (95% CI −0.24, +0.01). 
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Table 5-1 Cross-sectional relationship between presence of hip BMLs and bone density at the hip, femoral neck and spine 
 
 
  Total hip BMD (g/cm2)  Femoral neck BMD (g/cm2)  Spine BMD (g/cm2)  
BML Category 
 N* 
Mean 
(SD)  
Adjusted mean 
Difference (95% CI)†  N* Mean (SD)  
Adjusted mean 
Difference (95% 
CI)† N* Mean (SD)  
Adjusted mean 
Difference (95% CI)†  
Femoral BML           
No BML  
 412 0.97 (0.14)  412 0.77 (0.11)  414 1.02 (0.16)   
BML Present  
 15 0.99 (0.13) +0.01 (−0.07, +0.10) 15 0.80 (0.11) +0.02 (−0.06, +0.17) 15 1.03 (0.11) <0.01 (−0.08, +0.08)  
Acetabular BML            
No BML  
 361 0.98 (0.14)  361 0.79 (0.11)  363 1.03 (0.15)   
BML Present 
 66 0.93 (0.12) −0.05 (−0.09, -0.01) 66 0.73 (0.08) −0.06 (−0.09, −0.03) 66 1.00 (0.15) −0.03 (−0.08, +0.01)  
Dependent variable: BMD. Independent variable: Presence or absence of BMLs. 
Data adjusted for age, sex, body mass index and radiological hip OA (ROA).  
Boldface indicates statistically significant results (P<0.05) 
N* Numbers shown are from measurements of 198 subjects at phase 2 & phase 3 and include repeated observation on the same subjects.  Moreover, data 
for total hip and femoral neck BMD for one subject at phase 2 and 1 subject at phase 3 was missing. 
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Longitudinal association between hip BML and BMD 
Table 5-2 presents the association between incident and resolving hip BMLs and change in 
BMD. Resolving femoral BMLs were associated with a decrease while incident femoral 
BMLs were associated with an increase in femoral neck BMD. Conversely, resolving 
acetabular BMLs were associated with an increase in hip and femoral neck BMD while 
incident acetabular BMLs were not associated with BMD at any site. Persistent hip BMLs 
were not associated with changes in bone density.  
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Table 5-2 Longitudinal relationship between change in prevalence of hip BMLs and change in bone density of hip, femoral neck and spine 
 
 
 
 
 
   
Change in total hip BMD 
(g/cm2)  
Change in femoral neck 
BMD (g/cm2)  Change in spine BMD (g/cm2) 
BML Category N*  
Difference in mean (95% 
CI) †  
Difference in mean 
(95% CI) †  Difference in mean (95% CI) † 
Femoral BML         
No BMLs 175       
Resolved BML 2  −0.03 (−0.09, +0.03)  −0.04 (−0.09, −0.01)  −0.03 (−0.09, +0.03) 
Incident BML 4  +0.02 (−0.00, +0.04)  +0.03 (+0.02, +0.04)  <0.01 (−0.02, +0.01) 
Persistent BML 4  −0.01 (−0.04, +0.01)  <0.01 (−0.02, +0.03)  −0.03 (−0.06, −0.00) 
Acetabular BML        
No BML  146       
Resolved BML 12  +0.02 (−0.00, +0.34)  +0.01 (+0.00, +0.03)  <0.01 (−0.02, +0.02) 
Incident BML 10  <0.01 (−0.01, +0.23)  <0.01 (−0.01, +0.02)  <0.01 (−0.02, +0.01) 
Persistent BML 19  <0.01 (−0.02, +0.01)  <0.01 (−0.02, +0.01)  −0.02 (−0.04, −0.00) 
Dependent variable: change in BMD. Independent variable: change in prevalence of BMLs.  
*Number of subjects in each category excluding participants with missing data at baseline or follow-up.   
† Data adjusted for age, sex and body mass index.  
Boldface indicates statistically significant results (P<0.05) 
For these analyses, hip BMLs present at baseline and not at follow-up were categorized as resolved BMLs. Hip BMLs present at follow-up but not at 
baseline were categorized as incident BMLs. Hip BMLs present at both baseline and follow-up were categorized as persistent BMLs. 
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Lastly each 1 cm2 change in acetabular BML size was associated with a decrease in total hip 
and femoral neck BMD: β: −0.01, 95%CI: -0.03, −0.004 and β: −0.01, 95%CI: −0.03, −0.001 
respectively. Whereas per 1 cm2 increase in femoral BML size was positively associated with 
increase in femoral neck BMD: β: +0.03, 95%CI: +0.00, +0.05. 
Discussion 
Hip BMLs were associated with local (total hip and femoral neck) BMD, but not distant BMD 
(spine).  Furthermore, these associations vary according to site with femoral BMLs being 
associated with higher femoral neck BMD while acetabular BMLs are associated with lower 
hip and femoral neck BMD. The findings were consistent although not all were statistically 
significant.  
 
The relationship between BMD and OA has been investigated.201 Of these, only a few focus 
on the role of BMLs and bone density. Population based studies in both participants with and 
without OA suggests that those with knee BMLs have higher local subchondral BMD.202, 203 
Further, knee BMLs are associated with increased bone density of the compartment where 
they are located. It is unclear whether this is due to BMLs having a local effect on bone or 
whether they are consequences of changes in underlying bone pathology. Demineralization of 
the bone under or adjacent to the BMLs could be explained by histological studies that 
suggest BMLs consist of elevated cytokines and angiogenic factors which leads to higher 
bone turnover locally, hence lower BMD.63, 97  
 
At the hip, due to lack of data, the effects of BMLs on bone density or vice versa is currently 
unclear. One study reports osteoporosis in 4/8 resected femoral heads with hip BMLs but no 
correlation was found between this histopathological finding and hip BMLs,101 however OA 
bone has been found to be hypo-mineralized with increased levels of water and organic 
materials.39 In our study, femoral BMLs were associated with an increase in bone density. 
Longitudinally, resolving femoral BMLs were associated with decreasing and incident 
femoral BMLs were associated with increasing femoral neck BMD. Femoral BMLs would 
have been located in the similar or exact region in which total hip BMD was assessed. 
Conversely, acetabular BMLs that are adjacent but outside the region used to assess BMD, 
were associated with lower BMD. Cross-sectionally there was an estimated 5-6% decrease in 
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total hip and femoral neck BMD. Longitudinally, bone density was higher in subjects with 
resolving acetabular BMLs, while a 1% reduction in BMD from baseline to follow-up was 
noted in subjects with enlarging acetabular BMLs. These findings demonstrate opposite 
associations for acetabular and femoral BMLs with BMD and should be regarded as 
hypothesis generating. For instance, overall increase in BMD and bone porosity in subjects 
with OA and BMLs has been documented.63, 202 Additionally, femoral neck BMD in 
comparison to other locations at the hip is highest in early and severe radiographic hip OA.201 
It could be speculated that femoral BMLs located near the femoral neck may increase due to 
an increase in femoral neck BMD or because of changes in the subchondral bone due to 
increase in bone infiltrates.39 In contrast, acetabular BMLs that are located away from the 
femoral neck and the subchondral bone associate with a bone undergoing demineralization. 
Hence, unlike the knee, hip BMLs located in two different compartments might represent 
bone areas undergoing different pathological changes leading to variations in the bone density 
adjacent to that joint. Nevertheless, these results might differ if we were able to measure 
material bone density.   
 
It’s unclear if BMLs are the cause or effect of secondary mechanisms modifying the bone. 
Hip BMLs, in this study, were associated with changes in local BMD perhaps, due to 
continuous bone remodeling and/or bone reabsorption in bone areas with BML. Studies have 
found elevated bone biochemical markers such as bone alkaline phosphate (ALP), osteocalcin 
(OC), and increase in angiogenesis factors such as vascular endothelial growth factor 
(VEGF), cysteine-rich angiogenic inducer 61 (CYR61), in bone samples with BMLs, 
suggesting increased bone turnover.97 Moreover, BMLs may also reflect a paracrine effect of 
proinflammatory cytokines such as tumor necrosis factor (TNF), interleukin-6 (IL-6), 
interleukin-1 (IL-1) and leptin, which associate with pain,205 cartilage loss141 and lower bone 
density in subjects with OA.206, 207 Lastly, bone density may alter due to disuse of a painful 
joint mainly due to unloading which encourages reduction in bone formation or modeling.208 
Hence, both imbalances in the bone metabolism and disuse due to pain possibly cause 
changes in bone that encourage formation of BMLs. 
 
 
76 
 
 
 
Limitations 
Bone density was measured using DXA, which provides an aerial two-dimensional BMD 
measure; hence our apparent BMD findings might differ from material BMD findings. As 
BMD can be influenced by differences in bone size we adjusted for age, sex and BMI, which 
would largely compensate for any such differences. We were unable to vary the region of 
interest for our scans thus the region of interest where BMD was measured may include all, 
part or none of the hip BMLs depending on the location of the BML which may explain 
differing regional results. Longitudinal analyses were carried out with only a small number of 
hip BMLs, however the overall results were consistent. Hip BMLs were assessed by both 
presence and cross-sectional area, which might miss very small shallow or flat BMLs. 
However, our areal measure has excellent performance metrics in the knee.107  
Conclusions 
Hip BMLs were associated with local BMD (hip and femoral neck) but not with spine BMD 
and these associations vary according to site. BML prevalence and change was low in this 
study, hence these findings need confirmation. However, we hypothesize that these 
associations represent a combination of changes related directly to the BML pathology or 
changes adjacent to the disease process. 
 
Postscript  
A link between hip BMLs and local BMD (hip and femoral neck) was established in this 
chapter. At the hip, the association between BMLs and BMD may vary according to the site. 
As expected, no association between hip BMLs and spine BMD was found. Hypothetically 
these associations may represent a combination of changes related directly to the BML 
pathology or changes adjacent to the disease process. 
After demonstrating associations of subchondral hip BMLs, the next chapter describes the 
link between hip cartilage, clinical symptoms and structural changes occurring in older adults. 
 
77 
Chapter 6 : Correlates of hip cartilage defects: A cross-sectional study in 
older adults. 
Published in the Journal of Rheumatology (in press) 
Harbeer Ahedi, Dawn Aitken, Leigh Blizzard, Chang-hai Ding, 
Flavia Cicuttini and Graeme Jones 
This chapter has been 
removed for
copyright or proprietary 
reasons.
Now published in  vol. 43(7), 1406-1412
81 
 
 
 
partial thickness defect and grade 2=full-thickness defect with bone ulceration and/or 
exposure of bone. If more than one defect was present at one site, the highest score was used. 
In a reliability study of 40 subjects with re-measurements after four weeks, the intra-rater 
agreement (kappa) was 0.89.  
Furthermore, the inter-rater reliability (kappa) assessed by two readers (n=40) for presence of 
defects and defect categories was 0.84 and 0.63 respectively. These measures were conducted 
by HA and ML (Ming Lu). ML is an orthopedic surgeon with 7 years’ experience in reading 
MRI scans.   
 
 
Figure 6-1: Assessment of grade 1 and grade 2 hip cartilage defects on sagittal STIR MRI 
image 
Assessment of hip effusion 
Hip joint effusion was assessed manually by one observer (HA). HA selected the MRI slice 
with the largest effusion and then assessed the maximum cross-sectional area (CSA). The 
intra-rater agreement (kappa), for presence of hip effusion was 0.84 and the intra-class 
correlation coefficient (ICC) for hip effusion CSA was 0.97.  
Hip BMLs and high cartilage signal 
BMLs were identified as areas of increased signal intensity adjacent to the subchondral bone 
on the femoral head and/or the acetabulum and maximum BML CSA was assessed. The ICC 
for hip BMLs was 0.98.215 High cartilage signal was defined as a high signal intensity band 
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within the cartilage either adjacent to a hip BML or at any location on the STIR MRI slice if 
there was no BML present. High cartilage signal was graded as 0 for absent and 1 for present 
with an intra-rater agreement (Kappa) of 0.88.215  
Radiological assessment   
Antero-posterior weight-bearing radiographs of the pelvis were obtained. According to the 
OARSI (Osteoarthritis Research Society international)  grading system, the radiographic 
features of JSN and osteophytes of the right hip were graded on a 4-point scale, ranging from 
0 to 3 where 0=no disease and 3=most severe disease by using an Altman’s atlas.77 The total 
radiographic OA(ROA) score was calculated by summing the JSN and osteophyte scores.86 A 
non-zero score of either JSN or osteophytes was regarded as evidence of hip ROA. Thus, after 
combining JSN and osteophytes score, the presence of hip ROA was defined as a total score 
of 1 or greater. 
Statistical analyses 
Student’s t-test and chi-square tests were applied to determine the differences in means and 
proportions. Based on total WOMAC score which ranged from 0-45, hip pain was divided 
into three categories: category 0 comprised subjects with no pain, category 1 comprised 
subjects with pain score less than 4, and category 2 comprised subjects with pain score of at 
least or more than 4. Hip BMLs and effusion were dichotomized as 0=no BML/effusion and 
1=BMLs/effusion>0. Log binomial regression (a generalized linear model with log link and 
binomial error) was used to estimate associations with the binary outcome hip cartilage 
defects. Linear regression was employed to estimate associations with continuous outcomes. 
All models were adjusted for age, body mass index and hip BML (as required) because these 
factors produced at least 10% of change in the coefficient of the study factor. Results are 
presented stratified by sex (when the interaction of study factor with sex was statistically 
significant) or additionally adjusted by sex. Data on subjects at phase 2 and phase 3 were 
combined in analyses (194 subjects with MRI at both phases), and the correlation between 
repeated measurements on individuals was taken into account by adjusting standard errors 
using the sandwich (robust) estimator of variance.189, 190 An assessment was made of the fit of 
all the final models, with careful attention paid to the scaling of covariates and of the response 
variable in linear regression. Intra-rater and inter-rater reliability was computed using 
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weighted (w) kappa. All statistical tests were two sided and p values < 0.05 were considered 
significant. 
 
Results 
Characteristics of the sample population  
Table 6-1 summarizes the characteristics of the subjects with no defect, grade 1 and grade 2 
defects. Overall, 24% (n=48) subjects had no cartilage defects, 34% (n=66) had grade 1 and 
41% (n=80) had grade 2 cartilage defects. When a significant sex interaction was found, the 
data was stratified into men and women. In comparison to those with no cartilage defects, 
subjects with a grade 1 defect were of similar age, but heavier. Men with grade 1 defects had 
more hip pain and an increased proportion of high cartilage signal. Regardless of sex, subjects 
with grade 1 defects had more hip BMLs. In comparison to subjects with no defects, those 
with grade 2 defects had similar BMI but were older; and had a higher hip pain score, higher 
proportion of hip BMLs and high cartilage signal, larger effusion CSA and lower steps per 
day. The proportion with hip ROA in those with grade 2 cartilage defects was higher in men 
than in women. 
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Table 6-1 Characteristics of the sample population 
Tabl
e 6-
1: 
Char
acter
istic
s of 
the 
sam
ple 
popu
latio
n 
    
Characteristics 
Hip defect absent 
              (n=48) 
Grade 1 hip defect 
present 
(n=66) 
P-value 
Grade 2 hip defect 
present 
(n=80) 
P-
value 
Age (yrs.): mean (SD) 64.1 (6.73) 64.1 (6.84) 0.95 65.5 (7.70) 0.01 
BMI (kg/cm2): mean (SD) 27.2 (3.99) 28.2 (4.43) 0.02 27.5 (4.20) 0.53 
Hip pain†      
           Presence‡  40% 48% 0.14 46% 0.81 
                                    Men  22% 44% 0.002 - - 
                Women 62% 53% 0.2 - - 
                                  Interaction p-value                                                  p=0.003   
           Severity: § mean (SD) 1.32 (3.14) 2.10 (4.20) 0.07 2.60 (5.11) 0.03 
Leg strength (kgs): mean (SD) 101 (53.0) 99 (53.0) 0.71 98.0 (48.7) 0.73 
Steps per day: mean (SD) 7970 (3526) 7444 (3245) 0.15 7127 (3507) 0.04 
Any BML  5% 20% 0.003 23% 0.009 
Presence of high cartilage signal 42% 60% 0.002 62% 0.009 
                                    Men  40% 70% <0.001 - - 
               Women 44% 46% 0.81 - - 
                                  Interaction p-value  p=0.008   
Hip Effusion†       
          Presence¶  10% 18% 0.07 20% 0.09 
          Effusion CSA: ** mean (SD)  1.05 (0.79) 1.16 (0.96) 0.31 1.30 (1.01) 0.02 
Presence of radiological hip OA  28% 30% 0.94 40% 0.002 
                                    Men  22%                        - - 50% 0.001 
           Women 27% - - 27% 0.97 
                                  Interaction p-value  p=0.007 
Results of t-tests (continuous variables) and chi-squared tests (categorical variables), with standard errors of means calculated with clustering of observations on 
subjects at phase2 and phase3 taken into account. Two-way Anova test was used for estimating sex interactions. †Pain score calculated using Western Ontario and 
McMaster Universities Osteoarthritis index (WOMAC). ‡ Presence of hip pain defined as grade 0= no hip pain and grade 1= pain score>0. 
§ For subjects with hip pain score >0. ¶ Presence of hip effusion has been dichotomized as grade 0 = no effusion or/and effusion CSA ≤ 2.0 cm2 and grade 1= 
effusion ≥ 2.0 cm2. **Mean effusion and standard deviations have been obtained by using t-test including only subjects with effusion CSA>0. 
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Categories of hip pain and hip defects 
Table 6-2 presents the cross-sectional associations between categories of hip pain and 
hip cartilage defects. Those with higher hip pain had greater prevalence of any and 
grade 2 defects, but grade 1 defects were not associated with either categories of hip 
pain.   
 
Table 6-2: The cross-sectional associations between categories of hip pain and hip 
cartilage defects. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Any hip defect  Grade 1 defects Grade 2 defects 
Hip pain PR (95%CI) PR (95%CI) PR (95%CI) 
Category 0        1.00     1.00        1.00 
Category 1  1.00 (0.83, 1.20) 1.04 (0.77, 1.40)  0.96 (0.70, 1.40) 
Category 2  1.20 (1.02, 1.35)  1.22 (0.93, 1.60) 1.40 (1.09, 1.80) 
Independent variable: hip cartilage defects. Dependent variable: Hip pain category.  
Hip pain category 0 includes subject with no pain.  
Hip pain category 1 includes subjects with >0 & < 4 hip pain score.  
Hip pain category 2 includes subjects with >=4 hip pain score.   
†PR (95%CI) = prevalence ratios (95% confidence intervals) adjusted for age, sex and body 
mass index and with clustering of observation on subjects at phase 2 and phase 3 taken into 
account. 
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Structural abnormalities and grade 1 cartilage defects  
Table 6-3 summarizes the cross-sectional associations between structural 
abnormalities and grade 1 cartilage defects stratified by sex. The prevalence and size 
of hip BMLs was greater in men but no sex interaction was found. Similarly, an 
association between high cartilage signal and grade 1 defect was found in men, but 
not in women. Other abnormalities such as hip effusion and radiological aspects were 
not associated with grade 1 defects.  
 
Table 6-3: Cross-sectional associations between structural abnormalities and grade 1 
cartilage defects stratified by sex. 
 Men  Women  
 Hip defect present Hip defect present 
P value 
for 
interaction 
Study factor PR (95% CI) * PR (95% CI) *  
MRI abnormalities 
Any hip BMLs (Y/N)  1.42 (1.03, 1.96) 1.20 (0.80, 1.76)  0.50 
Hip BML CSA‡ 1.41 (1.11, 1.71) 1.25 (0.81, 1.68) 0.56 
High cartilage signal (Y/N) † 1.80 (1.04, 2.53) 0.92 (0.63, 1.22) 0.01 
Hip effusion (Y/N) 1.03 (0.60,1.83) 0.83 (0.60,1.20) 0.52 
Hip effusion CSA‡ 1.00 (0.83, 1.21) 1.08 (0.88, 1.30)  0.40  
Radiological abnormalities 
Radiological hip OA (ROA) 
(Y/N) 
1.20 (0.80,1.82) 0.90 (0.60, 1.44) 0.41 
Joint Space Narrowing (JSN) 
(Y/N) 
1.12 (0.62, 2.03) 0.80 (0.44, 1.41) 0.40 
Osteophytes (OST) (Y/N) 0.90 (0.50, 1.60) 1.20 (0.73, 1.88) 0.44 
Independent variable: structural abnormalities. Dependent variable: presence of hip cartilage 
defect 
*PR (95%CI) = prevalence ratios (95% confidence intervals) adjusted for age, sex and body 
mass index and with clustering of observation on subjects at phase 2 and phase 3 taken into 
account. 
†PR (95%CI) = prevalence ratios (95% confidence intervals) further adjusted for presence of 
hip BMLs. 
‡ CSA= cross-sectional area. 
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Structural abnormalities and grade 2 cartilage defects  
Table 6-4 presents the cross-sectional associations between structural abnormalities 
and grade 2 cartilage defects. In these analyses, subjects with grade 2 cartilage defects 
had a higher prevalence of hip BMLs and larger hip effusion size compared to 
subjects with no cartilage defects. Those with grade 2 defects also had a higher 
prevalence of high cartilage signal (PR: 1.30 95%CI: 1.03, 1.62) but this association 
became non-significant after adjusting for hip BMLs. The link between grade 2 
defects and radiological hip OA was only present in men.   
 
Table 6-4:Cross-sectional associations between structural abnormalities and grade 2 
cartilage defects 
 Hip cartilage defect 
Study factor PR (95% CI) * 
MRI abnormalities  
Any hip BMLs (Y/N)  1.45 (1.15, 1.85)  
Any hip BML CSA‡  1.42 (1.21,1.66) 
High cartilage signal (Y/N) † 1.20 (0.95, 1.52) 
Hip effusion (Y/N) 0.98 (0.65, 1.50)  
Hip effusion CSA‡  1.14 (1.01, 1.30)  
Radiological abnormalities  
Radiological hip OA (ROA) (Y/N)  1.30 (0.96, 1.70)  
                Men 1.60 (1.13, 2.25)  
               Women 0.80 (0.45, 1.40) 
               Interaction (p-value) ¶  p=0.04 
Independent variable: structural abnormalities. Dependent variable: presence of hip 
cartilage defect 
*PR (95%CI) = prevalence ratios (95% confidence intervals) adjusted for age, sex and body 
mass index and with clustering of observation on subjects at phase 2 and phase 3 taken into 
account. 
†
PR (95%CI) = prevalence ratios (95% confidence intervals) further adjusted for presence 
of hip BMLs. 
‡ 
CSA= cross-sectional area. 
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Steps per day and grade 2 cartilage defects  
Table 6-5 presents the cross-sectional relationship between steps/day and grade 2 
cartilage defects. Steps/day and its categories were associated with a lower prevalence 
of grade 2 defects. These associations persisted after adjustment for age (using the 
residual method).  
 
Table 6-5: Cross-sectional relationship between steps/day and grade 2 cartilage 
defects 
 
 
 
 
 
 
 
 
 
 
 
 Grade 2 hip cartilage defects 
Study factor PR (95% CI)* 
Steps/ day 0.97 (0.96, 0.99)  
Steps/day categories  
0-5000 steps 1.00 
5000-7499 steps 0.90 (0.77, 1.04)  
7500-9999 steps 0.87 (0.74, 1.01)  
10,000+ steps 0.77 (0.65, 0.91)  
Independent variable:  Steps per day and steps per day categories. Dependent variable: grade 
2 hip cartilage defects. 
*PR= prevalence ratios with 95% confidence intervals, adjusted for age residuals, sex and 
body mass index and with clustering of observations on subjects at phase 2 and phase 3 
taken into account. 
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Any hip defects and leg strength  
Figure 6-2 presents the association between any hip defects and leg strength stratified 
by sex. Presence of any hip defect was associated with lower leg strength among men 
(mean ratio: 0.83 95%CI: 0.67-0.98), but not women (mean ratio: 0.91 95%CI: 0.80-
1.03).  
 
 
 
Figure 6-2: Association between any hip cartilage defects and leg strength stratified 
by sex. 
Independent variable: leg strength. Dependent variable: Presence of any hip cartilage 
defects. Data adjusted for age, body mass index and with clustering of observations 
on subjects at phase 2 and phase 3 taken into account. 
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Discussion  
This is the first population-based study that describes the correlates of hip cartilage 
defects and these associations are similar to knee defects. Overall, 76% of the 
population had hip cartilage defects and correlates of hip defects, in this cohort, 
appeared to be somewhat influenced by sex. Any hip cartilage defects associated with 
greater hip pain and men with any defects had lower leg strength. Associations of 
grade 1 hip cartilage defects were restricted to high cartilage signal (men only) and 
hip BMLs. Grade2 cartilage defects were not only associated with higher hip pain, hip 
BMLs but also with hip effusion size and hip ROA (men only). Steps per day was 
protective of grade2 cartilage defects. 
   
In unadjusted analyses (table 6-1), presence of hip pain and hip pain severity was 
greater in subjects with grade 1 and grade 2 hip cartilage defects, respectively. In the 
multivariable analyses, any and grade 2 hip cartilage defects were associated with 
pain category 2 while grade 1 showed no such associations. Hip cartilage defects were 
not associated with hip pain category 1. In this study, hip pain was categorized using a 
cutoff point of 4. Earlier studies have used clinically relevant cut off points219, 220 and 
as presumed, those with higher pain score had greater prevalence of cartilage defects. 
An MRI based study validating a hip osteoarthritis score found higher odds of hip 
pain in those with hip cartilage defects but these analyses were not statistically 
significant.93 Subsequently, a case-control study of 85 subjects with mild to moderate 
hip OA, demonstrated a modest correlation between acetabular defects and hip pain 
(r= −0.25, p<0.02).112 Although different methods were applied to classify defects, 
our findings are consistent with these studies. For instance, Roemer et.al classified 
defects into grade (0-3) and Kumar et.al and Teichtahi et.al classified defects into 
grade (0-2 and 0-1 resp.) by sub-regions of the femoral head/acetabulum on MRI 
images.93, 112, 136 We categorized hip defects as grade (0-2) and found similar results. 
In addition, our data implies that those with greater cartilage damage may have higher 
probability of hip pain.  
  
The association between hip defects and leg strength is a novel finding. We found that 
men with hip cartilage defects had lower leg strength. No other study has explored 
this concept at the hip but some data exists for the knee.213, 221 In 87 women, knee 
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cartilage damage in combination with either pain or presence of loose bodies 
explained 28-38% of the variation in isokinetic extension strength. In women with 
knee cartilage damage, synovitis and/or effusion explained 34% variability in 
isometric flexor strength.213 In both men and women with lower quadriceps muscle 
strength, there was a greater prevalence of patella-femoral cartilage damage.222 The 
dynamometer used in the TASOAC study predominantly captures quadriceps and hip 
extensor strength. The associations between leg strength and hip cartilage defects 
were predominately seen in men, but are similar to the above studies. Our results 
suggest that hip cartilage defects (like knee defects) associate with muscle strength. 
However, longitudinal studies are required to assess cause and effect.  Age adjusted 
steps/day and doing +10,000 steps/day was associated with a lower prevalence of 
grade 2 cartilage defects. Any or grade 1 cartilage defects showed no such 
associations (data not shown). This concept has not been examined at the hip and the 
evidence for knee is controversial.  For instance, in an asymptomatic sample, 93% of 
subjects with a high level of physical activity had knee cartilage lesions.223 A 
longitudinal study demonstrated that subjects with a knee BML at baseline and doing 
10,000+ steps/day were more likely to have worsening knee cartilage damage.153 
Another longitudinal study showed physical work capacity was modestly and 
positively correlated with knee bone area but negatively with knee cartilage 
volume.224 Here, physical activity associated with lower prevalence of grade 2 hip 
cartilage defects. Again, longitudinal studies are required and there is a possibility that 
subjects with grade 2 defects take less number of steps per/day due to hip pain. Due to 
the lack of consistency in evidence and no other comparable data at the hip, it is hard 
to define at this point if physical activity is helpful or harmful for hip cartilage. 
 
Subjects with a hip BML had approximately 1.5 times higher risk of having a grade 1 
or grade 2 hip cartilage defects. BMLs have gained much attention and play a key role 
in OA. At the hip, studies have reported hip BMLs, articular damage and cartilage 
defects in subjects with and without symptomatic hip OA but these did not document 
associations between BMLs and cartilage defects.93, 101, 214 Neumann et.al, 
demonstrated a strong positive correlation between hip defects and hip BMLs(r=0.44, 
p<0.001) in subjects with and without hip OA.135 While Register et.al found a 
positive correlation between hip chondral defects and acetabular BMLs(p=0.009) in 
asymptomatic subjects with hip structural changes.214 Our study is consistent with 
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these findings and demonstrates associations between hip BMLs and defects in a 
community-based sample.  
 
Men with a high cartilage signal were 80% more likely to have a grade 1 defect; 
while, men and women with a high cartilage signal were 30% more likely to have a 
grade 2 defect (PR:1.30 95%CI:1.03,1.62). However, this association became non-
significant after adjusting for hip BMLs. The significance of high cartilage signal 
intensity has been described at the knee.122, 124, 128, 225 Our group was the first to 
outline its association with hip BMLs215 and in this study we demonstrated its 
association with grade 1 defects further validating its role as an early marker for 
cartilage changes. Its association with grade 2 hip cartilage defect was not 
independent of hip BMLs. Thus, the association of high cartilage signal with grade 2 
cartilage defects is mediated by hip BMLs, indicating a possibility of an underlying 
causal pathways between these structural changes.215  
 
Hip effusion CSA was associated with grade 2 defects and these subjects had 14% 
larger hip effusion. Presence of hip effusion did not associate with hip cartilage 
defects. Joint effusion at the knee has been linked with progression of cartilage 
defects216 but its role in hip OA has not been reported. Joint effusion is an 
inflammatory process and may directly affect the cartilage matrix or could be a 
consequence of cartilage damage.115 Either way, our findings support this hypothesis. 
 
In the current study, men with radiological changes were 60% more likely to have 
grade 2 hip defects. Grade 1 or any hip defects were not associated with hip ROA. 
Radiological changes at the hip are part of the diagnosis of hip OA,93, 112, 226 but less is 
known about its relationship with hip defects. Earlier studies reported greater cartilage 
damage with increasing KL-grade in subjects with severe hip OA.93 Furthermore, 
worsening KL-grade was associated with femoral (r=0.33, p=0.002) and acetabular 
defects (r=0.34 p=0.001).112 Our data is highly consistent with both these studies; 
however, the association between ROA and defects was stronger in men than women.  
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Limitation  
This study has some potential limitations. The analyses are cross-sectional. Assessing 
hip cartilage is challenging and the technique used to assess hip defects was adapted 
from earlier studies.126 We acknowledge that we are unable to provide arthroscopic or 
pathological validation and those with defects are at a higher risk of OA but having a 
defect may not be a precursor for hip OA. During measurements, it is possible we 
might have missed a small or shallow cartilage defect. However, our reproducibility 
was high, our previous measures have shown excellent measurement metrics and as 
hypothesized our findings are consistent with earlier studies at the knee and the hip. 
Lastly, the MRI sequence utilized could not separate synovitis from effusion and 
associations may vary if each is examined separately.  
Conclusion 
In conclusion, grade 2 defects in both sexes and grade 1 (mostly in men) are 
associated with clinical, demographical and structural factors relevant for OA. 
Damage to the hip cartilage could one of the major causes of rapid disease 
progression and pathophysiology of hip defects needs further study.  
Postscript  
The results from this chapter reveal that greater hip cartilage damage was associated 
with hip pain, BMLs, hip effusion, change in high cartilage signal and radiological 
findings. Furthermore, physical activity was associated with lower prevalence of hip 
cartilage defects and men with hip cartilage defects had lower leg strength. In general, 
correlates of hip cartilage defects are extensive and may lead to rapid disease 
progression.  
The aim of the next chapter is to describe the cross-sectional and longitudinal 
associations of hip effusion-synovitis in older adults.  
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Chapter 7 : Hip effusion-synovitis and it's cross-sectional and 
longitudinal associations with hip pain, cartilage damage, 
subchondral BMLs and early radiographic hip OA. 
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Introduction  
Osteoarthritis (OA) is characterized by alterations in composition, structure, and 
function of the various components of joint, including synovium.115, 116, 139 OA has 
been historically categorized as non-inflammatory arthritis.139 However, synovitis 
plays a key role in cartilage damage and vice versa.116, 139 Occurring in either early or 
late stages of OA, synovitis leads to increase in catabolic and proinflammatory 
mediators such as cytokines, nitric oxide, prostaglandin E, and neuropeptides. These 
mediators produce excess proteolytic enzymes, which cause cartilage matrix 
degradation. In turn, cartilage breakdown leads to worsening synovitis.139  
 
Joint effusion can be visually distinguished from synovitis using contrast-enhanced 
MRI. However, it has potential side effects and is not economical. Recently, the term 
‘effusion-synovitis’ has be proposed for effusion and synovitis because these two 
features cannot be differentiated by non-contrast MRI.143 
 
Several types of studies, including MRI-based studies have reported associations of 
knee effusion-synovitis proving that it is one of the causes of knee pain, has an 
adverse effect on cartilage and is linked with radiographic knee OA.115, 134, 144-146 
Although synovitis-effusion is a significant clinical prognostic factor for OA, at the 
hip it remains under-investigated.  
 
A small retrospective study was the first to report hip effusion in 12/12 subjects and 
severe synovitis in 9/12 subjects with hip RDOA (Rapidly Destructive OA) but did 
not demonstrate correlations of hip effusion.102 Subsequently, in a clinical study, hip 
effusion-synovitis was reported in 70% of the subjects and major or/and asymmetrical 
hip effusion-synovitis associated not only with hip pain but also with hip radiographic 
OA (ROA).147 In an MRI-based study evaluating hip effusion and synovitis 
separately, a weak association between grade 1 synovitis (but not grade 2) and hip 
pain was found. However, in subjects with either synovitis or effusion, severe hip 
ROA was prevalent.93 In a retrospective study, extensive synovitis was found in 
subjects with RDOA than in those with hip OA, indicating that higher synovitis could 
be related to  rapid disease progression.227 Similar and modest correlations between 
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synovitis-effusion and hip ROA were demonstrated in a recent study validating a 
scoring system to evaluate hip OA. However, there was no association between hip 
effusion-synovitis and hip pain score.94  
 
Effusion-synovitis may be associated with hip ROA and only one study reports its 
association with hip pain. To the best of our knowledge, a population-based 
longitudinal study examining hip effusion-synovitis has not been published. Given the 
impact of synovitis on the joint and cartilage, examining effusion-synovitis should be 
one of the primary focuses for research in OA. Such information could be beneficial 
to generate techniques to target effusion-synovitis for management and control of OA 
and also for preserving the cartilage and reducing pain. Hence, this study aims to 
describe the cross-sectional and longitudinal associations of hip effusion-synovitis in 
a large community-based sample. 
Methods and Materials 
Subjects 
The Tasmanian Older Adult Cohort (TASOAC) study is an ongoing prospective, 
population-based study initiated in 2002 and has been extensively described in 
previous studies.107  The current study is a sub-sample from the TASOAC cohort. 
During the TASOAC study, a hip protocol was added during the latter part of phase 2. 
A sample of 245 consecutive participants who had a STIR (Short T1 Inversion 
Recovery) MRI sequence at phase 2 and/or phase 3 were included. Of these 245 
participants, 30 participants were lost to follow-up in phase 3 and 17 subjects had no 
STIR MRI at phase 2. Of 198 subjects, hip effusion-synovitis could not be adequately 
assessed in the MRI scans of 2 subjects and these were excluded. Accordingly, a total 
of 196 subjects with complete data were included in this study. Written informed 
consent was obtained from all participants and the Southern Tasmanian Health and 
Medical Human Research Ethics Committee approved this study. 
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Clinical and hip pain measures 
Height, weight and body mass index (BMI) were measured using standard protocol. 
Hip pain for all the subjects was determined using a hip specific Western Ontario and 
McMaster Universities Arthritis Index(WOMAC).89 WOMAC uses a ten-point scale 
from 0(indicating no pain) to 9(indicating severe pain). Hip pain(five items) was 
assessed using the following questions: ‘Referring to your hips only, how much pain 
did you experience when walking on flat surface, going up and down the stairs, at 
night while in bed, sitting or lying, and standing upright.’ These five items were 
summed to create a total hip pain score, each with a possible range from 0 to 45 
  
Magnetic Resonance Imaging (MRI)  
The right hip was imaged in the sagittal plane using a 1.5 Tesla G.E signal whole-
body magnetic resonance unit with a phased-array flex coil. The following image 
sequence was used: STIR-weighted fat saturation two-dimensional fast spin echo 
sequence; repetition time 4340 msec, echo time 28.4 msec; field of view 20 cm; 15 
partitions and 512 x 512-pixel matrix. Sagittal images were obtained at a slice 
thickness of 3.5 mm with an interslice gap of 1.5mm. 
Quantitative assessment of hip effusion-synovitis  
For quantitative measurements of hip effusion-synovitis, the observer (HA) selected 
the MRI slice with the largest effusion-synovitis and measured the maximum cross-
sectional area (CSA) by drawing contours around the outer edges (Figure 1). If the 
effusion-synovitis was present at more than one site around the femoral head 
(anterior, posterior or both), then the largest CSA of effusion-synovitis on each site 
was assessed. The reproducibility was evaluated in 40 subjects, with a four weeks’ 
interval between the two measures. The intra-rater agreement (kappa) for the presence 
of hip effusion-synovitis was 0.84, and the intra-class correlation coefficient (ICC) for 
hip effusion-synovitis CSA was 0.97. 
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   Figure 7-1: Assessment of hip effusion-synovitis using OsiriX imaging software 
Assessment of hip cartilage defects, hip BMLs, and high cartilage signal  
Hip cartilage defects were assessed using OsiriX (Figure 2). Hip defects were 
identified as any change in the hip cartilage and were categorized as; grade 0=normal 
cartilage, grade1=focal blistering or irregularities on the cartilage surface or a partial 
thickness defect and grade2=full-thickness defect with bone ulceration and/or 
exposure of bone. If a hip cartilage defect was located at the femoral head, it was 
labelled as femoral cartilage defect and if a hip cartilage defect was located at the 
acetabulum it was labelled as acetabular cartilage defect.  If more than one defect was 
present at one site, the highest score was used. In a reliability study of 40 subjects 
with re-measurements after four weeks, the intra-rater agreement (kappa) was 0.89. 
Furthermore, the inter-rater reliability (kappa) assessed by two readers (n=40) for the 
presence of hip cartilage defects and defect categories was 0.84 and 0.63 respectively 
(Figure 7-2).  
Hip BMLs were identified as areas of increased signal intensity adjacent to the 
subchondral bone on the femoral head and/or the acetabulum. The observer manually 
selected the MR slice with the largest BML and then determined the BML size (cm2) 
(Figure 7-2).215 High cartilage signal intensity change122, 128 was defined as a high 
signal intensity band within the hip cartilage either adjacent to a hip BML or at any 
location on the STIR MRI slice if there was no BML present (Figure 7-2).215 
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Figure 7-2: Measurement of hip BML, high cartilage signal and hip cartilage defects 
using OsiriX imaging software 
     
Hip radiographs  
Antero-posterior radiographs of the pelvis with weight bearing and with both feet in 
10 degrees internal rotation were obtained and radiographs were assessed for 
radiographic hip OA at phase 1 (baseline). All images were scored for joint space 
narrowing (JSN) and osteophytes, each on the scale of 0-3 (0=normal and 3=severe) 
according to the Osteoarthritis Research Society International(OARSI) atlas.77 The 
JSN and osteophytes scores were summed to produce a hip total radiographic score 
and a total score of greater than 1 is defined as presence of hip ROA.86  A non-zero 
score of either JSN or osteophytes was regarded as evidence of hip ROA. Thus, after 
combining JSN and osteophytes score, the presence of hip ROA was defined as a total 
score of 1 or greater. 
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Statistical analyses  
Ninety-four percent of the population had any hip effusion-synovitis. We were unable 
to differentiate between physiological (e.g. normal joint fluid) and pathological joint 
fluid. Initial data driven cut off points did not reveal any significant results. For some 
analyses, the population was divided into two groups by median effusion-synovitis 
CSA. The first group included subjects with no or small (<0.77cm2) hip effusion-
synovitis and the second group included subjects with moderate or large hip effusion-
synovitis (≥0.77cm2). Within these two groups, differences in demographical 
characteristics were calculated by using unpaired t-tests and chi-square tests (Table 7-
1). Hip effusion-synovitis was also analysed by the number of sites affected 
(independent of size) and continuously as CSA. 
For cross-sectional analysis, log-binomial regression was employed to estimate the 
association between presence of hip pain, moderate/large hip effusion-synovitis and 
presence of hip effusion-synovitis at one or two/three sites. For estimating the 
relationship between severity of hip pain, moderate/large hip effusion-synovitis and 
effusion-synovitis at multiple sites, linear regression of the logarithm of pain score on 
a binary covariate for hip effusion-synovitis was used. Again, log-binominal 
regression models were applied to investigate the associations between presence of 
hip BMLs, high cartilage signal, hip cartilage defects, hip ROA and presence of hip 
effusion-synovitis while linear regression was used to test the relationship between 
these factors and hip effusion-synovitis CSA. Associations between presence of hip 
BMLs and presence of hip cartilage defects were also investigated using similar 
models. 
For longitudinal analyses, linear regression models were administered to estimate the 
relationship between change in hip pain and change in hip effusion-synovitis CSA. 
Similarly, the association between change in prevalence of hip BMLs, hip cartilage 
defects, hip ROA (baseline only) and change in hip effusion -synovitis CSA was 
examined using linear regression. Log binominal regression was employed to 
investigate if hip BMLs predicted incident and worsening of hip cartilage defects and 
vice versa (from phase 2 to phase 3). All models were adjusted for age, sex, body 
mass index (BMI), hip BMLs and hip cartilage defects as required. For cross-sectional 
analysis only, data on subjects at phase 2 and phase 3 were combined in analyses. All 
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statistical tests were two sided and p values < 0.05 were considered significant and 
were conducted using Intercooled Stata 12 for Mac (Stata Corp, College station, TX, 
USA). 
Results 
Characteristics of the sample population 
Table 7-1 presents the characteristics of the sample population split by the median 
effusion-synovitis size. Age, the percentage of males and BMI was similar in subjects 
with no/small and moderate/large hip effusion-synovitis. Presence of hip pain was 
higher in those with moderate/large hip effusion-synovitis but no other differences 
were observed between the two groups for structural or radiographic features of the 
hip. 
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Table 7-1: Characteristics of the sample population 
 
 
 
 
 
 
 
 
Characteristics  
Small or no hip 
effusion-
synovitis  
(N=63) 
Moderate or large 
hip effusion- 
synovitis 
(N=133) 
p-value 
Age (yrs.): mean (SD) 64.1 (6.72) 64.7 (7.01) 0.40 
Male sex (%)  46% 45% 0.94 
BMI (kg/cm2): mean (SD) 27.6 (4.45) 28.0 (4.40) 0.32 
Hip pain     
       Presence  30% 38% 0.04 
       Severity:  mean (SD) 1.96 (5.52) 1.98 (4.12) 0.95 
High cartilage signal  56% 58% 0.72 
Presence of any bone 
marrow lesions (BMLs)  
20% 14% 0.11 
Hip cartilage defects     
       Femoral defects 52% 60% 0.11 
       Acetabular defects 66% 66% 0.93 
       Any hip defects 68% 73% 0.33 
Presence of radiographic 
hip OA (ROA) 
50% 53% 0.81 
Data presented as means (SD) and proportions.  
Bold indicates statistically significant results (p<0.05).  
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Cross-sectional associations between hip pain and categories of hip effusion-
synovitis  
Table 7-2 shows the cross-sectional associations between the presence and severity of 
hip pain and categories of hip effusion-synovitis. Overall, subjects with 
moderate/large hip effusion-synovitis had 31% greater hip pain but this association 
was not statistically significant. Nevertheless, those with hip effusion-synovitis at 
multiple sites had 42% higher hip pain in comparison to those with hip effusion-
synovitis at only one site. Hip effusion-synovitis did not associate with severity of hip 
pain. 
 
Table 7-2: Cross-sectional associations between presence of hip pain and categories 
of hip effusion. 
 
 
 
Study factor  Presence of hip pain Severity of hip pain 
Categories of hip effusion-
synovitis  
Adjusted PR 
(95%CI) * 
Ratio of means 
(95%CI)** 
Moderate/large hip effusion- 
synovitis 
1.31 (0.98, 1.74) 0.81 (0.53, 1.08) 
Hip effusion- synovitis at 
two/three sites 
1.42 (1.05, 1.93) 0.99 (0.70, 1.40) 
Independent variable: presence and severity of hip pain. Dependent variable: hip effusion- 
synovitis (moderate/large & multiple sites) 
*PR (95%CI)= prevalence ratios (95% confidence intervals) adjusted for age, sex, BMI, 
presence of hip BMLs, presence of cartilage defects and with clustering of observation on 
subjects at phase 2 and phase 3 taken into account. 
** Ratio of means (95% confidence intervals) adjusted for age, sex, BMI, presence of hip 
BMLs, presence of hip cartilage defects and with clustering of observation on subjects at 
phase 2 and phase 3 taken into account. 
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Cross-sectionally, hip BMLs (PR:0.75 95%CI:0.36,1.60), high cartilage signal 
(PR:1.01 95%CI:0.85,1.21), hip cartilage defects (PR:1.12 95%CI:0.88,1.42) and hip 
ROA (PR:0.94 95%CI: 0.74,1.20) were not associated with the presence of hip 
effusion-synovitis. Nevertheless, any hip BMLs associated with any hip cartilage 
defects (PR: 1.22 95%CI 1.06, 1.40) independent of presence of hip effusion- 
synovitis.  
 
For hip effusion-synovitis CSA, independent of presence of hip BMLs, femoral 
cartilage defects (βeta: 0.32 95%CI 0.08, 0.56) associated with hip effusion-synovitis 
CSA. No other structural or radiographic features of hip showed statistically 
significant associations with hip effusion-synovitis size.  
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Change in hip pain and change in hip effusion-synovitis CSA  
Table 7-3 summarizes the longitudinal association between change in hip pain and 
change in hip effusion- synovitis CSA. Although, resolving hip effusion showed a 
reduction in hip pain and worsening or persistent hip effusion- synovitis showed an 
increase in hip pain but these analyses were not statistically significant.  
 
Table 7-3: Longitudinal associations between change in hip pain and hip effusion-  
 
 
 
Study factor   Change in hip pain Change in hip pain 
  n 
 Adjusted  
βeta (95% CI)* 
Further adjusted  
βeta (95% CI)** 
No hip effusion- synovitis 8   
Resolved hip effusion- 
synovitis 
11 -0.20 (-1.51, 1.20) -0.31 (-1.82, 1.20) 
Worsening or persistent hip 
effusion -synovitis 
174 +0.32 (-0.81, 1.46)  +0.30 (-0.91, 1.52) 
Independent variable: change in hip pain. Dependent variable: change in hip effusion- 
synovitis CSA/size   
*βeta co-efficient (95% confidence intervals) adjusted for age, sex and body mass index and 
with clustering of observation on subjects at phase 2 and phase 3 taken into account. 
** βeta co-efficient (95% confidence intervals) further adjusted for hip BMLs and hip cartilage 
defects at phase 2. 
Bold indicates statistically significant results.  
CSA= cross-sectional area 
 
106 
 
 
 
Change in prevalence of structure abnormalities and change in hip effusion-
synovitis CSA 
Table 7-4 outlines the longitudinal associations between change in prevalence of any 
large hip BMLs, hip cartilage defects, hip ROA (baseline) and change in hip effusion- 
synovitis CSA. Any large persistent hip BMLs and incident of hip cartilage defects 
was associated with an increase in hip effusion- synovitis CSA. These associations 
persisted even after adjusting for hip BMLs or hip cartilage defects. However, 
presence of hip ROA did not show an association with change in hip effusion- 
synovitis CSA.   
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Table 7-4: Longitudinal associations between change in hip effusion- synovitis size, 
structural anomalies and radiographic findings. 
 
 
Further longitudinal analyses (independent of hip effusion-synovitis) showed that any hip 
BML predicted incident (PR: 1.62 95%CI: 1.13, 2.34) and worsening hip cartilage defects 
(PR: 1.50 95%CI: 1.20, 1.86). Conversely, any hip cartilage defect predicted incident (PR: 
1.11 95%CI: 1.03, 1.20) and worsening hip BMLs (PR: 1.16 95%CI: 1.04, 1.30). 
 
 
  
Change in effusion- 
synovitis CSA 
Change in effusion- 
synovitis CSA 
Study factor n 
Adjusted  
βeta coefficient 
(95%CI)* 
Further adjusted 
βeta coefficient 
(95%CI)** 
Any large BMLs    
          Absent 186   
          Resolved 4 +0.34 (−0.18, +0.90) +0.34 (−0.20, +0.90) 
          Incident  4 −0.00 (−0.53, +0.52) 0.00 (−0.52, +0.52) 
          Persistent 1 +0.60 (+0.41, +0.76) +0.63 (+0.42, +0.85) 
Hip cartilage defects    
           Absent 48   
           Incident 16 +0.32 (+0.01, 0.62) +0.36 (+0.03, 0.70) 
           Persistent  130 -0.00 (-0.20, 0.19) +0.01 (-0.20, 0.21) 
Baseline hip ROA    
            Absent 124   
            Grade1/Grade 2 41 +0.11 (-0.14, 0.40) +0.13 (-0.14, 0.40) 
            Grade3/Grade 4 9 +0.30 (-0.30, 0.85) +0.42 (-0.15, 0.98) 
Independent variable: presence of structural/ radiographic factors. Dependent variable: 
change in hip effusion- synovitis size   
* Adjusted for age, sex and body mass index at phase 2.  
** Adjusted for hip cartilage defects or BMLs at phase 2 where appropriate.  
Analyses for hip ROA adjusted for both hip BMLs and hip cartilage defects.  
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Discussion  
This prospective cohort study describes the correlates of hip effusion- synovitis. 
Overall there was no association between hip effusion- synovitis and hip pain, 
however, presence of hip effusion- synovitis at multiple sites (presumably reflecting 
effusion-synovitis extent) was associated with presence of hip pain. Hip effusion- 
synovitis did not associate with worsening hip pain. Femoral defects were associated 
with hip effusion- synovitis CSA both cross-sectionally and longitudinally while any 
large persistent BMLs predicted an increase in hip effusion- synovitis CSA.  
Cross-sectionally, subjects with a hip effusion- synovitis at multiple sites were 42% 
more likely to have hip pain. Hip effusion- synovitis did not associate with severity of 
hip pain. Longitudinally, subjects with resolving hip effusion-synovitis showed a 
decrease in hip pain while subjects with worsening or persistent hip effusion- 
synovitis had an increase in hip pain. However, these analyses were not statistically 
significant and adjusting for hip BMLs or hip cartilage defects made no difference. At 
the hip, three studies besides ours have reported these associations and have found 
similar inconsistencies. The first study demonstrated that older adults with diagnosed 
hip OA with hip pain in mid-thigh and pain on palpation had higher odds of major hip 
effusion-synovitis.147 While in the second study, a weak association was found 
between hip pain and grade 1 but not grade 2 synovitis. 93 The third and the latest 
study aiming to validate a hip scoring system found no correlation between hip 
effusion-synovitis and hip pain score.94 These studies lack longitudinal data and 
measured effusion or synovitis semi-quantitatively. Also, only one of the above 
studies measured synovitis and effusion separately.  While our study has its strengths, 
we did not assess site-specific hip pain and a cross-sectional association was found 
only in subjects who had extensive hip effusion- synovitis. We could not differentiate 
between physiological or pathological joint fluid but overall, it appears that site and 
extent of effusion- synovitis at the hip may be relevant for pain in OA.  
Cross-sectionally, femoral cartilage defects correlated with larger hip effusion-
synovitis CSA. Subsequently, incident hip cartilage defects predicted an increase in 
hip effusion-synovitis size. Persistent hip cartilage defects were not associated with a 
change in hip effusion-synovitis CSA. An association between incident hip cartilage 
defects and hip effusion-synovitis has not been previously reported but most of the 
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existing evidence for knee OA coincides with our findings. For instance, subjects with 
large knee effusion-synovitis (>grade 2) at baseline had 2.7 times greater risk of knee 
cartilage damage at the end of 30 months follow-up.115 A recent longitudinal study 
reported that regional knee effusion-synovitis predicted knee cartilage defects; 
cartilage volume loss and knee BMLs and these associations were largely mediated by 
cartilage defects.134 Hence, causal pathways exist between knee effusion-synovitis 
and knee cartilage defects; and suggests that knee cartilage defects could lead to the 
development of BMLs and cartilage volume loss at the knee joint.134 Our results are 
comparable with these studies and so far, this is the first study to report these 
associations at the hip.  
Hip BMLs associated with hip effusion-synovitis longitudinally. Moreover, this 
association persisted after adjusting for hip cartilage defects. In knee OA, a positive 
and modest correlation was reported between knee effusion (but not synovitis) and 
knee BMLs.228 A longitudinal study, demonstrated an association between knee 
effusion-synovitis and knee BMLs but this association was not independent of knee 
cartilage defects.134 We found that persistent large hip BMLs over the period of 2.6 
years predicted an increase in hip effusion-synovitis size. Also, hip BMLs were 
associated with the formation and worsening of hip cartilage defects. These results are 
consistent with our previous work.114 However, these analyses were based on a 
limited number of hip BMLs and these results should be interpreted cautiously and 
further studies are necessary.  
Overall, incident hip cartilage defects and persistent large hip BMLs independently 
predicted an increase in hip effusion-synovitis. Also, hip cartilage defects predicted 
incident and worsening of hip BMLs and vice-versa. Our data suggests that the 
association of hip effusion-synovitis could be stronger and more consistent with 
cartilage defects than BMLs. This could be due to inter-dependency between effusion- 
synovitis and cartilage. Catabolic and proinflammatory mediators triggered by 
synovitis lead to intra-articular debris due to cartilage breakdown. In turn, presence of 
articular debris causes further inflammation of the synovium. Hypothetically, an 
increase in joint intra-capsular pressure could push synovitis into the subchondral 
bone through the cartilage defects causing the formation of BMLs.116, 134, 139 
Moreover, BMLs are known to correlate with not only knee subchondral bone mineral 
density(BMD)203 but also with local hip BMD.229 Thus, suggesting a definite causal 
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pathway between hip effusion- synovitis, hip defects, hip BMLs and alterations in the 
bone itself. 
High cartilage signal did not associate with hip effusion-synovitis but surprisingly 
there was no relationship between hip ROA and hip effusion-synovitis either. Here, 
subjects with grade 3 or 4 hip ROA at baseline had increase in effusion-synovitis CSA 
at follow-up but these analyses were not statistically significant. An association 
between hip effusion-synovitis and hip ROA has been described in previous studies. 
Two cross-sectional studies demonstrated that hip effusion or synovitis associated 
with greater odds147 and higher prevalence of hip ROA.93 A third study with 98 
subjects reported modest correlations between effusion-synovitis and hip ROA.94 
These studies measured effusion-synovitis semi-quantitatively. Additionally, the 
prevalence of severe hip OA (grade>2) in the above studies was between 15%-34% 
but in our cohort, it was low at 5.4%. We did not separate hip effusion from synovitis 
and this could affect our results but 2/3 studies above used similar methods. There 
could be a possibility that hip ROA does not associate with a change in hip effusion-
synovitis, in the long run. However, these analyses were conducted in a community-
based cohort with a lower severity of disease and further studies are necessary.  
Limitations 
This was the first study to assess hip effusion-synovitis quantitatively and we have 
applied similar methods previously114, 215 and obtained high reproducibility. The STIR 
MRI sequence used to examine joint effusion-synovitis did not allow separation of 
physiological and pathological effusion but our findings allow an assessment of this 
and match with other MRI-based reports using similar techniques.94, 134, 147 
Longitudinal analyses were carried out in a small number of subjects with hip BMLs 
but the results were statistically significant and coincided with existing literature.  
Conclusion  
Hip effusion- synovitis at multiple sites (presumably reflecting extent) may be 
associated with hip pain. Hip BMLs and hip cartilage defects are co-dependent and 
predict worsening hip effusion- synovitis, indicating shared causal pathways between 
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defects, BMLs, and effusion- synovitis. Together, these factors have a deleterious 
effect on the bone and also contribute towards progression of OA. 
Postscript  
The aim of this thesis was to determine the associations and understand the 
pathophysiological changes occurring in the bone in early OA. Structural changes 
such as BMLs and defects associated with major clinical outcomes such as pain and 
ROA. Generally, chapters 4-7 demonstrate that in preclinical OA there are shared 
underlying pathways between effusion-synovitis, cartilage defects, hip BMLs and 
changes in the bone which may eventually manifest as pain, inflammation, and joint 
deterioration.  
This chapter concludes the studies which focused on describing changes in joint 
structure and their associations in older adults. The goal of this thesis is not only to 
study changes in the joint structure but also assess muscle health. Thus, the next 
chapter includes a mechanist study which uses MRI’s to assess hip muscles and then 
describes their relationship with bone density and leg strength in the TASOAC cohort.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
112 
 
 
 
Chapter 8 : The association between hip muscle cross-sectional area, 
muscle strength and bone mineral density.  
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Introduction 
Loss of skeletal muscle mass and strength, also known as sarcopenia, has been 
recognized as a predictor of reduced muscle strength and bone mineral density 
(BMD),156, 230 possibly due common determinants.150, 231 Additionally, studies have 
found that subjects with lower skeletal mass are at higher risk of falls,157 fractures152 
and loss of function.232 Muscle cross-sectional area (CSA) is a validated surrogate 
measure for muscle mass. Research suggests that CSA of the thigh in the elderly 
predicts hip fractures233 and increased risk of osteoporosis.234 Similarly, individual 
muscle CSA associates with cartilage,159, 235 muscle strength,166, 236 joint biomechanics 
237 and bone structure.151, 238 
 
In comparison to skeletal mass, fewer studies have investigated the correlations 
between individual muscle CSA and BMD. For instance, Revel et.al compared the 
associations between psoas, erector spine and triceps brachii muscle CSA and BMD 
of lumbar spine in 89 post-menopausal women and found a correlation between psoas 
muscle CSA and spine BMD.163 The same group conducted a clinical trial in which 
67 post-menopausal women were selected for physical training targeting either the 
psoas or the deltoid muscles. After 12 months, women who had trained their deltoid 
muscle had a greater loss in spine BMD in comparison to women who had trained 
their psoas muscle [-8.87% v +0.14%].239 These studies suggest that local muscles, 
which insert directly into the bone, are involved in the preservation of bone density. 
Furthermore, in a magnetic resonance imaging (MRI)-based cross-sectional study, 
Klein et.al suggested that both upper arm muscle CSA and forearm muscle CSA were 
the best predictors of humerus and forearm cortical bone health.238 Lastly, in a 
longitudinal study using peripheral quantitative computed tomography (pQCT), 
Edwards et.al found larger forearm CSA was positively associated with higher radial 
bone mineral content and bone area but not bone density.151 These studies support the 
Wolf and Frost theory,65, 66 which proposes, that the increase in bone mass is due to 
muscle accumulation on bone and muscle recruitment and contraction during 
locomotion.  
 
Skeletal muscle is not only linked with bone mass but also influences variability in 
strength.237, 240 Although muscles have been examined as groups; studies investigating 
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the relationship between individual muscles and strength are rare. Masuda et.al 
investigated the correlation of isokinetic muscle strength and muscle CSA of the 
lower limb in 14 healthy soccer players (age 19-22 yrs.) and reported that CSA of 
gluteus medius and minimus (scored together) and gluteus maximus were strongly 
correlated with hip abductor strength. Additionally iliopsoas muscle CSA was 
moderately correlated with hip flexion strength.166 Takai et.al, conducted a cross-
sectional study in older adults (age 63-64 yrs.) and found a very strong correlation 
between quadriceps muscle CSA and isometric knee extension force during sit-to-
stand testing.167 Furthermore, Frontera et.al investigated the longitudinal changes in 
muscle CSA and muscle strength in 9 men (age 65yrs.) for 12 years and concluded 
that variation in muscle CSA was accountable for 90% of variability in muscle 
strength.  
 
In general, association between muscle mass and measured individually or as a group 
is positively associated with BMD and strength. However, firstly, less is known about 
the relationship of individual muscles and bone mass. Furthermore, studies suggest 
that muscles having a direct link with the joint and those which are recruited often, 
might have a greater influence on bone mass. Secondly, examining the relationship 
between muscle CSA and muscle strength provides greater understanding of muscle 
morphology and also aids in maintaining muscle strength in older adults. Thus, the 
objective of our study was to describe the cross-sectional associations between 
individual hip muscles, muscle strength and bone density at the hip, femoral neck and 
spine. 
 
Methods and Materials 
TASOAC cohort  
This study was conducted as a part of the Tasmanian Older Adult Cohort (TASOAC) 
study, a prospective, population-based study initiated in 2002 aimed at identifying the 
environmental, genetic and biochemical factors associated with the development and 
progression of OA at multiple sites (hand, knee, hip and spine). Subjects between the 
ages of 50 to 80 years were randomly selected from the electoral roll of Southern 
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Tasmania (population 229,000), with an equal number of men and women. The 
overall response rate was 57%. As TASOAC was designed to examine community-
dwelling older adults and hence all institutionalized older adults were excluded. 
Participants were also excluded if they had a contraindication for MRI, including 
previous hip replacements. Of all initially eligible participants, 1,100 enrolled in the 
study, and 1,099 attended a baseline (Phase 1) clinic between March 2002 and 
September 2004. Follow-up data (Phase 2) was collected for 875 participants at a 
clinic approximately three years later and then again for 769 participants (Phase 3) at 
a clinic approximately five years later.  
 
Hip MRI scans were added to the study in the later stages of phase 2. 328 subjects had 
a right hip MRI (T1-weighted) at phase 2 and of these 7 subjects had missing data or 
corrupted MRIs leaving 321 with complete data. No subject included in this study had 
a history of hip fracture at phase 2. In addition, at baseline (Phase 1) subjects included 
in the current study (n=321) were younger (age: 61.6 v 63.6, p<0.001) in comparison 
to the rest of the TASOAC cohort (n=778), however no other differences in sex, BMI, 
bone mineral density and leg strength were found between the two populations. 
Written informed consent was obtained from all participants and the Southern 
Tasmanian Health and Medical Human Research Ethics Committee approved this 
study. 
Clinical measurements 
Demographic characteristics, medical history, and lifestyle factors were assessed by 
self-administered questionnaires. Height was measured to the nearest 0.1 cm using a 
stadiometer (with shoes, socks and bulky clothes removed). Weight was measured to 
the nearest 0.1 kg (with shoes, socks and bulky clothes removed) using a single pair 
of electronic scales (Seca Delta model 707; Hamburg, Germany). Body mass index 
(BMI) was calculated as the weight (kg) divided by height (m2).   
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Magnetic Resonance imaging   
An MRI scan of the right hip was performed. The hip was imaged in the sagittal plane 
using a 1.5 Tesla G.E signal whole-body magnetic resonance unit with a phased-array 
flex coil. The following image sequence was used: a T1-weighted fat-suppressed 3-
dimensional gradient-recalled acquisition in the steady state; flip angle 55°; repetition 
time 58 msec; echo time 12 msec; field of view 16 cm; 60 partitions; 512 x 512–pixel 
matrix; acquisition time 11 minutes 56 seconds, and 1 acquisition. Sagittal images 
were obtained at a partition thickness of 1.5 mm and an in-plane resolution of 0.39 x 
0.39 mm (512 x 512 pixels). In this study the approximate range of hip MRI images 
was from the middle of greater sciatic notch in the pelvis to the end of the lesser 
trochanter of the femur.  
Measurement of muscle cross-sectional area (CSA)  
Hip muscles were identified and chosen for measurement as per MRI field of view 
(figure 3-3). Measurements of clearly visible muscle CSA, where the entire area of 
the muscle was visible and distinguishable from the adjacent muscles were made at 
the anatomical landmarks described in Table 8-1. Hip muscle area was assessed on 
MR images using OsiriX (Geneva) software measuring maximum muscle CSA (cm2) 
of gluteus maximus, obturator externus, gemelli, quadratus femoris, piriformis, 
pectineus, sartorius and iliopsoas (Figure 8-1). If any of the hip muscles above were 
not distinguishable from adjacent muscles they were not measured; hence not all eight 
muscles were measured in all subjects. The CSA of each hip muscle was measured on 
two consecutive slices by one trained observer (HA) and the average was taken as the 
final measurement. The majority of hip muscles were measured on sagittal MR 
images except iliopsoas, which was measured by reformatting the whole sagittal 
image to the axial plane. The superior and inferior gemelli were measured together. 
The intra-class correlation coefficient (ICC) for the retest-reliability after two weeks 
(n=40, same observer) was calculated for each muscle using the ICC (3,1) formula. 
The ICCs for all hip muscle CSAs ranged from 0.98-0.99.  
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Anatomical landmarks of hip muscle CSA 
Table 8-1: Hip muscles anatomical landmark chart. 
Hip Muscle Anatomical Landmark  
Hip extensor  
Gluteus Maximus First appearance of the femoral head cartilage in sagittal 
section  
Hip rotators  
Obturator externus First appearance of the femoral head cartilage in sagittal 
section  
Gemelli First appearance of the femoral neck.  
Quadratus femoris Round head of the femur is no longer visible in the sagittal 
section  
Piriformis First appearance of the bony femoral head in sagittal 
section 
Hip flexors   
Pectineus  First appearance of the femoral head cartilage in sagittal 
section (adjacent to obturator externus)  
Iliopsoas Total visibility of the femoral fovea in axial section  
Sartorius First appearance of the femoral neck in sagittal section  
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Figure 8-1: Measurement of hip muscle CSA using OsiriX imaging software.  
(Iliopsoas and quadratus femoris CSA shown as examples) 
 
Bone mineral density 
Bone density (g/cm2) was assessed using dual-energy X-ray absorptiometry (DXA) at 
the right total hip, femoral neck and spine using a single Hologic Delphi densitometer 
(Waltham, MA, USA). The longitudinal coefficient of variation for our densitometer 
using a spine phantom was 0.39%. 241 
Muscle strength 
Leg strength (Figure 8-2) was measured to the nearest kilograms in both legs 
simultaneously, using a dynamometer (TTM Muscular Metre, Tokyo, Japan). This 
test examines isometric strength, predominantly of the quadriceps and hip extensors, 
and has been described in detail previously.218  
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Figure 8-2: Demonstration of the leg strength measurement in TASOAC 
 
Physical activity  
 
Physical activity was assessed as steps/day determined by (Yamax SW-200, Yamax 
USA, San Antonio, Texas, USA). Each participant was instructed to wear the 
pedometer for seven consecutive days. This was repeated 6 months later for seasonal 
variations. Mean steps/day was calculated as the average of the days worn at both 
time points. 
Statistical analyses 
 
The characteristics of the subjects are summarized as means and standard deviations 
(SD), and for men and women separately because of the sex-related differences in 
muscle CSA. Associations between bone mineral density at the hip; femoral neck, and 
spine and muscle CSA are summarized as standardized regression coefficients. In 
order to test whether the association between muscle and spine BMD was independent 
to local BMD, the analysis for spine BMD was adjusted for hip BMD. The 
associations of hip and femoral neck BMD with pectineus and sartorius CSA varied 
by sex as determined by tests of statistical interaction, and are presented for men and 
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women separately. Regression analyses were also conducted with muscle strength as 
the response variable, and in this case the results of association with iliopsoas are 
presented for men and women separately, based on significant interaction. Lastly, 
regression models were used to examine the association between muscle strength and 
bone density. All statistical models were adjusted for age, sex (where appropriate) and 
steps per day but not body size as muscle size was a key focus of this study. All 
statistical tests were two sided and p values < 0.05 were considered significant. All 
statistical analysis was conducted using Intercooled Stata 12 for Mac (Stata Corp. 
College station, TX, USA) 
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Results 
Characteristics of the study sample  
Table 8-2 describes the characteristics of the study sample. There was similar mean 
age and mean BMI in men and women, however, men had higher mean muscle 
strength, muscle CSA, steps per day and bone mineral density of hip, femoral neck 
and spine.  
 
Table 8-2: Characteristics of the subjects 
Characteristics 
Men 
(n=167) 
Women 
(n=158) 
Age (yrs.) 64.04 (7.47) 63.26 (6.60) 
BMI (kg/m2) 27.50 (3.91) 28.13 (5.23) 
Total hip BMD (g/cm2) 1.02 (0.13) 0.90 (0.13) 
Femoral neck BMD (g/cm2) 0.80 (0.11) 0.74 (0.11) 
Spine BMD (g/cm2) 1.07 (0.17) 0.96 (0.15) 
Leg strength (kg) 135.32 (45.7) 63.11 (28.9) 
Steps per day 8268 (3703) 7384 (3234) 
Gluteus Maximus CSA (cm2) 51.40 (13.6) 42.20 (8.05) 
Obturator Externus CSA (cm2) 9.31 (1.83) 7.11(1.13) 
Gemelli CSA (cm2) 4.33 (1.00) 3.50 (0.93) 
Quadratus femoris CSA (cm2) 7.20 (2.46) 5.92 (1.70) 
Pectineus CSA (cm2) 10.31 (2.09) 7.71 (1.84) 
Piriformis CSA (cm2) 4.92 (1.52) 3.87 (1.24) 
Sartorius CSA (cm2) 10.24 (3.67) 7.71 (2.24) 
Iliopsoas CSA (cm2) 10.08 (1.81) 7.63 (1.48) 
Data presented as means (sd).  
CSA= cross-sectional area.  
BMD = bone mineral density.  
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Bone density and hip muscle CSA 
Table 8-3 shows the associations between bone density and muscle CSA as 
standardized regression coefficients. Apart from pectineus and sartorius, data for 
males and females are combined, as there was no interaction. For pectineus and 
sartorius CSA, the associations with bone density were stronger for women than for 
men. 
 
Both obturator externus and quadratus femoris CSA were positively associated with 
hip and, to a lesser extent, femoral neck BMD, but CSA of piriformis and gluteus 
maximus showed no association with BMD at any site. The associations of all hip 
flexors with bone density of hip and femoral neck were similar and statistically 
significant. Lastly, of all the hip muscles, only gemelli CSA was associated with spine 
BMD. 
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 Table 8-3:Cross-sectional relationship between hip muscle CSA and bone density at the hip, neck and spine 
  Total hip BMD (g/cm2) Femoral neck BMD (g/cm2) Spine BMD (g/cm2) 
Study factor  N 
Standardized βeta (95 % CI) 
(Adjusted) † 
Standardized βeta (95 % CI) 
(Adjusted) † 
Standardized βeta (95 % CI) 
(Adjusted) † 
 
Hip extensor     
Gluteus maximus (cm2) 84 0.01 (-0.28, 0.31) -0.00 (-0.35, 0.27) -0.03 (-0.19, 0.13) 
Hip rotators      
Obturator Externus  (cm2) 219 0.18 (0.00, 0.35) 0.26 (0.10, 0.40) 0.05 (-0.07, 0.16) 
Gemelli  (cm2) 130 0.04 (-0.12, 0.21) 0.03 (-0.14, 0.20) 0.20 (0.08, 0.33) 
Quadratus femoris (cm2) 236 0.19 (0.07, 0.31) 0.16 (0.03, 0.30) 0.04 (-0.06, 0.14) 
Piriformis (cm2) 240 0.11 (-0.02, 0.23) 0.06 (-0.06, 0.20) 0.07 (-0.02, 0.17) 
Hip flexors     
Pectineus (cm2) 153 0.22 (0.06, 0.37) 0.21 (0.05, 0.36) 0.09 (-0.06, 0.23) 
          Men 87 0.18 (-0.05, 0.42) 0.14 (-0.10, 0.37) - 
          Women 66 0.27 (0.05, 0.56) 0.31 (0.09, 0.52) - 
          Interaction (p value)  p=0.04 p=0.01  
Sartorius (cm2) 145 0.22 (0.06, 0.37) 0.26 (0.09, 0.42) 0.05 (-0.06, 0.17) 
           Men  55 0.13 (-0.15, 0.41) 0.09 (-0.19, 0.37) - 
           Women 90 0.29 (0.09, 0.48) 0.41 (0.23, 0.59) - 
          Interaction (p value)  p=0.06 p=0.001  
Iliopsoas (cm2) 215 0.20 (0.05, 0.36) 0.20 (0.03, 0.35) 0.03 (-0.08, 0.15) 
Bold face indicates statistically significant. Independent variable: hip muscles.  Dependent variable: BMD at hip, neck and spine. 
† Adjusted for age, sex and steps per day. Additionally, models for spine BMD have been adjusted for hip BMD 
βeta coefficient (standardized) represents cross-sectional increase in bone density at hip, neck and spine BMD with per unit increase in CSA of hip 
muscles.  
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Hip muscle CSA and muscle strength 
 Table 8-4 presents the associations between hip muscles CSA and muscle strength. 
All hip muscles except gemelli and gluteus maximus were positively but weakly 
associated with muscle strength.  
 
Table 8-4: Cross-sectional associations between hip muscle CSA and muscle strength. 
 
 
Lastly, hip BMD was associated with muscle strength (βeta: 0.12 95%CI 0.04, 0.20). 
Additionally, spine BMD showed a weak association with muscle strength (βeta: 0.10 
Study factor  N 
Standardized βeta  
 (95 % CI) 
(Adjusted) † 
Hip extensor   
Gluteus maximus (cm2) 81 0.11 (-0.01, 0.23) 
Hip rotators    
Obturator externus  (cm2) 206 0.16 (0.05, 0.28) 
Gemelli  (cm2) 125 0.08 (-0.06, 0.21) 
Quadratus femoris (cm2) 222 0.14 (0.04, 0.24) 
Piriformis (cm2) 226 0.12 (0.02, 0.23) 
Hip flexors   
Pectineus (cm2) 144 0.16 (0.04, 0.28) 
Sartorius (cm2) 135 0.12 (0.01, 0.23) 
Iliopsoas (cm2) 205 0.24 (0.12, 0.37) 
      Men  95 0.32 (0.15, 0.49) 
      Women 110 0.17 (0.01, 0.35) 
       Interaction (p value)  p=0.02 
Bold face indicates statistically significant  
Independent variable: hip muscles.  Dependent variable: leg strength. 
n= number of observations. 
† Adjusted for age, sex and steps per day. 
βeta coefficient (standardized) represents cross-sectional increase in leg strength with per 
unit increase in CSA of hip muscles.  
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95%CI: 0.00, 0.21) and the association between femoral neck BMD and muscle 
strength (βeta: 0.07 95%CI: -0.00, 0.15) did not reach statistical significance. 
 
Discussion 
 
This is the first population-based study describing the associations between hip 
muscles CSA, muscle strength and bone density. In the present study, all hip flexor 
CSAs were associated with bone density and of these, associations for pectineus and 
sartorius were stronger for women in comparison to men. Among the hip rotators, 
obturator externus and quadratus femoris was associated with hip and femoral neck 
BMD. Gemelli was the only hip muscle that associated with spine BMD. Lastly, most 
of the hip muscles were associated with muscle strength and overall, muscle strength 
was weakly correlated with BMD.  
 
In general, all hip muscles were positively associated with bone density of the hip, 
femoral neck and spine. We adjusted for age and sex but not for body size. We 
acknowledge that this could lead to bias but we believe that as both, muscle size and 
BMD correlate with body size, any adjustment for body size would be an over 
adjustment. For instance, when we adjusted for BMI in the analyses between total hip 
BMD and muscle CSA, we noted a 2% to 63% reduction in the standardized 
regression coefficients (average of 44% change). This change occurs because of the 
strong correlation between muscle CSA and BMI. Thus, the issue with adjustment for 
BMI or any mass related factor is that it may also reduce any genuine association 
between muscle size and BMD.  
  
Most of the hip muscles, especially hip flexors, were associated with hip and femoral 
neck BMD but these associations differed in men and women. Of the hip rotators, 
quadratus femoris and obturator externus showed a weak association with BMD of 
hip and femoral neck but no difference by gender was found. The reasons for this are 
unclear. The literature on the relationship between skeletal muscle mass and bone 
density in men and women is controversial.151, 152, 231, 242-244 The available data does 
not allow clear conclusions due to differences in methodology, subjects and study 
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designs. One possible explanation is that there are higher flexion and greater hip 
contact forces in women in comparison to men.245-247 Thus it could be speculated that 
due to higher flexion and greater hip contact forces the relationship between bone 
density and hip flexion is stronger in females, however we did not measure 
biomechanical factors in this study.  
 
Unexpectedly, some muscles did not show any associations with bone density or 
strength. For instance, no association was found between gluteus maximus size, 
muscle strength and bone density. This muscle is known to associate with muscle 
strength 166 but its association with bone density is currently unknown. These 
irregularities could be explained by our inability to assess the maximal muscle bulk 
due to limited MRI field of view (especially for the gluteus maximus muscle although 
it should be noted that the measured CSA was greater than any of the other measured 
muscle). An alternative potential explanation as to why gluteus maximus CSA was 
not associated with muscle strength is that other hip extensor muscles, which were not 
assessed in this study, may have been recruited preferentially to this muscle during the 
strength assessment.  
 
Studies show that piriformis is activated during exercise and is mainly involved in hip 
rotation and does contribute to hip strength and stability.248 In the present study, 
piriformis was weakly associated with muscle strength but not with bone density. Our 
findings support this fact, however like, gluteus maximus, the relationship of 
piriformis with bone density is unknown and nor does it associate with hip cartilage 
volume in subjects with or without hip OA.235 Thus, evidence suggests that 
preservation of piriformis may result in better hip stability and perhaps this muscle 
has no role in maintenance of bone mass. 
 
Skeletal muscle mass has been found to be associated with hip and spine BMD231, 
however in this study the correlations between hip muscle CSA and BMD were 
mostly local (i.e hip and femoral neck) with the exception of gemelli, which was 
associated with spine BMD. Gemelli, is a deep hip rotator and has been proposed to 
play a vital role in hip/pelvic stability.249 For instance, when hip rotators were spared 
during surgery, hip dislocation and function deficit rates dropped dramatically149 and 
one study reports that gemelli CSA was positively associated with hip cartilage 
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volume in subjects without hip OA (p=0.02).235  Thus, gemelli may play a role in 
osteoarthritis disease progression however its association with spine BMD is unclear. 
Nevertheless, it has been suggested that gemelli may fuse with its neighboring 
muscle, obturator internus and mimic its functions.250 Obturator internus plays a vital 
role in stabilization of the pelvis, which is interdependent on the spine for its stability. 
Thus, we could speculate that due to its association with obturator internus, gemelli 
might show an association with spine BMD. Again, this is purely hypothesis 
generating and future studies need to explore this concept further.  
 
The mechanostat theory of Wolf suggests that muscles have a direct impact on bone 
and muscle contraction and/or stress on the bone, stimulates an increase in bone 
mass.65, 66, 251 Our findings are in accord with this theory and demonstrate that 
increasing hip muscle size was positively associated with increased local bone density 
and muscle strength. A few studies support our findings and suggest that muscle CSA 
and strength could predict changes in bone health and perhaps bone density,151, 238 
although some variations do exist. In studies by Edwards and Klein et.al, the 
association of bone parameters, muscle strength and muscle CSA of the arm and 
forearm was investigated. Consistent with our results, both studies reported that 
muscles CSA (forearm and arm) but not muscle strength was a better predictor of 
bone measures. However, one of the studies measured radial cortical bone area using 
MRI238 and the other study used pQCT for assessing bone.151 In the second study, an 
association between muscle CSA, bone area, bone mineral content and bone strength 
but not bone density was found151. In comparison to these, we found lower but 
significant associations between hip muscles and bone density. This may suggest that 
assessment of actual bone area or bone structure by MRI or pQCT could be more 
sensitive than bone density measured by DXA or that relationships alter with 
increasing age.252  
 
The relationship between muscle strength and muscle CSA has been investigated151, 
236, 237, 253 and both of these factors are affected by age238 and disease.161, 236 Our data 
is consistent with current literature and expands it showing moderate, consistent 
associations between hip muscles and muscle strength in older adults (albeit the 
associations were weaker as compared to other studies). Additionally, not all hip 
muscles showed an association with strength.  Our study includes community-based 
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older adults who were unlikely to be involved in vigorous activity, which may 
influence this association. Furthermore, we used only one parameter for assessing 
muscle strength that is mostly applied for measuring hip extensor strength and hence 
may not equate with other strength measures used in other studies.166, 167 For instance, 
Takai et.al reported a strong correlation between quadriceps CSA and knee extension 
force that was measured by myometer.167    
 
It is evident that decline in muscle mass has a significant impact on bone mass and 
strength.156, 231 Even though muscle morphology has been explored in biomechanical 
studies164, 168 it has gain less attention in osteoporosis and/or osteoarthritis (OA). In 
addition, unlike bone, muscles have some capacity to regenerate.64, 254 Hence MRI 
studies, like ours, looking into individual muscles can be used for better 
understanding of changes in muscle morphology in older adults, who are more 
vulnerable to the development of OA or osteoporosis. Such studies could aid in 
targeted rehabilitation, which can be applied for management of disease progression 
and maintenance of bone mass.  
Limitations 
This is a cross-sectional study, thus we are unable to determine causal pathways but 
our results were consistent with the existing data. Bone density was measured using 
DXA, which provides an aerial two-dimensional BMD measure that can be influenced 
by differences in bone size. However, we adjusted for age and sex, which are 
reasonable surrogates of bone size differences but did not adjust for other body size 
related covariates for the reasons outlined above. In addition, the comparison of 
unilaterally measured BMD and muscle CSA with bilaterally assessed leg strength 
might have influenced our findings. We measured isometric strength and the 
associations may differ with alternate strength measures. In this study we were unable 
to exclude muscle infiltrates and also could not capture the maximal muscle bulk of 
some muscles due to limited MRI field of view. Furthermore, some muscles were not 
visible on the MRI scans thus we were unable to assess all hip muscles in each 
participant or adjust for independent effects of each muscle.   
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Conclusions 
Overall, hip muscle CSA (especially the hip flexors), and to a lesser extent, muscle 
strength were positively associated with hip BMD. This data suggests that both higher 
muscle mass and strength may contribute to the maintenance of bone mass and 
prevention of disease progress in the older adult. 
Postscript  
CSA is a well-known surrogate measure for muscle mass and this study uses this 
measure to describe the link between muscle mass, muscle strength, and bone density.  
The study outlined in the next chapter uses DEXA images from phase 1 of the 
TASOAC cohort and ASM (software) to assess the global shape of the proximal 
femoral head.  Furthermore, it aims to describe the importance of variations in shape 
of the hip bone and how it could relate to factors associated with progression of hip 
OA. This is the only study in which TASOAC phase 4 data has been used and this 
study were conducted in collaboration with the University of Aberdeen, U.K. 
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Chapter 9 : Hip shape as the predictor of osteoarthritis progression 
in a prospective population cohort.  
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Introduction  
Osteoarthritis (OA) is a musculoskeletal disorder that affects the elderly population 
around the globe and imposes a considerable economic burden on society.10 Though 
OA is a disease of the whole joint, bone and cartilage still remain the focus of its 
clinical manifestation.17 Structural changes such as bone marrow lesions (BMLs) and 
cartilage defects may have a link with progression of hip OA.135, 136, 215, 229 In addition 
to these, morphology of the hip may also predict development of hip OA,170 but most 
current assessments are semi-quantitative and focus on changes in the cartilage and 
the presence of bony outgrowths.171, 172 However, subtle morphological changes are 
difficult to detect by predefined geometrical measures and do not capture the total 
morphology of the hip.  
Statistical shape modelling (SSM)255 is a sophisticated technique that yields a 
quantitative measure of hip morphology from two-dimensional images of the joint, 
such as radiographs,170 and can identify subtle shape variation within a population. An 
SSM generates a set of linearly independent ‘modes of variation’, each of which 
describes a coordinated pattern of variation in hip shape within a study group.  Each 
mode has a mean of zero and unit standard deviation. Every image is then assigned a 
score for each mode describing how many standard deviations it lies from the mean. 
For instance, in a longitudinal study using radiographs from the Rotterdam study, 
subjects who had low scores for mode 6 (describing the upper femoral neck with a 
sharper transition from the femoral head into the lower femoral neck) at baseline were 
at higher risk of developing severe hip OA and total hip replacement (THR).170 
Subsequently we have shown that SSM can be used to model DXA (dual-energy x-
ray absorptiometry) images256-258 and that Kellgren-Lawrence (K-L) grading can be 
applied to these images with as much precision as to radiographs.258 In another 
longitudinal, nested, case-controlled study of elderly women, hip shape modes 
specifically reflecting sizes of the femoral head, femoral neck or greater trochanter 
modestly predicted hip OA.182 Moreover, hip shape modes could also predict THR 
independently of clinical, geometrical and radiological factors.259 However, shape 
modes describing radiographic OA (ROA) may not necessarily associate with clinical 
descriptors such as pain or crepitus.183, 184 Hence, different shape modes might be 
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better at predicting either clinical or radiological progression of hip OA and may 
differ between males and females as they have different hip and pelvic shapes.260    
OA is a multifactorial disease and it is unknown to what extent morphological aspects 
of the hip relate to disease progression. Studies to date have shown that SSM is a 
powerful quantitative tool and is sensitive to changes in bone shape,170, 175, 182, 183, 259, 
261 but it has not been used to study hip OA in a large community-based cohort and 
has not previously been tested for associations with BMLs or effusion-synovitis. 
Thus, the aim of this study was to describe the association between hip shape 
measured at baseline and clinical, demographical, structural and radiological features 
of hip OA both at baseline and over time in an older adult Australian cohort using a 
combination of radiographic, MRI, DXA and patient questionnaire data. 
Materials and Methods 
Subjects  
The Tasmanian Older Adult Cohort (TASOAC) study is an ongoing prospective, 
population-based study initiated in 2002. A total of 1,100 subjects were enrolled in 
the study between March 2002 and September 2004 (phase 1). Follow-up data for 
three clinic visits (phase 2, 3 and 4) were collected for 875, 769 and 531 participants 
respectively. These visits were conducted approximately 3 years, 5 years and 10 years 
from baseline (phase 1). 
A total of 1099 subjects attended a clinic for baseline measurements (phase 1). Of 
these, 264 subjects did not have a DXA image and images for 4 subjects were 
corrupted, leaving 831 subjects with complete baseline data. Hip joint shape was 
measured from baseline DXA scans. All other measures were collected from clinical 
visits or questionnaires between baseline and the 5 year (phase 3) follow-up apart 
from THR which was recorded up to 10 years (phase 4) (Figure 9-1). Written 
informed consent was obtained from all participants and the Southern Tasmanian 
Health and Medical Human Research Ethics Committee approved this study. 
At baseline and all follow-up assessments demographic characteristics, medical 
history and lifestyle factors were assessed by self-administered questionnaires. Height 
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and weight were measured and body mass index (BMI) calculated using standard 
protocols.86 At each follow-up assessment, participants were asked if they had 
undergone total hip replacement surgery and in which hip. 
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Figure 9-1 Flow chart presenting the measures used in the current study at each time point. 
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Pain 
At baseline, self-reported hip pain was recorded as yes/no using a standardized 
questionnaire. The presence and severity of hip pain for all the subjects at the follow-
up visits for phases 2 and 3 were determined using a hip-specific Western Ontario and 
McMaster Universities Osteoarthritis (WOMAC) index pain score89.   
Muscle strength  
Muscle strength (leg strength) was measured at each visit to the nearest kilogram-
force in both legs simultaneously, using a dynamometer (TTM Muscular Metre, 
Tokyo, Japan) as described previously.218  
Magnetic resonance imaging (MRI)  
The right hip was imaged in the sagittal plane using a 1.5 Tesla GE Signa whole-body 
magnetic resonance scanner with a phased-array flex coil using two sequences.  
Sagittal images were obtained at a partition thickness of 1.5 mm with an in-plane 
resolution of 0.39 x 0.39 mm (512 x 512 pixels)81 using, a T1-weighted, fat-
suppressed, 3-dimensional gradient-recalled acquisition in the steady state. The 
parameters for this were: flip angle 55 degrees; repetition time 58 ms; echo time 12 
ms; inversion time (IT) 130 ms; field of view 16 cm; 60 partitions; 512 x 512–pixel 
matrix; acquisition time 11 mins 56 s, and one acquisition.  
A second set of sagittal images was obtained with a slice thickness of 3.5 mm and an 
inter-slice gap of 1.5 mm215 using a STIR-weighted, fat saturation two-dimensional 
fast spin echo sequence. This sequence used a repetition time 4340 ms, echo time 28.4 
ms; field of view 20 cm; 15 partitions (16 slices) and 512 x 512-pixel matrix.  
Hip cartilage volume  
Baseline femoral head cartilage volume was measured for each individual from the 
T1-weighted images by one reader at an independent workstation using the software 
program Osiris (Windows version 3.5; Geneva University Hospital, Geneva, 
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Switzerland). The volume of the femoral head cartilage was calculated by manually 
drawing contours around the cartilage boundaries on each image section. These data 
were then resampled by bilinear and cubic interpolation for the final 3D rendering. 
Intra-observer reliability was assessed and the coefficient of variation (CV) was 
2.5%.81  
Hip bone marrow lesions (BMLS) 
Quantitative assessment of subchondral hip BMLs was done using OsiriX software 
(University of Geneva, Geneva, Switzerland). BMLs were identified as areas of 
increased signal intensity adjacent to the subchondral bone on the femoral head and/or 
the acetabulum.215, 229  
High cartilage signal 
High cartilage signal intensity was identified as an increase in the signal intensity of 
the articular cartilage due to increased water content that appears as a bright band in 
the cartilage122, 128 either adjacent to a hip BML or at any location on the STIR MRI 
slice if there was no BML present. High cartilage signal was graded as 0 for absent 
and 1 for present.215, 229 
Hip effusion-synovitis 
Hip effusion-synovitis was identified and assessed in STIR images from phase 2 and 
phase 3. The observer (HA) manually selected the MR slice with the largest effusion-
synovitis and determined the maximum cross-sectional area (CSA) of the bright 
region by manually drawing contours around the outer edges. In a reliability study of 
40 subjects with re-measurements after four weeks, the intra-rater agreement (kappa) 
for presence of hip effusion-synovitis was 0.84, and the ICC (3, 1) for hip effusion-
synovitis CSA was 0.97.  
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Radiological assessment 
Antero-posterior radiographs of the pelvis were obtained with the individual weight-
bearing and with both feet in 10 degrees’ internal rotation.  Radiographic features of 
joint space narrowing (JSN) (axial and superior) and osteophytes (superior acetabular 
and femoral) of both hips were graded separately on a 4-point scale, ranging from 0 to 
3 where 0= no disease and 3= most severe disease. The total radiographic OA score 
was calculated by summing the JSN and osteophyte scores.86 A non-zero score of 
either JSN or osteophytes was regarded as evidence of hip ROA. Thus, after 
combining JSN and osteophytes score, the presence of hip ROA was defined as a total 
score of 1 or greater. For the purpose of this study data for left hip ROA was used.  
DXA imaging and Statistical shape modelling (SSM) 
At phase 1, DXA images were taken of the left hip using a Hologic Delphi scanner. 
Images were extracted from the Hologic data files using custom-made Matlab 
software (Math Works Inc, Natick, United States) and saved as 8-bit BMP files.  
An 85-point SSM was built to assess the shape of the femoral head, acetabulum and 
femoral neck using the Active Shape Modelling toolkit (University of Manchester, 
Manchester, UK). This model included not only the femoral head shape but also 
osteophytes, the acetabulum and cortical thickness. The SSM template is a set of 
landmark points that define the shape to be identified. For comparison between 
images, each point is always placed on the same anatomical feature on the outline of 
the bone (Figure 9-2).  
 
The coordinates of the points were collected and transferred to custom-written 
SHAPE software (University of Aberdeen, UK). Using SHAPE, the data underwent 
Procrustes transformation, to remove size and orientation effects, and were subjected 
to principal components analysis to generate an independent set of orthogonal mode 
scores for each image.183 The distribution of each mode is normalized to zero mean 
and unit standard deviation so that the scores assigned to each image are in units of 
standard deviations. Reference to a ‘lower’ score, therefore, implies a position 
towards the more negative end of the distribution rather than smaller in absolute 
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terms. A scree plot was generated to visualize the variance described by each mode 
and the first 6 shape modes (figure 9-3) were selected; all explained more than 3.5% 
of the total variance. 
 
A set of 10 images were selected at random from the dataset and the points placed on 
the images by two independent observers (HA & FRS). Point-to-point variability 
between observers (the distance between a point’s coordinates when placed by each 
observer) was assessed using custom code in Matlab and the median was 1.6 pixels.  
Testing for normality using the Shapiro-Wilk test showed a non-normal distribution 
so the median was used rather than the mean.179 
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Figure 9-2: 85-point hip model describing the proximal femur, acetabulum and 
osteophytes  
(Where no osteophytes are present, points are mapped onto the neighbouring bone 
surface). Each line of the template is shown in a different colour. 
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Figure 9-3: The six hip shape modes from TASOAC cohort. 
A) Mode1: changes in femoral head and neck (lower aspect), greater trochanter along 
with longer shaft. B) Mode 2: changes in the femoral head and neck (upper aspect), 
acetabulum and greater trochanter. C) Mode 3: specific shape variations in the upper 
femoral neck, greater trochanter, and shaft. D) Mode 4: femoral head (upper aspect) 
and longer femoral shaft. E) Mode 5: larger greater trochanter and shaft in comparison 
to the femoral head. F) Mode 6: mild changes in greater trochanter and acetabulum.  
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Statistical analyses 
Characteristics of the population were summarized as means and standard deviations 
or as percentages and frequencies. At baseline, the associations of hip shape mode 
scores with the presence of hip pain and radiographic features were assessed using log 
binominal regression analyses. Pairwise Pearson’s correlations were used to calculate 
the correlations of hip shape mode scores with age, body mass index (BMI), hip 
cartilage volume and leg strength while a generalized linear model was applied to 
calculate the link between hip shape mode scores and sex. At follow up, to estimate 
the longitudinal associations of baseline hip shape with the presence of hip pain, MRI-
based structural findings and THR, log binomial regression was used. Linear 
regression analyses were used to investigate the longitudinal associations of baseline 
hip shape mode scores with hip pain severity. To examine the correlations between 
hip shape, hip BMLs and effusion-synovitis size, again pairwise correlation 
coefficients were applied. All models were adjusted for age, sex and body mass index 
(BMI). Follow up data (phase 2 and 3, plus phase 4 for THR) were combined in 
analyses, and the correlation between repeated measurements on individuals was 
taken into account by adjusting standard errors using the sandwich (robust) estimator 
of variance.187-189 All statistical analyses were performed using Intercooled STATA 
12 (Stata Corp, College station, Texas, USA).  
Results  
Characteristics of the study population 
A summary of characteristics of the sample population is presented in Table 9-1 and a 
graphical summary of the significant changes in mode scores resulting in an increased 
prevalence may be found in figure 9-4. At baseline, the average age of the subjects 
was 63 years; they were overweight, 49% of the subjects were males and 41% had hip 
ROA. At follow up, the proportion with hip pain was slightly greater than the 
proportion with self-reported hip pain at baseline (47% vs. 42%). During the time 
frame of ten years, 29 subjects underwent THR. Overall, only about one-fifth of the 
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cohort had a hip BML whereas about three-quarters had a high cartilage signal and 
hip effusion-synovitis.  
Table 9-1: Characteristics of the TASOAC cohort 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Characteristics  
Mean (S.D)  
(n=831) 
Baseline  
Age (yrs.) 63.2 (7.45) 
Sex (Males) 49% 
Body Mass Index (BMI)  27.7 (4.63) 
Hip cartilage volume (cm3) 5340 (1100) 
Presence of hip pain (Y/N) 42% 
Radiological hip OA (ROA) (Y/N) 41% 
Follow up*  
Presence of hip pain (WOMAC) (Y/N) 47% 
Hip pain score (WOMAC) 2.60 (5.24) 
Leg strength (kg) 93.1 (48.5) 
Presence of hip bone marrow lesions (BMLs) (Y/N) 18% 
Hip BML size (CSA) (cm2) 0.20 (0.52) 
Presence of hip cartilage defects (Y/N) 72%  
Presence of high cartilage signal (Y/N) 74% 
Presence of hip effusion-synovitis (Y/N)  95% 
Hip effusion-synovitis size (CSA) (cm2) 1.96 (1.60) 
Total hip replacement (Y/N) **            2.64% 
Data presented as means and standard deviations or percentages and frequencies 
BMD= bone mineral density  
WOMAC= Western Ontario and McMaster Universities Osteoarthritis 
CSA= cross−sectional area  
* Includes data from phase2 and phase3 
** Includes all hip replacements (left or right) from all follow-up assessments 
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The patterns of variation for each of modes 1 to 6 are shown in Figure 9-3. Modes are 
determined in order of the fraction of the total variance they contain. These six modes 
explained 68% of the total variation in the population. Modes 1 and 2 together 
described 45% of the variance and all were greater than 3.5%. Mode 2 was not 
associated with sex. Prevalence ratios for females and males were for mode 1, PR = 
0.84 (P<0.001), indicating men had, on average, higher mode 1 scores than females, 
while higher scores for modes 3-6 were more common among females (range of PR: 
1.16-1.35, P<0.001).     
Associations of hip shape with pain and radiographic features at baseline 
Table 9-2 presents associations of hip shape with hip pain and radiographic features 
of hip OA at baseline. Self–reported hip pain was not associated with shape but 
modes 2 and 6 were associated with the presence of ROA. Analysis of the 
components of ROA showed that several modes were associated with different 
features of hip ROA. For instance, lower scores of modes 1 and 2 showed a weak 
relationship with the presence of JSN and lower mode 4 scores were associated with 
increased prevalence of osteophytes. Mode 6 was positively associated with all the 
major features of ROA with each standard deviation increase in score corresponding 
to a 23%, 15% and 13% higher prevalence of JSN, osteophytes and hip ROA, 
respectively.   
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Table 9-2: The associations of hip shape with hip pain and radiographic features of hip OA at baseline. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hip shape 
modes 
Presence of hip pain  
Presence of hip joint space 
narrowing (JSN)  
Presence of hip 
osteophytes (OST)  
Presence of hip 
radiographic OA   
 PR (95%CI) * PR (95%CI) * PR (95%CI) * PR (95%CI) * 
1 1.03 (0.92, 1.14) 0.88 (0.78, 0.99) 0.94 (0.82, 1.09) 0.94 (0.84, 1.05 
2 0.99 (0.90, 1.11) 0.76 (0.70,0.85) 1.05 (0.91, 1.22) 0.85 (0.76, 0.95) 
3 0.97 (0.90, 1.08) 0.96 (0.85, 1.09) 1.09 (0.94, 1.26) 0.98 (0.90, 1.11) 
4 0.97 (0.90, 1.08) 1.03 (0.91, 1.17) 0.79 (0.70,0.92) 1.07 (0.95, 1.20) 
5 1.04 (0.93, 1.17) 0.93 (0.83, 106) 0.94 (0.81, 1.09) 0.93 (0.82, 1.04) 
6 0.96 (0.90, 1.07) 1.23 (1.09, 1.40) 1.15 (1.00, 1.33) 1.13 (1.01, 1.27) 
Independent variable: hip shape modes at baseline. Dependent variable: Presence of hip pain, ROA, JSN and OST at baseline.  
*PR (95%CI) = prevalence ratios (95% confidence intervals) adjusted for age, sex and body mass index at baseline.  
 Bold text represent statistically important results. 
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Correlations of shape modes at baseline 
Correlations of hip shape modes with age, BMI, and baseline MRI-based structural 
findings are presented in Table 9-3. Although small some of these correlations were 
significant. Age at baseline was significantly associated with lower mode 2 scores, 
describing a wider neck, loss of joint space and greater femoral head coverage.  
Lower scores for modes 1-4 were modestly correlated with greater BMI. Greater 
mode 1 scores, along with lower scores for modes 3-6, were associated with greater 
leg strength and greater hip cartilage volume.   
 
Table 9-3: Correlations of hip shape modes with age, BMI and MRI-based structural 
findings at baseline 
 
 
 
Hip shape 
modes 
Baseline age 
(yrs.) 
Baseline BMI 
(kgs/m2) 
Baseline leg 
strength (Kg) 
Baseline hip 
cartilage volume 
(cm3) 
 
Correlation 
(r)  
Correlation 
(r)  
Correlation 
(r)† 
Correlations (r)† 
1 −0.04 −0.12*** 0.20*** 0.40*** 
2 −0.13*** −0.07* 0.00 −0.03 
3 −0.03 −0.11*** −0.15*** −0.20* 
4 −0.04 −0.10*** −0.13*** −0.25*** 
5 −0.04 −0.04 −0.22*** −0.13 
6 −0.04 −0.02 −0.13*** −0.21* 
Independent variable: hip shape modes at baseline. Dependent variable: hip cartilage 
volume (baseline), hip BML CSA and hip effusion-synovitis CSA. 
* denotes P<0.05, ** denotes P<0.01 and *** denotes P<0.001  
†Correlations adjusted for age, sex and body mass index at baseline. 
Bold indicates statistically significant results.  
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Shape modes and pain at follow-up 
Although not associated with the presence of hip pain at baseline, hip shape was 
associated with the presence and severity of hip pain at follow-up (Table 9-4). Higher 
mode 1 scores and lower scores for modes 3 and 6 predicted an increase in the 
prevalence of hip pain at follow-up. Mode 3 score was also negatively associated with 
the severity of pain.  
 
 Table 9-4: Associations of hip shape modes at baseline with presence and severity of 
hip pain at follow-up 
 
 
 
 
 
 
Hip shape  Presence of hip pain  Severity of hip pain 
Modes PR (95%CI) * βeta coefficient (95%CI) ** 
1 1.09 (1.00,1.20) 0.17 (−0.20, 0.55)  
2 0.99 (0.91, 1.09) −0.13 (−0.50, 0.21)  
3 0.91 (0.82, 0.99) −0.43 (−0.84, −0.02)  
4 0.99 (0.90, 1.09)  −0.12 (−0.55, 0.30)  
5 1.03 (0.94, 1.14)  0.10 (−0.24, 0.45)  
6 0.91 (0.84, 0.99) −0.05 (−0.40, 0.30)  
Independent variable: hip shape modes at baseline. Dependent variable: Presence of hip 
pain (yes/no) and hip pain score (hip WOMAC score ranging from 0-45) at follow up. 
*PR (95%CI)= prevalence ratios (95% confidence intervals) adjusted for age, sex, body 
mass index  with clustering of observation on subjects at phase2 and phase3 taken into 
account. 
**βeta co-efficient (95% confidence intervals) adjusted for age, sex and body mass index 
and with clustering of observation on subjects at phase 2 and phase 3 taken into account. 
 Bold text represents statistically significant results. 
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Shape modes at baseline, especially modes 2 and 4, also correlated with MRI-based 
hip structural changes at follow-up (Table 9-5). Mode 4 was strongly associated with 
the presence of both BMLs and high cartilage signal, and lower scores indicated a 
greater prevalence of both. It was also negatively correlated with BML size and 
effusion-synovitis size, although not the presence of multiple effusion-synovitis. 
Lower scores were also strongly associated with a greater prevalence of THR over the 
study period. A change of -1 SD in mode 4 predicted 40% greater prevalence of hip 
BMLs. Both the presence and the size of an effusion-synovitis were positively 
associated with increasing values for mode 2. Interestingly, modes 2 and 4 were both 
strong predictors of THR.  
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Table 9-5: Associations of hip shape modes at baseline with MRI based structural findings and total hip replacement (THR) at follow up. 
 
 
 
 
Hip shape 
mode 
Presence of any hip 
BMLs 
Presence of high 
cartilage signal 
 
Presence of hip 
effusion-synovitis at 
two or more sites 
THR 
 
BML CSA 
(cm2)  
 
hip effusion-
synovitis 
CSA (cm2) 
 PR (95%CI) *   PR (95%CI) *   PR (95%CI) *   PR (95%CI) *   
Correlations 
(r)‡ 
Correlations 
(r) ‡ 
1 1.30 (0.92, 1.81) 1.03 (0.92, 1.20) 1.12 (0.91, 1.40) 0.84 (0.63,1.12) 0.06 0.20*** 
2 1.22 (0.89, 1.70) 1.06 (0.96, 1.20) 1.22 (1.00, 1.50) 1.60 (1.20,2.15) 0.08 0.21*** 
3 1.12 (0.82, 1.52) 1.04 (0.93, 1.15) 0.95 (0.77, 1.20) 0.75 (0.60, 1.00) −0.00 −0.10 
4 0.60 (0.42, 0.82) 0.89 (0.80, 0.99) 1.13 (0.92, 1.41) 0.63 (0.50, 0.84)  −0.13* −0.11* 
5 0.82 (0.60, 1.14) 1.02 (091, 1.15) 0.88 (0.72, 1.08) 1.34 (0.99, 1.80) −0.09 0.07 
6 0.90 (0.62, 1.30) 0.97 (0.87, 1.08) 0.91 (0.71, 1.20) 0.96 (0.72, 1.30)  −0.07 0.00 
Independent variable: hip shape modes at baseline. Dependent variable: clinical, structural factors at follow up. 
*PR (95% CI)= prevalence ratios (95% confidence intervals) adjusted for age, sex and body mass index with clustering of observation on 
subjects at phase2 and phase3 taken into account. 
‡Correlations adjusted for age, sex and body mass index with clustering of observation on subjects at phase2 and phase3 taken into account. 
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  Figure 9-4: Summary of the results at baseline and follow up 
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Discussion 
This is the first study to link the predictive power of SSM for ROA & THR to BMLs 
and effusion-synovitis in addition to pain and anthropometric data. In this population-
based cohort, SSM was used to quantify the shape of the proximal femur and 
acetabulum. By comparing the shape at baseline with participant data at baseline and 
over the following 10 years, we have identified features of hip shape that are 
associated with both the incidence and the progression of hip OA. These associated 
features and outcomes include pain, BMLs, effusion-synovitis and total hip 
replacement. In addition, morphological variation was found between males and 
females with higher scores for mode 1 and lower scores for modes 3-6 being more 
common in males. Mode 1 represents the largest changes and is associate with 
increasing head size and femoral neck length and width (Figure 9-3).  
Baseline: Leg strength and radiographic features 
Interestingly, these modes had similar positive associations with greater hip cartilage 
volume and leg strength, even after correction for sex. Associations with ROA were 
largely negative and no association was found with pain.  Lower mode 1 scores, for 
instance, indicating a shorter, narrower femoral neck, were associated with greater 
joint space narrowing. Surprisingly, none of the first 6 modes showed any variation in 
the location of the points marking the positions of osteophytes although modes 4 and 
6 both predicted the presence of osteophytes as seen in the images. 
Decreasing scores for mode 2 identified characteristics such as increasing acetabular 
coverage, a smoother transition of the upper femoral head into the femoral neck, 
increasingly non-spherical femoral head and larger greater trochanter, some of which 
may indicate a pistol-grip-like deformity.172 At baseline, a lower score for this mode 
associated with greater prevalence of both JSN and ROA.  Lower scores of mode 4, 
with prominent features of pistol group deformity, along with higher mode 6 scores, 
which represented those with a flatter femoral head, short femoral neck and sharp 
transition of the femoral head into the neck were associated with a greater prevalence 
of osteophytes. Associations of shape modes with hip ROA have been previously 
published and variations in the shape of the femoral head, its transition into the 
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superior aspect of the neck and the length of the femoral neck have been reported to 
be associated with risk of hip ROA.170, 182-184, 259, 260   
Follow-up 
Hip pain and shape modes 
Higher scores of mode 1 and lower scores of mode 6 were associated with incident 
hip pain. Lower mode 3 scores were associated with greater prevalence and severity 
of hip pain. Lower scores of mode 3 included shorter femoral neck and sharp 
transition of lower femoral head into femoral neck. Previous studies have shown that 
morphological variations in the femoral neck are predictive of hip pain.183, 262 Modes 
1 and 6 were associated not only with radiographic features (at baseline) but mode 1 
also correlated with hip effusion-synovitis CSA (at follow-up). These factors might 
explain the associations of these modes with hip pain. Overall, our results are 
consistent with previous studies that have demonstrated associations between shape 
modes and hip pain.183, 260 
Structural changes and hip shape 
Modes 2 and 4 appear to associate strongly with structural changes in the subchondral 
bone of the hip which are risk factors for progression of OA.215, 229 For instance, at 
baseline, lower scores of these modes associated with greater JSN and prevalence of 
osteophytes respectively. Similarly, at follow-up, a low score for mode 4 predicted 
OA-related features such as higher probability of the presence of BMLs, high 
cartilage signal and correlated with larger BML and hip effusion-synovitis size. In 
contrast, greater values for mode 2 were found to be associated with effusion-
synovitis and THR. Features highlighted by both these modes corresponds to cam 
deformity and pistol grip deformity (Figure 9-3), which are well known risk factors 
for development of hip OA.172, 263 As this is the first study to identify the link between 
hip shape and structural changes such as BMLs, there are no previous data exploring 
the association; these morphological features could encourage structural changes in 
the subchondral bone and cartilage.170, 182, 259, 260 
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Higher scores of both modes 1 and 2 modestly correlated with larger effusion-
synovitis CSA and a +1 SD higher mode 2 score predicted a 22% greater prevalence 
of the presence of hip effusion-synovitis. In further analyses, longitudinal associations 
were found between baseline shape and change in hip effusion-synovitis (from phase 
2 to phase 3). Over this period, a one SD lower baseline mode 1 score was associated 
with greater hip effusion-synovitis CSA (Beta: -0.20; 95%CI: -0.30, -0.06), whereas 
no association was found with mode 2. Mode 1 thus appears to be predictive not only 
of pain but also effusion-synovitis and future studies will explore whether this is an 
early indicator of later ROA as suggested by other studies.147  
Total hip replacement and shape modes 
The same two modes that associated most strongly with MRI structural features, 
modes 2 and 4, also showed the strongest associations with hip replacement. 
Increasing mode 2 associated with increasing effusion-synovitis and decreasing mode 
4 scores also predicted increasing effusion-synovitis along with BMLs and high 
cartilage signal.  Every +1 SD change in mode 2 increased the risk of THR by about 
60% and a -1 SD change in mode 4 increased the risk of THR by about 40%.  Both 
these modes identified shape patterns related to OA such as the transition of the 
femoral head into the femoral neck, the size of the greater trochanter a flattening of 
the femoral head itself and mode 2 captured coverage of the femoral head by the 
acetabulum183. Overall, improper coverage of femoral head by the acetabulum also 
known as femoral-acetabular impingement (FAI), along with features related to pistol 
grip deformity are known to associate with greater risk of hip OA.172, 173, 263   
Limitations 
A number of limitations need to be noted. This study uses DXA images of the left hip 
while MRI-detected anomalies were measured in the right hip, so the joint 
appearances may not be directly comparable. Nevertheless, it has been demonstrated 
that OA in the ipsilateral joint strongly predicts and associates with OA in the 
contralateral joint and studies using SSM have reported similar results.264, 265 Recently 
statistical shape modelling has been upgraded to adjust automatically for shape 
variations attributable for subject positioning. One such study demonstrated that 
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proximal left and right femur were highly symmetrical.185 The effect of the internal / 
external rotation of the femur, arising from variations in patient positioning, cannot be 
ruled out and even when using standardized protocols in which the position of the feet 
is carefully controlled, this might influence the DXA images. Nevertheless, SSM has 
the potential to pick up the effects of rotation from the variation in shape during the 
development of the model.170, 175, 183 
Conclusion  
In this population-based study, two-dimensional hip shape measured on entry to the 
study is shown to be associated with not only with ROA and muscle strength at 
baseline but is also predictive of THR, hip pain, BMLs, effusion-synovitis and hip 
structural changes occurring up to 10 years later. These data suggest that different 
morphological features identified by shape modes have relevance for multiple facets 
of hip osteoarthritis, both radiographic and clinical. It adds further evidence for the 
possible use of SSM as an imaging biomarker for the incidence and progression of 
OA. 
 
Postscript  
In this chapter we demonstrated how statistical shape modelling (SSM) could be used 
to assess bone shape in a large cohort. Subsequently, hip bone shape associated with 
several factors which are relevant for hip OA. The following chapter discusses all the 
main findings presented in this thesis along with implications and future directions.  
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Chapter 10 : Discussion and future directions  
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Background 
Musculoskeletal disorders such as OA are the dominant source of chronic pain.10 OA 
has a considerable physical and psychological impact on individuals and on health 
care systems.10, 12 It’s one of the most common forms of arthritis and the hip is the 
second most frequently affected joint. Hip OA is a slow and progressively debilitating 
disease leading to pain, joint stiffness and lower quality of life which eventually leads 
to the destruction of the joint.266, 267  
Despite the large disease burden, there are no proven or totally effective strategies to 
manage and control OA. Orthodox treatments of OA remain palliative and expensive, 
and do not target disease progression. New techniques such as cartilage regeneration 
remain experimental, and there is no certainty that replacing the cartilage would halt 
the development of the disease.  
Radiographic measures for assessment of hip OA are adequate but x-rays are two-
dimensional and structures other than bone are invisible. In comparison to X-ray, MRI 
is functionally superior and is the imaging modality of choice. Treatment strategies 
for hip OA will not improve the mechanisms behind its cause, progression and 
consequences have been better investigated. The novel findings from this research 
make some important preliminary contribution to the understanding of the 
determinants of hip OA.  
The following sections describe the primary findings of the studies presented in this 
thesis followed by implications and directions for future research.   
Main Findings  
Chapter 4 outlines associations between hip BMLs, hip and knee pain and high 
cartilage signal. In this community-based population, 28% had either femoral or/and 
acetabular BML. Of these, 8% of the subjects had a large hip BML. Cross-sectionally, 
those with larger hip BMLs had greater hip pain. In longitudinal analyses, an incident 
of larger BMLs was independently associated with an increase in hip pain. 
Furthermore, resolving femoral BMLs was associated with a decrease in knee pain.  
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Chapter 5 extents the findings from chapter 4, and describes the cross-sectional and 
longitudinal associations between hip BMLs and BMD. In this study, irrespective of 
BML size, hip BMLs were associated with hip and femoral neck BMD but not with 
spine BMD. Unexpectedly, these associations varied according to site of the BML. 
For instance, femoral BMLs associated with higher femoral neck BMD, and 
acetabular BMLs associated with lower total hip and femoral neck BMD.  
Chapter 6 examines the cross-sectional associations of hip cartilage defects with 
clinical, demographical, structural and radiographic features relevant to hip OA. The 
overall prevalence of hip cartilage defects, irrespective of the extent of cartilage 
damage was 76%. In this cohort, correlates of hip cartilage defects were somewhat 
influence by sex. Greater hip cartilage damage was noted in subjects who had higher 
hip pain, greater proportion of hip BMLs, larger hip effusion-synovitis and early 
radiographic changes. Physical activity and leg strength were also associated with hip 
cartilage defects. 
Chapter 7 describes the associations of hip effusion-synovitis. Cross-sectionally, the 
extent of hip effusion-synovitis associated with higher prevalence of hip pain and 
femoral defects associated with larger hip effusion-synovitis size. Longitudinally, 
independent of each other, persistent hip BMLs and incident hip cartilage defects 
predicted 32-60% increase in hip effusion-synovitis CSA. Moreover, independent of 
presence of hip effusion-synovitis, hip cartilage defects predicted incident and 
worsening of hip BMLs and vice versa.  
Chapter 8 describes the associations between hip muscle CSA and BMD at the hip, 
femoral neck, and spine. Muscle CSA of the hip rotators and flexors were modestly 
associated with muscle strength and BMD. Hip flexors had a stronger relationship 
with BMD for women than for men. Unexpectedly, a link between gamelli muscle 
CSA and spine BMD was found and gluteus maximus showed no associations.  
In chapter 9, shape of the proximal femoral head was quantified using statistical shape 
modelling. The first six shape modes were extracted and their associations at baseline 
and over the period of 10 years were described. Most of shape modes were associated 
with hip cartilage volume and muscle strength but some were specifically associated 
with particular features of hip OA. At baseline, modes 1, 2, 4 and 6 were associated 
with radiological features. Over time, hip shape features represented by modes 1, 2 
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and 3 influenced clinical factors relevant for OA such as hip pain and hip effusion-
synovitis.  However, increasing score of mode 2 also predicted a higher risk of THR. 
Mode 4, was strongly associated with structural changes at the hip joint and also 
predicted greater risk of THR. While mode 2 showed characteristic of FAI, mode 4 
presented with features of pistol grip deformity. Overall, the shape of the hip joint is 
an important feature and this hypothesis-generating study demonstrates that 
morphological features identified by shape modes are relevant for hip osteoarthritis.  
Strengths and limitations  
Strengths 
Most of the studies presented in this thesis are novel because large population based 
studies at the hip are rare.  
 
The TASOAC cohort is a community-based study in which all subjects were 
randomly selected with equal number of men and women. This cohort is unique, as 
most of previous data on hip is based on cohorts with mild or severe hip OA and the 
severity of the disease makes it difficult to understand pathophysiology OA in such 
samples. Thus, the cohort used in this thesis is generalizable and included mostly 
healthy older adults. Such a study sample provides opportunities to examine the 
pathophysiology of the disease in preclinical stages.  
 
TASOAC is an ongoing prospective study which includes four-time points with an 
extensive set of MRI/DXA images and clinical data which was collected using 
standardized protocols. The data collected included potential mediators, effect 
modifiers, and confounders that could be used to in the analytical process. This 
provides unparalleled opportunities for combining quantitative analyses to study the 
determinants of hip OA.  
 
The study presented in chapter 9 is the first large Australian-based study to use 
ASM/SHAPE imaging software for assessing the global morphology of the hip.  
 
158 
 
 
 
The findings presented in this thesis helps to fill in a few of the gaps and improve our 
understanding of the determinants of early hip OA. 
Limitations 
Limitations relevant to each study have been described in chapters 4-9 of this thesis.  
As this is a large cohort and due to budget limitations, hip MRIs for all the 
participants included the TASOAC study were not done. Many of the associations are 
cross-sectional so one cannot determine causal pathways. In addition, many 
associations are inconsistent and/or data driven meaning replication in other cohorts is 
desirable.  
This thesis aimed to understand a few mechanisms behind development of hip OA 
and several relevant features for hip OA were measured, but there may be a few other 
unmeasured factors such as labrum (rim of soft tissue or fibrocartilage which provides 
joint stability and protects cartilage) which could also play a role in progression of hip 
OA.  
Implications  
The aim of this thesis was to study the hip as a whole and describe the associations of 
major factors involved in the pathogenesis of hip OA and if possible explain the 
conceivable mechanisms.  
Pain and BMLs 
Pain in OA is multifactorial, and this thesis we established the link between large hip 
BMLs and hip pain. Hence, BMLs are one of the potential causes for hip pain and 
may lead to referred knee pain in older adults with early hip OA. Hip BMLs associate 
with early changes in the hip cartilage.  
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Bone density and BMLs 
For the first time, a cross-sectional and longitudinal association between hip BMLs 
and local bone density was reported and established in a population-based cohort. 
Hypothetically, BMLs might represent disease pathology which includes 
demineralization of the bone. 
Hip cartilage defects  
Correlates of hip cartilage defects were extensive. In early stages of hip OA, hip 
cartilage defects not only associate with hip pain but also with several structural and 
radiological findings. Thus, structural changes in the joint are linked with the cartilage 
and may have a deleterious effect on the cartilage and vice versa. Changes in the hip 
cartilage might influence leg strength or vice versa and physical activity may be 
beneficial for hip cartilage.  
Hip effusion-synovitis 
For the first time, the associations of hip effusion-synovitis were described in a 
community-based cohort. Hip effusion-synovitis associates with hip pain, hip 
cartilage defects, and hip BMLs, but not with early hip radiographic changes. Hip 
BMLs and hip cartilage defects are co-dependent on each other and predict larger 
effusion-synovitis. Our studies suggest that in early hip OA there are shared 
underlying pathways between effusion-synovitis, hip cartilage defects, hip BMLs and 
changes in the bone which may eventually manifest as pain, inflammation, and joint 
deterioration. 
Muscles CSA, muscle strength, and bone density 
In older adults, hip muscle CSA (mostly flexors) associated with BMD and muscle 
mass modestly associates with leg strength. Biological differences in muscle mass by 
sexes and case-to-case are obvious, and this study suggests that targeted strengthening 
of certain muscles may be useful in attaining preservation of muscle mass and perhaps 
increase joint stability. 
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Bone shape and early OA 
X-rays may be adequate but are insensitive towards early signs of OA. Global 
assessment of the hip shape using SSM might be a more accurate and better way of 
predicting and tracking the progression of hip OA.170 The ASM/SHAPE imaging 
software’s can extend the application of X-ray and DEXA images in clinical practice 
as these are usually performed for older adults. SSM can be used to predict and 
identify those at higher and lower risk of developing hip OA. In general, use of SSM 
might simplify monitoring, tracking and examining bone changes in those with OA at 
the hip and/or other joints affected by OA. 
Future directions 
Observational studies 
This thesis provides an extensive (mostly preliminary) research on early hip OA. A 
population-based study including subjects with moderate to severe hip OA would be 
very beneficial. A comparison between almost healthy cohort such as TASOAC and a 
sample population with advanced disease is necessary for understanding the 
unpredictable nature of hip OA. 
BMLs play a key role in OA because they are not only linked with clinical symptoms 
but also associate with changes in the bone density. This is an interesting concept 
which requires further study. Advanced techniques such as pQCT (peripheral 
quantitative computed tomography) or Micro-CT (Micro-computed tomography) 
provide a better information about the bone structure and cover several parameters 
determining bone health.151 A study, using these techniques and comparing the 
differences in bone health in those with or without BMLs could provide further 
insight in to the pathophysiological mechanisms between BMLs and BMD.  
Another method which could aid in understanding the relationship between 
subchondral BMLs and BMD is by using Active Appearance Models (AAM)268, 269 
Unlike ASM, AAM models are designed to identify differences in the quality or 
texture of bone. Such statistical shape models have been successfully applied to 
predict hip fractures. This method may not provide as many measurements as pQCT 
and Micro-CT, and is dependent on the quality of x-ray or DEXA images, but it is 
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economical and can be applied in cohorts where the data is already collected.  In 
general, finding from such studies could highlight the fact that BMLs present in OA 
could be a potential target for future interventions.  
Cartilage is at the heart of the disease process in OA, but studying hip cartilage is 
challenging. Applying methods such as T2 mapping and SSM could aid in 
quantification of hip cartilage. There is current evidence that both T2 mapping and 
SSM can be applied to produce 3D models of the knee cartilage270. Such data cannot 
be derived from traditional semi-quantitative methods. A pilot longitudinal study 
investigating cartilage using 3D models could provide the whole picture of the extent 
of cartilage damage in both symptomatic and asymptomatic subjects.  
Hip effusion-synovitis still remains under-investigated. Several researchers have 
reported the roles of knee effusion-synovitis.134, 143 Although, our study in chapter 7 
highlights the correlates of hip effusion-synovitis, further research exploring the role 
of hip effusion-synovitis are needed. Future studies using advanced imaging 
modalities such as gadolinium to assess hip effusion-synovitis could be useful in 
understanding the extent of the role of joint fluid in hip OA.  
SSM models can be modified to identify other risk factors of hip OA such as FAI 
(femoroacetabular impingement) in young and older adults.  
 
Clinical trials 
In the preliminary research conducted in this thesis, several structural abnormalities 
such as BMLs, cartilage defects, effusion-synovitis and high cartilage signal were 
identified. A clinical trial investigating if interventions targeting one structural 
abnormality also reduces/effects of other structural abnormalities. Also, to identify if 
separate or combination of interventions would be required to slow down the 
structural damage. 
Clinical trial aiming to examine longitudinal relationship between hip cartilage, hip 
muscles, and physical activity. Such longitudinal study could identify the benefit or 
risk of various types of physical activity, and can include young and older adults. 
 
162 
 
 
 
Conclusions 
Overall, structural changes are slow and relatively uncommon in the preclinical stages 
of hip OA. Nevertheless, hip BMLs, hip cartilage defects, high cartilage signal and 
hip effusion-synovitis are inter-related and contribute to changes in the subchondral 
bone; with a probable role in the pathogenesis of hip OA. Additionally, muscle bulk 
and strength could aid in the preservation of bone density and assessing bone shape 
using ASM could benefit in improving assessment and monitoring of disease 
progression and identifying those at higher risk of OA.  
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Chapter 12 Appendices  
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Appendix I: An example of Western Ontario and McMaster Universities 
Osteoarthritis (WOMAC) index for assessing hip pain. 
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Appendix II: An example of Western Ontario and McMaster Universities 
Osteoarthritis (WOMAC) index for assessing knee pain. 
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Appendix III: An example of pedometer dairy used in TASOAC Phase 2  
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Appendix IV: An example of pedometer dairy used in TASOAC Phase 3  
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